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.IONIZING RADIATION
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Operational evaluation of the radiation hazard to man is dependent on the
nature and tlming of the radiation flux incident on the vehicle, the compo-
sition and three-dimensional thickness of the shielding, the geometrical
position of the human behind the shielding, the self-shielding of the body, the
current-to-dose conversion factors in the body, and the pathophysiology of
radiation damage. The following are data which may be used for calculation
of specific organ doses, radiation shielding, and mission risk-hazard analysis
for man. Emphasis will be placed on the interaction between radiation and
man. The physical nature of space radiation and the molecular aspects of
radiobiology will be covered only as they contribute directly to the evaluatlon
of radiobiological risks and operational problems.
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SPACE RADIATIONS
The physical nature of the radiation environment has received much study
and review. Space radiation can be defined as falling into three categories:
primary cosmic or galactic radiation; the geomagnetically trapped radiations
of ti_e Van Allen belts; and solar wind and flare events. Cosmic radiation is
now preferably called galactic radiation to distinguish it from trapped radia-
tion and solar-particle fluxes. The current hypotheses assume that these
nuclei have traveled for eons in galactic space, gradually being accelerated
in turbulent magnetic fields or arise from supernovas or other events near
the center of our own galaxy. The galactic radiation spectrum has been
described in great detail but is continually changing as new data are obtained
from geophysical satellites and other sources (87, 90, 16Z, Z43). Table 3-16
preser, ts the composition of the primary cosmic-ray flux outside the atmos-
phere at northern latitudes. The truly primary galactic radiation (i. e., the
flux contalning no secondaries produced locally in a compact absorber),
consists of 85 percent hydrogen nuclei (protons, 14 percent helium nuclei
(alpha particles), and l percent of the heavler nuclei up to iron (Z = Z6) as
regular constituents and so-called superheavy nuclei beyond iron occasionally
recorded. These particles transfer energy to matter by ionization along their
pathway, by terminal absorption ("thindowns'), and by inelastic collision
("star formation">, which result in highly localized areas of very dense ioniza-
tion. The intensity of galactic radiation in the vicinity of the Earth varles
with the ll-year solar cycle, with magnetic storms, and possibly with the
appearance of supernovae near the solar system.
Trapped particle radiation is a problem in the Van Allen belts, where
protons and electrons are injected and trapped in the Earthls magnetic field.
Though the topological conditions and direction of injection are still obscure,
it is currently thought that the trapped particles arise from protons and
electrons from the primary cosmic-ray beam backscattered from the Earth's
atmosphere - the source of the bulk of this component is neutrons decaying
into protons and electrons; protons from the solar wind; and primary cosmic-
ray protons, which are assumed to be of minor importance.
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Estimation of exposures during space flight in these toroidal belts is
most difficult because of the complicated geomagnetic and particle interactions
determining the geometric distribution of the radiation. Magnetic storms
can influence the nature of the belts (163, Z35 , Z96 ). The inner belts contain
not only protons, but sizable fluxes of soft electrons of natural origin and
from fission electrons injected into the trapping region by high altitude nuclear
weapons testing.
A summary of the particles' energies has been recently presented from
/
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which the following data are taken directly (145). In going vertically up from _" '_
sea level at the geomagnetic equator, the flux of trapped protons in the inner ! _ii/ i
belt is found to start rising sharply at I. 16 Earth radii (about 1,000 km _ ..... _ • _
altitude above sea level) and reaches a first maximum at I. 5 Earth radii _ • _• .... i•i
(3, 185 kin), with an integral flux of slightly more than I0,000 protons/cm Z ii_i/i _
sec of 40 MeV minimum energy. In the heart of the inner belt, a flux of
2,000 protons/cm Z sec per unit solid angle in the energy interval from 40 to
ii0 Me\ r, corresponds to a range interval in aluminum from 2 to 12 g/cm Z.
Since the radiation sensors on Relay I discriminated fluxes only in the energy
intervals from i. I to 14 MeV, from 18. 2 to 35 MeV, and from 40 to ii0 Me'v _,
the slope in the last interval can only be inferred indirectly by extrapolation
plotting df the three flux fractions. The flux then drops slightly and reaches
a second flat maximum smaller than the first one at Z. Z Earth radii and
finally drops below 100 protons/cm Z sec at Z. 8 Earth radii. The correspond-
ing altitude profiles toward higher magnetic latitudes show gradually smaller
fluxes up to geomagnetic latitude 37. 5° , which marks the boundary at which
the fluxes of high-energy protons and electrons drop to insignificant levels.
A phenomenon of special importance for satellite missions in near-Earth
orbits is the so-called South Atlantic anomaly. It is a region where the
mirror points of the trajectories of trapped protons in the inner belt dip
down more closely to the Earth than at any other longitude, due to an asym-
metry of the geomagnetic field. Dose rates below i. 5 g/cm Z shielding come
close to i00 mrads/hr at altitudes as low as IZ0 miles, as direct dose-rate
measurements on the Gemini IV mission indicate. Since the point of inter-
section of a satellite orbit with the geographic equator continuously drifts
westward due to the rotation of the Earth, any mission comprising a large
enough number of revolutions passes through the anomaly on some orbits.
Although the time of a single passage is less than 15 rain and the accumulated
passage time on a mission of many orbits remains well below I0 percent of
the total time in orbit, the proton exposure in the anomaly accounts for more
than 90 percent of the total exposure. The accumulated exposure in the
anomaly will be a limiting factor for long-duration, low-orbital missions.
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A large fraction of the artifically injected electron fluxes shows lifetimes
of at least several years, and it might still take 30 years for the natural •
radiation levels to be restored. It now seems reliably established that elec- J
irons injected into regions of L<l. Z Earth radii, corresponding to an altitude
of I, 275 km above sea level at the geomagnetic equator, are rapidly removed
by the Earth's atmosphere. Electrons injected into L regions beyond 1.7
(4,460-kin altitudes) are also removed comparatively rapidly by magnetic
fluctuations due to solar activity. These are the same fluctuations that cause
3-2
r
the large variations of natural flux levels noted above. In the intermediate
altitude reglon between I. Z and 1.7 L, however, artificially injected electrons
become semipermanently trapped with I/e decay times of the order of 5 to
i0 _ears. In January 1963, the flux at I. 5 g in the plane of the geomagnetic
equator was 5 x 108 electrons/cm 2 sec for the energy band from about 0. 5 to
5 _4e\_ a_d i. 5 x 107 electrons/cm Z sec for the band higher than 5 MeV. The
combined exposure hazard from protons and electrons in the heart of the
artificial electron belt, which happens to coincide with the heart of the
natural inner proton belt, v_.as predominantly due to electrons 6 months after
creation of the artificial belt. Whereas the decay times for the fluxes in the
outer regions and the inner fringes of the artificial belt are on the order,
respectively, of months and weeks, they grow to the order of at least several
years in the center of the belt. In the natural outer belt of electrons, fluxes
show large irregular fluctuations. At 4. 0 Z (sea-level altitude of 3 Earth
radii at the magnetic equator), peak electron intensities closely approach the
ma>:i:T_um values found in the heart of the artificial belt at i. 5 L.
Models of the trapped radiation environment are available as are com-
puter codes for their use in establishing dose rates (91 , 184, Z84, Z85).
Solar alasma comes from the Earth in three ways: the solar wind, solar
corpuscular streams, and solar flare emissions or plasma shells. Solar
wind Is a perpetual outflow from the solar corona all over the sun. The solar
wind is distinguished from the other two flows which are called ejected flows.
The magnetic fields and low energy particles of the solar wind have been
recently reviewed (163, 195, 235 ). The solar wind does not appear to repre-
sent a significant human hazard.
The solar corpuscular stream is an intermittent emission continuing for
weeks and months, apparently from the same reglon of the sun. These spiral
streams interact with the solar wind and the cosmic galactic radiation (163).
The solar flare emissions are of much shorter duratlon, usually lasting about
an hour or less. The solar ejected flows vary from one event to the next in
the differential energy spectrum and intensity of the proton and alpha particles.
Anal)ses of these spectral data are available ( 14 , 30 , 93 , 14Z, 162 , 242,
295). The proton:alpha flux ratio for equal rigidity intervals in four events
were i:I and in 3 events were >5:1. Calculations of the exponential rigidity-
flux relationship and rigidity-kinetic energy relationship for the time-inte-
grated spectra are available (184). Values of Po or characteristic rigidity
are uniformly distributed between 45 and 150 mV for all events of solar cycle
19 when the largest solar particle events were recorded. (See discussion
of Table 3-33). The typical characteristic rigidity is i00 mV and may be
used for first-order dose computations. Data are now available on large
events during the quiet sun period (Z37).
ReViews of Soviet studies on the geophysical aspects of space radiations
are available (35 , 255).
z -.,
K •2"i_
r r • k
k
r k.
_ • • • _. / r/ ¸
_k ¸ _
3-3
... ..
NOMENCLATURE AND DOSAGE FACTORS
The basic terms for expressing the exposure field and absorbed dose of
radiation are seen in Figure 3-1. RBE {relative biological effectiveness)
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expresses the effectiveness of a particular type of radiation in producing the
same specific biological response as 250 kVp X-radiation or gamma radiation
having a linear energy transfer (LET) equivalent to 3. 5 kilovolts per micron of
water and delivered at the rate of about I0 rads per minute. When an RBE is
used not for a specific biological endpoint but for general considerations of
health protection, it is referred to as QF or quality factor (41). The exact
degree of relative effectiveness is dependent also on the criterion of effect,
the tissue or organ of interest, the dose rate, and whether the response is
early or delayed (41 , 76 ). High-LET radiations (arbitrarily taken as those
radiations having a mean LET greater than 3. 5 keV/_) are more effective
per rad thar: the conventional x and gamma rays normally used as standard
radiations. For late or delayed effect of low dose rate, the QF-LET relation-
ship shown in Table 3-2 has been proposed (IZZ). To a first approxlmation,
Table 3-2
Values of CIF L for Late or Delayed Effects as a Function of Average LET
(After ICRP (122)
LET.
(ke%/_, IN WATE_) QF
X raw and ch'ctrolls of any I.LT
35 or less I
3.5-7 1-2
7-23 2-5
23-53 5-10
53-175 10-2[I
this relationship may be represented as:
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QF = 0.8- 0.16E (1)
L
where Z is the mean LET in keV/u. No official committee or organization
has made specific recommendations with respect tothe OF-LET relationship
for early effects. Accurate calculation of the biological effect should refer to
detailed LET spectra where available.
in general, early responses to large doses delivered at high dose rates
are less dependent on LET than are late responses to low doses at low dose
rates. The relationship generally follows the equation:
QF E = 0.9 + 0, 05 _ (Z)
For gross evaluation it is suggested that the general QFE-LET relationships
shown in Table 3-3 be applied to early responses from high-intensity space-
radiation exposure (145). For computer programming of more exact dosage
Table 3-3
Suggested QF E Values for Early Effects of High-Intensity Space-Radiation Exposure
(After Langnam (ed.)-NAS-NRC (145))
COMPONENT QF
Skin responses Low LET (_ 3.5 kcV/.a) I
High LZT (> 3.5 keV/.a) 3
prodromal syndrome Total flux l
Hematological responses Total flux I
Lethality, hematological Tota] flux I
s_,ndrome
Lethality intestinal Low LrT _3.5 keV/a) I
syndrome High Lr-•r (> 3.5 keV/t_) 3
Atroph_ of germinal Low _.'r (=< 3.5 keV/_) 1
epithelium H _gh LET (> 3.5 keV/.a) $
- . . . ,. :
? _ - .
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schedules under operational conditions, more specific energy-LI_T-CF
relationships can be used when available. It must be kept in mind that RB_,,
or QF is dose-rate dependent (41 , 76 ). In general, radiation of low LET
tends to be more sensitive to dose rate factors than does radiation of high
LET. Particles of high LET may have higher RBE or QF at low dose rates
than at higher dose rates. Specific examples will be noted below. In all
cases, the biological dose equivalent for late and early responses should be
calculated separately.
Examples of I_BE or QF values for late effects at low dose rates used
in ground laboratories are seen in Table 3-4. In some animal studies, RBI_ls
of over 35 have been reported for genetic changes after neutron irradiation
(251). At high dose rates, the QF_ of Table 3-3 may be used for neutrons
and the other radiations of Table 3-z4 (134).
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Table 3-4
Typical QF L for Late Effects at Low Dose Rate in Ground-Based Exposure
. -h . . ,
Type of radiation RBE or OF
X- rays 1
Gamma rays I
Beta particles, l.O mev l
O. l mev l
Neutrons. thermal energy 2.8
0.0001 mev 2.2
0.005 mev 2.4
• 0.02 mev 5
0.5 mev 10.2
1.0 mev 10.5
10.0 mev 6.4
Protons greater tnan 100 mev 1 -2
" 1.0 mev 8.5
0.1 mev 10
Alpnaparticles, 5 mev 15
1 mev 20
For more specific calculations of organ doses in experimental ground-
based studies, the energy-LET-QF relationship will be covered in more
detail below.
Reference Equivalent Space Exposure (RES)
Quantitative evaluation of the factors that modify radiation responses is
singularly the greatest uncertainty in establishing human response criteria
for space radiation exposure. The most obvious modifying factors are radia-
tion quality, dose rate (as influenced both by protractlon and fractionation),
and dose distribution (both topical and depth). For space applications it has
been suggested that "dose equivalent" in"rems" used in conventional occupa-
tional radiation protection, be replaced by "reference equivalent space
exposure" (RES) in "reference equivalent units" designated "reu" (145).
Conceptually, the method of evaluation is the same as that employed in con-
ventional radiation protection. The space radiation dose (D) is multiplied
by a radiation quality factor (QF) and subsequently by other appropriate
modifying factors to give the reference equivalent space exposure:
RES (reu) = D (rads) x QF x (fl " f2 "'" fn )' (3)
where f.... f are the appropriate modifying factors for early vs. late effects,
£ n
dose protractlon, and dose distribution of the particular response being
evaluated. In principle, this procedure is applicable to evaluation of both
early and late radiation responses. However, inadequate knowledge of the
quantitative influence of the relevant modifying factors such as dose dis-
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tribution and dose protractlon and their interdependence necessitates the
choice of a set of values for each specific situation on the basis of rather
arbitrary slmplications and generalizations.
Dose Distribution Factors
Dose distributlon in space radiation exposure will be highly non-uniform
with respect to depth, area, volume, and region or organ systems exposed.
More detailed evaluation will be made for each organ system. At present,
only very arbitrary simplifying generalizations will be made.
With respect to depth-dose distribution the acquired dose is calculated
or measured at the average depth or anatomical site (volume) of interest for
the particular response. The point of interest for skin responses is at a
depth of 0. 1 ram; for hematological depression, a depth of 5 cm; for hemato-
po_e'_ic and gastrointestinal lethality, a depth of 11 cm; and for prodromal
response and general physiological injury a 1 5-cm diameter sphere in the
n_id-eplgastric region. At these depths the penetration factor (fp) will be
considered to be one.
Vfith regard to region or volume exposed, it has been suggested for pro-
dromal, hematological and early lethal responses a dose involving a major
portion of the trunk be considered as capable of eliciting full response and be
assigned a "volume factor" (fv) of one (145). Exposure of the extremities
exclusive of the trunk would be much less effective. Based on fraction of
total body mass and active bone marrow, an arbitrary choice of a fv of i/5
mlght be suggested for the extremities when only the hematological response
is considered.
Sk__n and germinal epithelium responses must be considered specifically.
A severe response of even a small skln area, regardless of location, could
be highly uncomfortable particularly under a space suit. Furthermore, dose
values are usually established for skln areas of _35 to I00 cruZ; and early
ery_herna and desquamation are somewhat area-dependent up to _300 to 400
crn-. The area-effect over this range amounts to an increase in effective
dose of_Z5 percent. It is suggested, therefore, that an area-effectlveness
factor (fa) of _i. 25 be applied to the doses given when exposure involves
skin areas greater than _150 cm Z
In the case of the germinal epithelium response is considered a local
effect. ]Because of the limited size and localization of the testicles, it is
reasonable to assume that they either will or will not be in the exposure field
in which case fv w111 either be unity or zero. In n_entlonlng the germinal
epithelium it is emphasized that the response in this case is considered of no
significance in evaluating rlsk of early performance decrement but may have
social or emotional significance to the astronaut.
, _r r¸ / k-
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Dose Protraction
The effect of dose protraction has been studied to some degree for most
of the earl\" slgns and symptoms ( 32, 41 , 73 , 148 , 172, 191 , 201 , Z05,
ZZ8, Z31 , 238 ). Some suggestions are possible regarding general "dose-
effectiveness' factors (fr) tha' are useful for exposure periods up to three or
four weeks. To derive the factors, it has been assumed that the decrease per
rad in biological effect associated with a dose-rate decrease can be compen-
sated for by an increase in total dose required to produce the given effect
(145}. Thus the ratio of total doses required for low dose-rate versus high
dose-rate exposure will determine the "dose-rate-effectiveness" factors.
This is not the same as taking a ratio of dose rates, however, since for some
tissues the latter may change by a factor of I0 or more while being accom-
panied by a change in effect of only about 2. There is also considerable dif-
ference in protraction period over which the change from maximum to mini-
mum effect occurs in the various tissues and systems.
Table 3-5 attempts to encompass all of these variables for exposure
periods varying from a few hours to a few weeks with respect to total doses
Table 3-5
Suggested Dose-Rate or "Rate-Effectiveness" Factors (fr) for Early Responses
Following Exposure to Low-LET Radiations at High Intensity. (See text for specific definitions)
(After Langham (ed.)-NAS-NRC (145))
Duration of Exposure to Produce Same Response Level
Skin Er ythema Hematological
and Prodromal Depression and
Desquamation Signs Lethahty
A. }{igh Dose-Rate
Duration of Exposure for l - 2. hours
Maximum Effectiveness or less
B. Low Dose-Rate
Duration of Exposure tor 4 - 6 days
Minimum Effectiveness or longer
Ratio of Total Doses to Produce
S,_me Response Level (B/A) 3
Rate-Effectweness Factor
(fr) 1/3
2 - 4 hours i - 2 days
or less or tess
2 - 4 days 3 - 4 weeks
or longer
2.5 2
I/2. 5 1/2
-. " , .
2 - -
:ii
high enough to elicit the more slgnificant early responses. The rate-effec-
tlveness factors (fr) are glven as the reciprocals of the ratios of total doses.
In general, "maximum dose" implies no repair is possible. For the pro-
dromal syndrome, fractionated doses longer than 7 days apart can be con-
sidered as single doses with no residual effects from the prior doses. For
the hematological syndrome, the range of population sensitivity will spread
with prolongatlon beyond 3-4 weeks and an increasingly larger fraction will
show no effects as the doses are separated by longer intervals. The terms
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"high" dose rate and "low" dose rate are difficult to define for all situations.
What is considered a high and a low dose rate for early responses might be
quite different from high and low dose rates for progressive and late responses.
Furthermore, a high and a low dose rate for early skin responses might be
different from those for early hematological and prodromal responses. In
general, Table 3-5 attempts to take these variations into consideration for
the important early responses. As an example of the use of this table, a
given prodromal sign (e.g., nausea) may have a i0 percent probability of
occurrence following an exposure of 50 fads delivered over 2 to 4 hours (dose
rate 12 to 25 rads/hr), while an exposure of 125 rads (2. 5 x 50) would pro-
duce the same probability of response if the dose was protracted over 2 to 4
days (dose rate 30 to 60 rads/day). It is suggested, therefore, that the space
radiation dose (D) be multiplied by the appropriate rate-effectiveness factor(fr) from Table 3-5 to evaluate RES when exposures are protracted over
periods comparable to those specified.
Radiation recovery rates are influenced by LET and for this reason, the
fr values given in Table 3-5 are specified for low-LET radiations. Techni-
cally, the rate-effectiveness factors should be applied only to the low-LET
components of space radiation. Correction of fr for LET appears unnecessary
under shielding conditions that result in only a small fraction of the absorbed
dose at the site of interest being delivered at high LET. Information on early
skin responses suggests, however, that the slopes of the time-dose response
curves decrease with increasing LET. For early skin responses under ex-
posure conditions of very light to nominal shielding, where from _ i0 to,-_75
percent of the absorbed dose at 0. l-ram depth from solar flare events may be
due to densely ionizing components, adjustments should be made by assum-
ing fr is unity for that fraction of the dose delivered at or above some arbi-
trary cut-off for high LET e.g.,_ 15 keV/_/.
Application of the information given in this section to an evaluation of a
risk of early performance decrement may be illustrated (using skin erytbema
as the early response) by a hypothetical mission during the triplet solar flare
event of July i0-16, 1959. No attempt is made to make the assumptions con-
form necessarily to the actual conditions. If it is assumed that the average
effective shielding of the spacecraft was 2 g/cm 2, the accumulated skin dose
(D) during the 6-day period of the triplet flare would have been 674 fads.
Let it be assumed also that the QF E was 1.45, the skin area involved was a
major portion of the front surface of the body, the dose received was mea-
sured at a depth of 0. 1 mm, and 25 percent was delivered at a LET of
>15 keV/_. Under these conditions, QF E = 1.45, fa = 1. 25, fp = l, and fr =
(i/3 x 0. 75 + 1 x 0. 25) = 0. 5. The reference equivalent space exposure,
evaluated from Equation I would be:
RES = 674 x 1.45 x 1.25 x l x 0. 5 = 610 reu.
Since 1 reu is equivalent in effectiveness to 1 rad of reference radiation,
comparison of lIES with the reference radiation dose-response relationship
given in Table 3-47 suggests that the probability of an erythema response
under the specified conditions would have been of the order of 50 percent.
kj• . - r ¸_ :
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Since most exposures to radiation in space flight are expected to be at
low dose rates, the dose factors noted for early effects following high dosage
of radiation must be modified. Under space flight conditions a gradually
accun_ulating injury to the bone marrow may be expected. Since injury and
recovery may be concurrent for long periods of time, the dose distribution and
protraction factors applied to acute injury cannot be directly applied to this
situation. Suggestions for dosage factors covering these "progressive per-
formance decrements" will be presented in a separate section below. Dosage
factors for late or delayed injury following acute exposures will also be
covered as a separate entity.
INTERACTION OF RADIATION WITH BIOLOGICAL MATERIALS
In order to calculate the rate of energy transfer, QF or RBE_ tissue
range, and stopping power of space radiations, data are needed on the inter-
action with tissue. Since the bulk of absorption takes place in bone or muscle,
n_uch of the data have been generated for these model tissues. Table 3-6
represents the model composition of muscle and bone which can be used in
the many calculations noted above.
To apply the general purpose nucleon transport codes to the calculation
of usable current-to-dose conversion factors of sufficient generality of
application, the nuclear density must be known. A tissue of composition
C- M O N- with a density of 1 gm/cm 3 results in the nuclear densities
Z1 140_ 57 3
seen in ±a-]Jle 3-7. The average ionization potentials can be used in the
stopping-power formulas for the computation of particle ranges in tissue.
Energy-LET and Quality Factors
The stopping power and rate of energy loss given as MeV/cm or keV/
micron (LET) for protons in standard muscle and bone is given in Table 3-8.
The caiculations of DE/DZ, DE/DX, and LET (127) were made from the
ICRU data of Table 3-6 (190), and the energy loss equations of references
II , 17 , and 218. The resulting information can be applied to the dosi-
metric measurement of the protons found in the space environment and can
be used in the design of tissue-equivalent radiation detectors. Similar data
on proton path length, straggling factors, percent scattering, and probability
of inelastic nuclear interaction are available for n_uscle and other materials
(125).
When particles of high energy pass through solid materials, star forma-
tion occurs with the release of many nucleons and mesons of different type.
These stars are not as frequently generated in biological materials because
of the low _ values. The secondary particles from wall materials can pass
through biological tissue. Tables 3-9 and 3-i0 represent the stopping power
and range of muons, pions, kaons, and protons in muscle and bone for a
wide range of energies. Powers of i0 are indicated by the symbol E; e.g.,
i. 234E02 means i. 234 x 10 2 . The mean excitation energy, ladj, (in eV) is
indicated by the symbol I. These data for protons replace previous data
3 -i0
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Table 3-6
Composition of ICRU Muscle and Bone
Data compiled by Janni (127) from the Report of the International
Commission on Radiological Units and Measurements (ICRU)(190))
Muscle*
Atomic Atoms/ Percent Atomic
Element number molecule _
H 1 10 11905 10.20 1 0|
C t) 1, 02415 12 30 12.01
N "; 0. Z4986 3 50 t4 01
O e, 4. 55625 72. 90 It, 00
Na 11 00348 0 08 23 O0
Mg 12 t 00082 v.02 24 33
p 15 0 0J64b . 20 30 9_
r_0 32, 07
S ,,b _ Ulqg9
- 3( 3a. ] i
E IQ ., 007u-
C,, ,10 00 i 7 .... 4t, u_'
| :.: ..
. ....
b. Bone**
Atomic Atom s Pe r c ent Ato _11_
Eiei_ent nun_ber moleCUle _
H I 6 3491 o, 40 1. 01
C 6 2 31474 27 80 12 01
N 7 ] 19275 2.70 14 Ol
O g 2.5625 41.00 lb.00
Mg 12 0.00822 0 ZO 24 32
p 15 0.22599 7 00 30 97
S 16 C.00628 0 20 32 07
Ca 20 O 3667- 14.70 40.08
-- Dcnsltv oi muscle is . gram per gn- cm 3
3
"" Dt, nslty of bone is 1 85 gram per gm/cm
etectron det, sitv 3. 313 x i023 electrons grn
electrondenslty 3 193 x 1023 electrons/gin
Table 3-7
Composition and Mean Excitation Potentials
for Model Tissue
(After NBS (189), Kinney and Zerby(139))
Element
Nucleon density 2
{nucle_./crn-) x 10 -4
Mean excltatxon
potential.
eV
H 6 265 x 10 -2 17.5
O Z 55075 x 10 =2 99,0
C 9.3975 x 10 -3 74 44
N l. 3425 x 10 .3 86 0
3 -ii
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Table 3-8
Stopping Power and Rate of Energy Loss of Protons
in Standard Muscle and Bone
(After Janni (127))
ICRU Muscle
PRUTON
ENERGY OE/DZ DEIOX L E T
MEV MEV CM21GM MEVICM KEVIRICRON
0.50 4C8.62 408.62 40.86
0.60 365.03 365.03 36.50
0.70 331.02 331.02 33.10
0.80 302.30 302.30 30.23
o.go 279.13 279.13 27.ql
l. O0 259.74 25q.74 25.97
2.00 158.7C 158.70 15.87
3.00 117.37 117.37 ll.7k
4.00 94.26 94.26 9.43
5.C0 79.28 7q.28 7.93
6.C0 68.72 68.72 6.87
7.00 60.83 60.83 6.08
8.00 54.67 54.67 5.47
lO.O0 45.73 45.73 4.57
20.00 26.08 26.08 2.61
30.00 18.76 18.76 1.88
40.00 14.87 14.87 1.4q
50.00 12.44 12.44 1.2_
60.C0 ]0.77 10.77 I.OR
80.00 8.62 8.62 0.86
100.00 7.28 7.28 0.73
200.00 4.49 4.49 0.45
300.00 3.51 3.51 0.35
400.00 3.03 3.03 0.30
500.GO 2.74 2.74 0.27
800.00 2.33 2.33 0.23
ICO0.O0 2.21 2.21 0.22
_- .
)
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Table 3-8 (continued)
b, ICRU Bone
PROTON
ENERGY
MEV
0.50
0.60
0.?0
0.80
0.90
l. O0
2.00
3.00
4.00
5.00
6.00
7.00
8.00
lO.O0
20.00
30.00
40.00
50.00
60.00
80.00
I00.00
200.00
300.00
400.00
500.C0
800.00
ICO0.O0
DEIDZ
MEV CM2/G"
369.42
329.59
2qR.75
273.26
252.56
235.24
164.9l
107.65
86.68
73.02
63.41
56.2l
50.58
42.38
24.2g
17.5l
13.90
11.64
10.09
8.08
6.83
4.22
3.31
2.85
2.5R
2.20
2.08
DF/DX
MEVICM
683.43
60q.7S
552.6g
505.53
467.25
435.1q
268.08
lqq. IS
160.36
135.10
lt7.31
103.99
93.58
78.41
44.94
32.40
25.72
21.54
L8.67
14.95
12.64
7.80
6.12
5.27
4.77
4.06
3.85
LET
KEVIMI CRON
68.34
60.q7
55.27
50.55
46.72
43.52
26.8[
lq.qt
16.04
13.51
I1.73
I0.40
g.36
7.84
4.49
3.24
2.57
2.15
1.87
1.4g
1.26
0.78
0.61
0.53
0.48
0.61
0.3g
.... k
• ' t _ • _:",: _i',
1
J
3-13
• /i/¸ .... r
L '_, / ::i / / t _ _ •
Table 3°9
Stopping Power, MEV/CM2/G
(See text for explanation of symbols)
(Adapted from Berger and Seltzer ',24))
MUON PION KAON PROTON
ENERGY MUSCtE BONE MUSCLE BONE MUSCLE BONE MUSCLE BONE
_EV I= 66.2 I= 85ol I= 66.2 I= 85.1 |- 66°2 Is 85.1 l- 66.2 |= 85.1
2.901E 0[ 2.b80E 0[ 3.638E O1 3.353E 01 1.029E 02 g.356E O1
1,651E Ol 1.533E 01 2.070E Ol [.gIBE O1 5,7_0E 01 5.232E O1
1.193E Ol I.IIOE O_ 1.491E 01 1.385E O1 4.[58E O1 3.827E Ol
9.520E O0 8.870E O0 1.185E Ol 1.102E Ol 3.293E Ol 3.038E 01
8.023E O0 7._83E OO 9.939E O0 9.258E O0 2.746E Ol 2.538E O1
6.256E O0 5.842E O0 7.680E O0 7.164E O0 2.088E Ol 1.935E Ol
5.243E O0 _.901E O0 6.380E O0 5°957E O0 1.703E Ol 1.581E Ol
_.5_7E O0 _.290E O0 5.533E O0 5.170E O0 1.448E Ol 1.34bE Ol
4.127E O0 3.862E O0 4.g3bE O0 4.615E O0 1.267E Ol 1.179E 01
3.787E O0 3.545E O0 _._94E O0 4.20_E O0 1.131E Ol 1.053E Ol
3.526E O0 3°302E O0 4.153E O0 3.886E O0 1.025E Ol 9.549E O0
3.319E O0 3.10BE O0 3.882E O0 3.634E O0 g._03E O0 8°762E O0
3.152E O0 2.952E O0 3.662E O0 3.429E O0 8.705E O0 8.115E O0
3.015E O0 2.825£ O0 3.480E O0 3.259E O0 8.122E O0 7.574E O0
2.901E O0 2°718E O0 3.326E O0 3o114E O0 7.627E O0 7. L15E O0
2.682E O0 2.513E O0 3.034E O0 2.842E O0 6.663E O0 6.220E O0
2.531E O0 2.368E O0 2.827E O0 2.649E O0 5.962E O0 5.569E O0
2,421E O0 2.266E O0 2.672E O0 2.504E O0 5.429E O0 5°073E O0
2°337E O0 2°188E O0 2.556E O0 2,390E O0 5,OIOE O0 _°683E O0
2.272E O0 2.128E O0 2.465E O0 2,306E O0 4.671E O0 4.369E O0
2.222E O0 2.08IE O0 2.39[E O0 2.238E O0 4°393E O0 4,IOgE O0
2.182E O0 2.0_4E O0 2°331E O0 2._83E O0 4.159E O0 3.892E O0
2.|50E O0 2°014E O0 2.282E O0 2.137E O0 3.961E O0 3.707E O0
2.123E O0 1.989E O0 2°241E O0 2°099E O0 3.790E O0 3°549E O0
2.102E O0 1,958E O0 2.207E O0 2.067E O0 3.642E O0 3.411E O0
2°084E O0 1°951E O0 2.178E O0 2.040E O0 3°513E O0 3.290E O0
2.069E O0 1.937E O0 2.154E O0 2.017E O0 3.397E O0 3.181E O0
2.057E O0 1.926E O0 2.133E O0 1.998E O0 3.296E O0 3,086E O0
2°047E O0 1.916E O0 2.115E O0 1,981E O0 3.205E O0 3.002E O0
2.039E O0 I°908E O0 2.099E O0 1.96_E O0 3,123E O0 2.925E O0
2.026E O0 I°896E O0 2.074E O0 1.942E O0 2°983E O0 2°794E O0
2.018E O0 1.889E O0 2.055E O0 1.924E O0 2°86bE O0 2.686E O0
2.012E O0 1.885E O0 2.0_IE O0 1.9[OE O0 2.TbBE O0 2.593E O0
2.009E O0 1.882E O0 2.031E O0 1.900E O0 2.SB3E O0 2.515E O0
2.008E O0 Io881E O0 2°023E O0 1.893E O0 2.613E OO 2.449E O0
2.008E O0 1.882E O0 2,017E O0 I°888E O0 2.55|E O0 2.386E O0
2.009E O0 1.883E O0 2.013E O0 [.885E O0 2.498E O0 2.337E O0
2.010E O0 I,885E O0 2.010E O0 1.883E O0 2.451E O0 2.293E O0
2.013E O0 1.888E O0 2.009E O0 I.B82E O0 2.409E O0 2.254E O0
2.G15E O0 1.891E O0 2.008E O0 1.881E O0 2.372E O0 2.220E O0
2.0
4°0
b.O
S°O
I0.0
14.0
18.0
22.Q
25.0
30.0
3_,.0
38.0
_,2.0
4,0.0
50.0
60.0
70.0
80°0
90.0
I00.0
110.0
120.0
130.0
L_,O. 0
150,0
160.0
170.0
180.0
190.0
200.0
220.0
2_0.0
260.0
280.0
300.0
320.0
_,0.0
360,0
380.0
_00.0
1.679E 02 1.513E 02
9.876E O1 8.980E Ol
7.049E O1 0.424E O1
5.509E Ol 5.037E Ol
4.622E Ol _°2&gE Oi
3.520E Ol 3.245E Ol
2.869E Ol 2.b51E O_
2.437E O! 2.255E Ol
2.127E 01 l.q70E 01
1.893E Ol 1.756E Ol
l.?llE Ol 1.588E Ol
I.Sb4E 01 I._52E Ol
I._43E Ol 1.341E Ol
I°3_IE Ol 1.247E Ol
1.255E Ol 1.167E Ol
1.086E OI _,OIIE Ol
9.630E O0 8.972E O0
8o687E O0 8=098E O0
7.942E O0 7.408E O0
7.338E O0 b. B47E O0
6.838E O0 6.383E O0
6.418E O0 5.992E O0
6.059E O0 5ob59E O0
5,749E O0 5o371E O0
5.47BE O0 5.119E O0
5.240E O0 _.Bg8E O0
5._29E O0 4°701E O0
_.840E O0 4.52bE O0
4.b71E O0 _.368E O0
4.518E O0 4.226E O0
4.252E O0 3.979E O0
4.030E O0 3°772E O0
3.841E O0 3.596E O0
3.679E O0 _°445E O0
3.538E O0 3.314E O0
3.414E O0 3.197E O0
3.306E O0 3.095E O0
3°209E O0 3.005E O0
3.123E O0 2.925E O0
3.046E O0 2.853E O0
L
k
3 14
Table 39 (continued)
MUON PION
ENERGY MUSCLE BONE MUSCLE
MEV l= 66.2 I= 85.1 l= 66.2
420.0 2.018E O0
4_0.0 2.022E 00
kBO.O 2.025E 00
480.0 Z.O29E 00
500.0 2.032E O0
520,0 2.03bE 00
540.0 2.040E O0
560.0 2.044E O0
580.0 2.048E 00
bO0.O 2.052E O0
620.0 2.C56E O0
b&O.O 2.060E O0
660,0 2.063E 00
690.0 2,067E O0
700.0 2°071E 00
720.0 2.C75E 00
740,0 2.079E O0
760.0 2.082E O0
780.0 2.086E 00
800°0 2.089E 00
820.0 2.093E O0
840.0 2.096E 00
860.0 2.100E O0
880.0 2.103E O0
900.0 2°107E 00
920°0 2.110E O0
9_0.0 2.113E O0
960.0 2.11bE O0
980°0 2.llgE 00
lO00.O 2.123E O0
1200.0 2.151E O0
l_O0.O 2.17bE 00
1600,0 2.198E O0
2000.0 2,235E O0
2_00.0 2°266E O0
2800°0 2.292E 00
3200.0 2.314E O0
3600.0 2.334E O0
_000.0 2.351E O0
5000.0 2.388E O0
BONE
I= 85°1
KAON
MUSCLE
I= 66.2
1°894E 00 2,008E O0 1.882E O0 2.338E O0
l°8g8E O0 2.008E O0 1.883E 00 2.308E O0
I.g02E 00 2.009E O0 I.884E 00 2.282E 00
1,906E*00 2,0lIE O0 I°E86E O0 2o257E O0
1.910E O0 2.012E 00 1.888E O0 2.236E O0
[,91kE O0 2,014E 00 I,890E O0 2.216E O0
l,gl8E O0 2,01BE O0 1.892E O0 2,1ggE O0
1,922E O0 2°GIgE O0 1.895E O0 2.183E O0
1.926E O0 2.021E O0 1.898E O0 2.168E O0
1.930E O0 2.024E O0 k.901E O0 2.155E O0
1.934E O0 2.C27E O0 1o904E 00 2.[42E O0
1.939E O0 2,029E 00 1.907E O0 2.131E 00
1,943E O0 2.032E O0 1,910E O0 2.121E O0
1.947E O0 2.035E O0 1,913E O0 2.111E O0
1°951E O0 2.G3BE 00 1,916E O0 2°102E O0
1°955E O0 2.041E 00 1,919E 00 2,094E O0
1.958E O0 2.044E O0 1,922E 00 2°OB7E O0
1.962E 00 2,0_7E O0 1°925E 00 2.OBOE 00
1.966E O0 2.050E O0 1°928E O0 2.074E O0
z.g70E O0 2,053E O0 1.932E O0 2.068E O0
1,974E O0 2°056E O0 1°935E O0 Z.O63E O0
L.gTTE O0 2,059E 00 1,930E O0 2°058E O0
_,9BIE 00 2.062E O0 _.941E O0 2,C53E 00
1°98_E O0 2°065E O0 1.9_E O0 Z.O49E O0
1°988E O0 2°068E O0 1°9_7E O0 2.0_5E O0
].991E 00 2.070E O0 _.950E O0 2.041E 00
1°995E 00 2,073E O0 1o953E O0 2°038E 00
1.998E O0 2°076E O0 1°956E O0 2°035E O0
2.00_E O0 2°079E O0 I°959E 00 2,032E O0
2.00_E O0 2.082E O0 1.962E O0 2.030E O0
2.034E 00 2°108E 00 1.989E O0 2°0|3E O0
2°060E O0 2.132E O0 2°Ol_E O0 2o008E O0
2.083E O0 2.153E O0 2.036E O0 2.009E O0
2.122E O0 2.189E O0 2.07_E O0 2.OlgE O0
Z,15_E O0 2.219E O0 2.105E O0 2.035E O0
2.IBOE O0 2,265E O0 2oI3ZE O0 2.052E O0
2.203E O0 2.267E O0 2.155E O0 2.068E O0
2.226E O0 2.287E O0 2,176E O0 Z.O84E O0
2.242E 00 2,305E O0 Z. Ig_E O0 2.099E 00
2.280E O0 2,342E O0 Z.Z32E O0 Z.133E O0
BONE
I= 85. I
2°189E 00
2.162E 00
2.137E O0
2°I14E O0
2°094E 00
2.076E 00
2.060E O0
2o045E 00
2.031E 00
2°018E O0
Z.OO7E O0
1.996E O0
1,986E O0
1°977E O0
1.969E 00
1.961E O0
l.95_E O0
_.9_8E O0
_.9_1E O0
1.936E O0
1,931E 00
_,926E O0
_.921E 00
L.917E O0
_,9_6E O0
L.9_OE O0
_°907E O0
1.904E O0
1°902E O0
_°899E O0
1.885E O0
I,B81E O0
_.883E O0
1.896E O0
1°9_2E O0
_°930E O0
[=968E O0
1.964E O0
I°9BOE O0
2.015E O0
PROTON
MUSCLE
[= 66°2
2o976E O0
2.913E O0
2,B55E O0
2.802E 00
2.754E O0
2.710E O0
2.667E O0
2.630E O0
2o596E O0
2.565E O0
2°534E 00
2°506E 00
2.48CE 00
2.455E O0
2,_32E 00
2°411E O0
2.390E 00
2°371E GO
2.353E 00
2°337E 00
2.321E O0
2,305E O0
2.291E O0
2.277E O0
2,265E 00
2.253E O0
2.2_IE 00
2.23_E O0
2.220E 00
Z.21ZE O0
2°_36E O0
2.088E 00
2°_57E 00
2.02_E O0
2.01_E O0
2°008E O0
2.O_OE O0
2.016E O0
2.023E O0
2°0_5E O0
BONE
I- 85.1
2.768E O0
2.729E O0
Z.b75E O0
2.bZ5E O0
2.580E O0
2.539E 00
2.500E 00
2._65E O0
2°_27E O0
Z°397E 00
2.370E 00
2.3_4E 00
2.320E O0
2.297E 00
2.27bE 00
2.256E 00
2°238E 00
2.220E 00
2.203E O0
2.188E O0
2.173E 00
2°159E 00
2.146E 00
2.133E 00
2,121E O0
2.110E O0
2.099E O0
2.089E 00
2°080E O0
Z°071E O0
2.000E O0
1,955E O0
1.925E O0
1.894E O0
1.883E O0
_.BB2E O0
_.B85E 00
1°892E O0
_.900E O0
1,923E O0
,%
• _ -. . ..
:- ,:- - . •
, ".. : , . .':.'
3-15
MUON
ENERGY MUSCLE BONE
MEV |= 66.2 |= 85.1
Table 3-10
Range, G/CM 2
(See text for explanation of symbols)
(Ad_3ted from 8erger and Seltzer (24))
PION KAON
MUSCLE BONE MUSCLE BONE
I= 66.2 != 85.1 I= 66.2 [= 85.1
2.0 3.813E-02 4o154E-02 3.042E-02 3.324E-02
4.0 1.33BE-01 1.447E-01 1.067E-01 1.157E-01
6.0 2,785E-01 3.005E-01 2.223E-01 2._03E-01
8.0 4.677E-01 5.03be-0| 3.7_1E-01 4.035E-01
[0.0 6,976E-01 7.502E-01 5.593E-01 6.024E-01
L4.0 1.268E O0 1.362E O0 1.022E O0 1.099E O0
18,0 1.971E O0 2.113E O0 1.597E 00 1.715E O0
22.0 2.7£9E 00 2.989E O0 2°273E O0 2.k38E O0
26.0 3,711E O0 3,974£ O0 3.040E O0 3.259E O0
30.0 4.72&E O0 5.057E O0 3,BOIE O0 4.169E O0
34.o 5.E20E O0 6.227E O0 4o816E O0 5.160E O0
38.0 6o_IE O0 7.&77E O0 5.815E O0 6.225E O0
42.0 B.229E O0 8.799E O0 6oB77E O0 7.359E O0
_6.0 goSZTE O0 i.Ol8E Ol 7.99BE O0 8.557E O0
50.0 io088E 01 l.lb3E 01 9.175E O0 9o813E O0
bO.O 1°4_7E O1 1.546E O1 1,233E 01 l°31BE Ol
70.0 1,B32E 01 1.957E 01 1.575E 01 1°bB3E 01
dO.O 2.236E 01 2.389E 01 I.939E 01 2.072E 01
90.0 2.b57E 01 2.839E 01 2.322E Ol 2.481E 01
100.0 3,091E 01 3.302E 01 2.721E 01 2,907E 01
110.0 3°536E Ol 3.778E 01 3°133E 01 3.368E 01
120,0 3°99]E 01 _.263E 01 3.557E O1 3.800E 01
130.0 _,452E O1 4.756E 01 3o991E 01 _.264E 01
l_O.O 4.921E 01 5.255E 01 4.433E 01 4.736E 01
150,0 5.39_E Ol 5°761E 01 _.883E 01 5.216E 01
160.0 5,872E 01 6,271E 01 5,339E 01 5,703E 01
170.0 6,353E 01 6.786E Ol 5.801E Ol 6.196E O1
L80°O 6._38E 01 7.303E OZ b,2686 Ol beb94E 01
190.0 7o325E 01 7,826E 01 6.738E Ol 7.197E Oi
200.0 7.815E 01 8.347E 01 7.a13E 01 7.704E 01
220.0 8.799E 01 9,399E Ol B.172E Ol 8,728E O1
2_0.0 9o788E 01 1.046E 02 g°IWIE 01 9.763E 01
260.0 1.078E 02 1.15ZE OZ 1.012E 02 1,0BIE 02280,0
1.178E 02 1.258E 02 1.110E 02 I,IBbE 02
300.0 1.277E 02 1.364E 02 1.209E 02 1.29le 02
320.0 1.377E 02 1,470E 02 1.30BE 02 1,397E 02
_0.0 l._7bE 02 1.577E 02 1.407E 02 1o503E 02
360.0 1.5766 02 1.683E 02 1o506E 02 1,609E 02
380.0
1.675E 02 1.789E 02 1,606E 02 1,715E 02
_00.0 1.775E 02 1.895E 02 1,705E 02 1.82ZE OZ
1.124E-02
3.e39E-O2
7.989E-02
1.344E-01
2.012E-01
3.700E-01
5.835E-01
B.3g2E-Pl
1.135E O0
1.470E O0
l.B&2E O0
2.2506 00
Z.692E O0
3.16BE O0
3,677E O0
5,084E O0
b.674E O0
B,435E O0
1.035E 01
1.2_2E Ol
1.463E 01
1.697E 01
1,944E. 01
Z.Z02E 01
2.471E 01
Z.TS1E Ol
3.041E 01
3.340E 01
3.647E 01
3,963E Ol
_.619E 01
5.303E 01
_°014E 01
6.748E 01
7.503E 01
8.278E 01
9,071E Oi
9.8791 01
1.070[ 02
I,154[ 02
1.250E-02
4.230E-02
8o749E-02
1,466E-0l
2.189E-01
4.014E-01
6.315E-01
9.068E-02
1.215E O0
1.585E O0
1.9B_E O0
2._22F O0
2.897E O0
3._OBE 00
3.9536 O0
5.461E O0
7,164E O0
9°04BE O0
1,110E O1
1.331E Ol
1.568E Ol
1.818E Ot
2.0BIE 01
2,357E 01
2°6456 Ol
2°943E Ol
3.253E 01
3,572E Ol
3=900E O]
_,238E Ol
4.9386 Ol
5.b68E Ol
6.426E Ol
7.210E Ol
8.016E Ol
8.844E 01
9.691E 01
1.05bE 02
1.143E 02
1.233E 02
PROTON
MUSCLE
I= 66.Z
7.233E-03
2.335E-02
&.?67E-02
8.OOBE-02
1.198E-01
2.200E-01
3.467E-01
4.985E-01
6.747E-01
8.745E-01
1,C97E O0
1.3&2E O0
1.608E O0
Io896E 00
2.205E O0
3.064E O0
4,0_4E O0
5.1_9E O0
6.345E O0
7.656E O0
9.069E O0
1.058E Oi
h21BE 01
1.38BE 01
1,566E Ol
I.753E Ol
1,948E 01
2,1516 01
2.3616 01
2,579E 01
3.035E 01
3.519E 01
4.027E 01
4,560E 01
5.114E 01
5.690E 01
6o285E 01
6.900E 01
7.531E Ol
8,180E 01
, •:L
eONE :::.
8,162E-03
2.594E-02
5.2656-02
8.820E-02
1,315E-01
2.4036-01
3.775E-01
5.417E-Gl
7.320E-01
9.474E-01
1.1876 O0
I,451E 00
1.738E O0
2,04BE O0
2.379E O0
_.303E O0
_.355E O0
5.530E O0
6.823E O0
B.ZZBE O0
9,742E O0
1.13_E 01
1.308E O1
1.689E 01
1,6BOE 01
1,880E 01
2,088E O1
2.305E Ol
2,530E 01
2.763E Ol
3.2file Ol
3°7_8E 01
4°311E 01
4.BBOE 01
5.472E 01
6.087E 01
_.723E 01
7,379E 01
B.O53E 01
B.746E 01
_7
3 -16
Table 3-10 (continued)
MUON PION
ENERGY MUSCLE BONE MUSCLE
MEV I= 66o2 l = 85.1 1= 6602
420.0 1.874E 02 2°O00E 02 1._05E 02
440.0 1.973E 02 2.10bE 02 l,gO5E 02
460.0 2.072E 02 2.2[IE 02 2°004E 02
480,0 2.170E 02 2.316E 02 2.104E 02
500.0 2.2bgE 02 2.421E 02 2.203E 02
520.0 2.367E 02 2.526E 02 2.303E 02
540.0 2,465E 02 2.630E 02 2,402E 02
560.0 2.563E 02 2.734E 02 2.501E 02
580.0 2.b61E 02 2.B38E 02 2._OOE 02
600.0 2.759E 02 2.942E 02 2°bggE 02
620.0 2.856E 02 3.045E 02 2.798E 02
6_0.0 2°953E 02 3,149E 02 2,896E 02
660.0 _.CSOE 02 3.252E 02 2.g95E 02
680.0 3.147E 02 3.354E 02 3°093E 02
700,0 3.244E 02 3,457E 02 3.191E 02
720.0 3.340E 02 _,559E 02 3.28gE 02
740.0 3.436E 02 3.bb2E 02 3.387E 02
760.0 3.533E 02 3.764E 02 3°_85E 02
780°0 3.629E 02 3.866E 02 3o583E 02
800.0 3.724E 02 3.gbTE 02 3.680E 02
820.0 3.820E 02 4.06gE 02 3.777E 02
840.0 3,915E 02 4.170E 02 3.875E 02
860°0 4,OlIE 02 4°271E 02 3,g72E 02
880.0 4,106E 02 _.372E 02 4.069E 02
900.0 4.201E 02 4.472E 02 4.165E 02
920.0 4.296E 02 _,573E 02 4,262E 02
940.0 _°391E 02 4.673E 02 4.35gE 02
960.0 4,485E 02 6°774E 02 _,455E 02
gBO.O 4,580E 02 4.874E 02 4.551E 02
lOOr.O 4.674E 02 4°973E 02 4,647E 02
1200.0 5.610E 02 5.964E 02 5°602E 02
1600.0 6.534E 02 b.940E 02 6.545E 02
1600.0 7.448E 02 7.906E 02 7°479E 02
2000°0 g.252E 02 g,807E 02 9°321E 02
2400.0 I.I03E 03 l,I68E 03 l.II4E 03
2800.0 t.278E 03 1,352E 03 1.293E 03
3200.0 1.452E 03 I°535E 03 1.470E 03
3600.0 1.624E 03 1.716E 03 1°646E 03
4000.0 1,795E 03 1.895E 03 1°820E 03
5000.0 2.217E 03 2.337E 03 2.250E 03
BONE
I= 85.1
MUSCLE
[= b6,
KAON PROTON
BONE MUSCLE BONE
2 1 = 85.1 I" 66°2 l" 85.1
1.928E 02 1.239E 02 1.324E 02 8.845E O1 g,455E 0l
2°034E 02 I°325E 02 1,416E 02 9.524E 01 _.OI8E 02
2.140E 02 I°412E 02 I°509E 02 I,022E 02 1.092E 02
2.246E 02 I°500E 02 l,b03E 02 1.092E 02 1.168E 02
2°352E 02 1.589E 02 I°698E 02 I°164E 02 1.244E 02
2._58E 02 1.679E 02 1o794E 02 1.238E 02 1.323E 02
2.564E 02 1.770E 02 1.890E 02 1.312E 02 1,402E 02
2.670E 02 1.861E 02 I.g88E 02 1.388E 02 I.482E 02
2.775E 02 1.953E 02 Z,086E 02 I;464E 02 L.564E 02
2.880E 02 2.046E 02 2.185E 02 1.542E 02 1.647E 02
2.986E 02 2.139E 02 2.284E 02 1.620E 02 I°731E 02
3.091E 02 2.232E 02 2.384E 02 1.700E 02 I.B16E 02
3.195E 02 2.326E 02 2.485E 02 1.780E 02 1.902E 02
3.300E 02 2._21E 02 2.586E 02 1.8bIE 02 I°988E 02
3.40_E 02 2.516E 02 2.687E 02 1.943E 02 2.076E 02
3.509E 02 2.bile 02 2°789E 02 2.025E 02 2,164E 02
3°613E 02 2.707E 02 2.8glE 02 2.109E 02 2.253E 02
3.717E 02 2.803E 02 2.Q93E 02 2.193E 02 2.343E 02
3°821E 02 2.899E 02 3.096E 02 2.277E 02 2.433E 02
3.924E 02 2.gQ6E 02 3.I9gE 02 2.363E 02 2.524E 02
4°028E 02 3.092E 02 3.303E 02 2.448E 02 2.616E 02
4.131E 02 3.190E 02 3.407E 02 2.535E 02 2°708E 02
4.23_E 02 3°287E 02 3.511E 02 2.622E 02 2.801E 02
4.337E 02 3.384E 02 3°615E 02 2.710E 02 2,895E 02
_.440E 02 3,482E 02 3,719E 02 2.798E 02 2o989E 02
_.543E 02 3.580E 02 3,824E 02 2.880E 02 3.083E 02
4.645E 02 3°678E 02 3.929E 02 2.975E 02 3.178E 02
4.747E 02 3.776E 02 4,034E 02 3.065E 02 3.274E 02
4.850E 02 3°875E 02 4.139E 02 3.155E 02 3,3TOE 02
_.952E 02 3.973E 02 4.244E 02 3.245E 02 3,466E 02
5.964E 02 4.963E 02 5.301E 02 4.166E 02 _.450E 02
6ogb3E 02 5,958E 02 6.364E 02 5.11_E 02 _.462E 02
7.951E 02 6, gS_E 02 7.426E 02 6,080E 02 6.494E 02
9.897E 02 8oQ41E 02 9.544E 02 8,043E 02 8,591E 02
1.181E 03 1.091E 03 1,164E 03 l.O03E 03 I,071E 03
1°370E 03 1.287E 03 1.373E 03 1,202E 03 1.28_E 03
Io556E 03 I,481E 03 I,579E 03 I.401E 03 1.496E 03
1.741E 03 1.676E 03 1.783E 03 1.600E 03 1.708E 03
I,g24E O_ 1.665E 03 1.986E 03 1°798E 03 1.919E 03
2,376E 03 2,338E 03 2.487E 03 2.289E 03 2.442E 03
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which were erroneously calculated ( 17 ). The data for protons are slightly -_
different from those of Table 3-8 because of different assumptions regarding ' /_ _ ._i
the molecular properties of the tissues in question. Similar data are available " ...."
for other materials (24). • _i "
Similar stopping powers, ranges, and radiation yield(bremsstrahlung _ -
efficiency) for electrons are seen in Tables 3-II and 3-12. These can be used
for secondary electrons or primary electrons in the Van Allen belts. These
tables replace previous data which were erroneously calculated (Z5). Similar ." •
data are available on other non-biological materials (Z4). The angular dis- r-_.
tribution of thick-target bremsstrahlung including multiple electron scattering .. -/
is now under study (Z48). Figure 3-13 compares the rate of energy loss for _ __
electrons and protons in tissue. Neutron mean free paths in ICRU muscle vs.
energy are seen in Figure 3-14.
In the past, stopping power and range for ions>Z = 18 have been poorly
investigated either theoretically or experimentally. The Omnitron accelerator
may make available ions up to 500 MeV/atomic mass unit (amu) and Z numbers
through 92. A program has been recently written which computes range,
energy, and stopping power data. These are available for hydrogen, helium 4,
carbon IZ, neon 20, argon 40, krypton 84, xenon [31, and uranium-Z38 inci-
dent upon water, aluminum, copper, silver, lead, and uranium (262). Pro-
grams are available in Chippewa, Fortran, and Fortran IV. The calculations
have been corroborated by comparison with experimental data available on
ions of Z< I0 (197). Figures 3-15a, b, and c represent only water, alumin-
um, and lead targets most pertinent to the space radiation problem. The
stopping power has been plotted as a function of ion residual range. The
symbols on each curve match points corresponding to various energies. The
Ne-C and Xe-U crossovers are low energy, and although possibly a physical
reality, occur in regions of low confidence of the calculations. Discontinuities
and irregularities in several of the curves are caused by different equations
and assumptions used for calculation of Z < I0 and for 4 separate energy
regions of Z>I0 (262).
LL r
As noted in the discussion of Figure 3-15a, b, and c, calculation of
LET's for the primary galactic cosmic-ray flux is difficult. Table 3-16
shows theoretical considerations of dose and energy distribution in tlssue
from the constituents of the primary cosmic-ray flux. The sections, energies,
and angles of emissions, as well as relative frequencies of alternate decay
schemes for the various types of secondaries, are not well enough known to
allow more than a tentative designation for this table. Data are available for
some of the nuclei above iron in the primary cosmic ray spectrum (90). A
large percentage of the absorbed dose appears to be derived from particles
giving very heavy ionizatlon.
r
Figure 3-17 presents examples of prlmary cosmlc-ray data graphically.
Contrary to conditions 1or electrons, where the LET reaches its maximum at
the very end of the particle track, the maximum LET occurs for nuclear
particles a very short distance before the end (2 micra T for protons, 46
micra T for Ca nuclei) and then drops steeply to zero. As the exact shape
of this final descent of the LET to zero is not known, the exact height of the
- • . _ L
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ENERGY
MEV
0.010
O.01fi
0.020
0.025
0.030
0.035
0.0_0
0.045
0.050
0.055
0.060
0.065
0.070
0.075
0.080
0.085
0.090
0.095
0,I00
0,150
0,200
0.250
0.300
0.350
0.400
0.450
0.500
0.550
0.600
0.650
0.700
0.750
0.800
0.850
0.900
0.950
1.000
i. I00
1.200
1.300
Table 3-11
Electrons in Muscle
(After Berger and (Seltzer (24))
STOPPING POWER
COLLISION RADIATION TOTAL
MEV CM2/G MEV CM2/G MEV CM2/G
2.292E Ol 4,971E-03 2.292E Ol
1.670E Ol 4.874E-03 1.670E Ol
i,334E Ol 4.810E-03 1.335E Ol
1.123E 01 4.766E-03 1.123E Ol
9.763E O0 4.735E-03 9.768E O0
8.686E O0 4.705E-03 8.691E O0
7.859E O0 _.702E-03 7.863E O0
7.202E O0 _.71CE-03 7.207E O0
6,669E O0 4.726E-03 6.673E O0
6,225E O0 4.749E-03 6.230£ O0
5.851E O0 4.777E-03 5.856E O0
5,531E O0 4.808E-03 5.536E O0
5.25_E O0 4.843E-03 5.259E O0
5.012£ O0 4,881E-03 5.017E O0
4.799E O0 4.921£-09 4.804E O0
4.609E O0 4.952E-03 _.614E O0
4.4-40E O0 4.995E-03 4.445E O0
4.287£ O0 5.041£-03 4.292E O0
4.149E O0 5,087E-03 4.15_E OO
3.261E O0 5.609E-03 3.267E O0
2,811E O0 6.169E-03 2.817E O0
2.543E O0 6.781E-03 2.550E O0
2.366E O0 7.420E-03 2.373E O0
2.2W4E O0 8.088E-03 2.252E O0
2.155E O0 8,754E-03 2.16_E O0
2.088E O0 9,432E-03 2.097E O0
2.036E O0 I.OIIE-02 2.046E O0
1.996E O0 1,078E-02 2.007E O0
1.964£ O0 1.146E-02 1.976E O0
1.939E O0 1.21_E-02 1,951E O0
1.918E O0 1.282E-02 1,931E O0
1.901E O0 1.350E-02 1.915E O0
1.887E O0 1,418E-02 1,902E O0
1.876E O0 1.487E-02 1,891E O0
1,867£ O0 1,556E-02 1.882E O0
1.859E O0 1.525E-02 1.875E O0
1.852E O0 1.694E-02 1.869E O0
1.843£ O0 1,834E-02 1.861E O0
1.836E O0 1,975E-02 1.856E O0
1,832E O0 2,116E-02 1.854E O0
RANGE RADIATION
YIELD
GICM2
2,467E-04 1.236E-04
5,061E-04 1.674E-04
8.435E-0_ 2,072E-04
1.254E-03 2,443E-04
1,733E-03 2.794E-0_
2.276E-03 3,128E-04
2.882E-03 3,449E-04
3,547E-03 3,761E-04
4.269E-03 _,086E-04
5.045E-03 4,365E-04
5.873E-03 4,659E-0_
6.752E-03 4,9_8E-0_
7,679E-03 5.234E-04
8.653E-03 5.516E-04
9,672E-03 5,795E-04
1.073E-02 6.071E-04
1.184E-02 6,344E-04
1.298E-02 b,615E-04
1,417E-02 6.88_E-04
2,792E-02 9,497E-OW
4,451E-02 1,201E-03
6,323E-02 1,446E-03
8,359E-02 1,687E-03
1,052E-01 1.926E-03
1,279E-01 2.162E-03
1,514E-01 2,397E-03
1,755E-01 2,629E-03
2.002E-01 2,859E-03
2.253E-01 3,086E-03
2.508E-01 3.311E-03
2,766E-01 3.534E-03
3.026E-01 3,754E-03
3.288E-01 3,973E-03
3.552E-01 4.190E-03
3.817E-0I 4,405E-03
4.083E-01 4,619E-03
_.350E-01 4,831E-03
&.886E-Of 5.252E-03
5,424E-01 5,668E-03
5,963E-01 6,081E-03
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rTable 3-11 (continued)
ENERGY
MEV
1.400
1.500
1,600
1.700
1,800
1,900
2.000
2,200
2,400
2o600
2.800
3,000
3.500
4.000
4.500
5,000
5.500
6.000
6.500
7,000
7.500
8.000
8.500
9.000
9.500
i0.000
20.000
30.000
40,000
50,000
60,000
80,000
100.000
200.000
300.000
400.000
500.000
600.000
800.000
I000,000
STOPPING POWER
COLLISION RADIATION TOTAL
MEV CM21G MEV CM21G MEV CM2/G
RANGE RADIATION
YIELD
G/CM2
1,830E O0 2,259E-02 1.853E O0 6.503E-01 6.490E-03
1,829E O0 2,402E-02 1.853E O0 7.043E-01 6,895E-03
1.829E O0 2.5_6E-02 1,854E O0 7,582E-01 7.299E-03
1.830E O0 2.687E-02 Io857E O0 8.121E-01 7.698E-03
1,831E O0 2,833E-02 1,859E O0 8,660E-01 8,096E-05
1.833E O0 2.981E-02 1.862E O0 9,197E-01 8,492E-03
1,835E O0 3,130E-02 1,866E OO 9,733E-01 8,887E-03
1.839E O0 3,432E-02 1,874E O0 1,080E O0 9,674E-03
1.844E O0 3.739E-02 1.882E O0 1.187E 00 1,0_6E-02
1.850E O0 4.050E-02 1.890E O0 1.293E O0 1.124E-02
1,855E O0 4.354E-02 1.899E O0 1.398E 00 1.203E-02
1o861E 00 4.673E-02 1,907E O0 1.504E O0 1.2BOE-02
1.874E O0 5.495E-02 1.929£ O0 1.764E O0 I'.476E-02
1,886E OO 6.346E-02 1.950E O0 2.022E O0 1.673E-02
1.898E O0 7.230E-02 1,970E O0 2.277E O0 1.871E-02
1.908E O0 8.129E-02 1.990E O0 2.530E O0 2.072E-02
1,918E O0 9.045E-02 2.008E O0 2,780E O0 2.274E-02
1,927E O0 9,977E-02 2.026E O0 3,028E O0 2,_77E-02
1,935E O0 1.092E-01 2.044E O0 3.273E O0 2,682E-02
1,942E O0 1.188E-01 2.061E O0 3.517E O0 2,887E-02
1.949E O0 1.285E-01 2.078E O0 3.758E O0 3,093E-02
1.956E 00 1,384E-01 2.094E O0 3.998E O0 3.299E-02
1,962E O0 1,483E-01 2.110E O0 4.236E O0 3.506E-02
1.967E DO 1.593E-01 2,127E O0 4,472E O0 3.715E-02
1.973E O0 1.695E-01 2.142E O0 4,706E O0 3.925E-02
1.978E O0 1.798E-01 2.158E O0
2.043E O0 3.986E-01 2.441E O0
2.079E O0 6.311E-01 2.710E O0
2.103E 00' 8.701E-01 2.973E O0
2.123E O0 I.II3E O0 3.236E O0
4.939E O0 4.135E-02
9.Z89E O0 8.266E-02
1.317E Ol 1.214E-01
1,670E 01 1.570E-01
1,992E 01 1,894E-01
2,138E O0 1.360E O0 3._98E O0 2.289E Ol 2,189E-01
2,163E O0 1.859E O0 4,021E O0 2.822E Ol 2.710E-01
2,182E O0 2.363E O0 4.545E O0 3,289E O1 3.152E-01
2.2_IE O0 4.927E O0 7.167E O0 5.027E Ol 4,654E-01
2.275E O0 7.521E O0 9.796E O0 6.215E Ol 5.542E-01
2,299E O0 I.OI3E Ol 1.243E Ol 7,119E Ol 6.139E-01
2.318E O0 1,274E 01 1.506E 01 7,849E 01 6,574E-01
2,334E O0 1.536E Ol 1.769E O] 8.461E Ol 6,908E-01
2o358E O0 2,061E Ol 2.296E OI 9,_51E Ol 7,391E-01
2.377E O0 2,585E Ol 2,823E Ol 1.023£ 02 7,727E-01
: : _
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Table 3-12
Electrons in Bone
(After Berger and (Seltzer (24))
ENERGY
MEV
0.010
0,015
0.020
0.025
0.030
0.035
0°040
0.045
0,050
0.055
0,060
0,065
0,070
0,075
0,080
0.085
0,090
0,095
0.100
0.150
0.200
0,250
0,300
0,350
0,400
0.450
0.500
0,550
0.600
0.650
0,700
0,750
0,800
0,850
0,900
0.950
Io000
I.I00
1,200
1,300
STOPPING POWER
COLLISION RADIATION TOTAL
MEV CM2/G MEV CM2/G MEV CM2/G
2,101E Ol 6,373E-03 2.101E Ol
Io536E Ol 6,282E-03 1.537E Ol
1,231E O1 6.206E-03 Io231E 01
1.037E 01 6.172E-03 1,038E 01
9.030E O0 6.159E-03 9,036E O0
8.041E O0 6.153E-03 8.047E O0
7.281E O0 6.169E-03 7.287E O0
6,678E O0 6.196E-03 6.684E O0
6.186E O0 6.231E-03 6.193E O0
5.778E O0 6.Z71E-03 5,785E O0
5,434E O0 6.316E-03 5.440E O0
5,139E OO 6.365E-03 5.145E O0
4,883E O0 6,417E-03 4.890E O0
4,660E O0 6,472E-03 4,666E O0
_,_63E O0 6,528E-03 4.469E O0
4.288E O0 6.571E-03 4.29_E O0
4.131E O0 6.631E-03 4.138E O0
3o990E O0 6,693E-03 3,997E O0
3.862E O0 6,757E-03 3,869E O0
3,041E O0 7.442E-03 3,0k9E O0
2,623E O0 8.154E-03 2.631E O0
2,374E O0 8.941E-03 2.383E O0
2,210E O0 9,765E-03 2,219E OO
2,092E O0 1,063E-02 2,103E O0
2.011E O0 1,148E-02 2,022E O0
1,949E O0 1,235E-02 1.961£ O0
1,901E O0 1,321E-02 1.914E O0
1.864E O0 1,407E-02 1,878E O0
1.835E O0 1,493E-02 1,850E O0
1.811E O0 1.578E-02 1,826E O0
1.791E O0 1.664E-02 1,808E O0
1,775E O0 1.750E-02 1.793E O0
1,762E O0 1,836E-02 1,780E O0
1,751E O0 1.925E-02 1,770E O0
1o742E O0 2,012E-02 1,762E O0
1,734E O0 2,098E-02 1.755E O0
1,728E O0 2,185E-02 1.750E O0
1.720E O0 2,359E-02 1.743E O0
1.714E O0 2,533E-02 1.7_OE O0
1.711E O0 2.708E-02 1.738E O0
RANGE
GICM2
2.711E-04
5,533E-04
9.195E-04
1.364E-03
1.882E-03
2.469E-03
3.123E-03
3.841E-03
4.619E-03
5,455E-03
6.347E-03
7,292E-03
8.290E-03
9,337E-03
1.043E-02
1,157E-02
1,276E-02
Io399E-02
1.526E-02
3,001E-02
4,778E-02
6,781E-02
8o960E-02
1,128E-01
1,371E-01
1.622E-01
1.880E-01
2.144E-01
2,_12E-01
2,68_E-01
2.959E-01
3,237E-01
3.517E-01
3.799E-01
4.082E-01
4.366E-01
4,652E-01
5,22_E-01
5.798E-01
6,374E-01
RADIATION
YIELD
1,726E-04
2.341E-04
2,898E-04
3,418E-04
3,913E-04
4,387E-0_
_.846E-04
5,292E-04
5,730E-04
6,159E-04
6.581E-04
6.998E-04
7.409E-04
7,814E-04
8,216E-OW
8,612E-04
9,003E-04
9,392E-04
9,778E-04
1.351E-03
1,706E-03
2,050E-03
2.388E-03
2.723E-03
3.054E-03
3.380E-03
3,701E-03
4,019E-03
4,333E-03
4,642E-03
4.948E-03
5,250E-03
5,550E-03
5,847E-03
6.141E-03
6,433E-03
6.722E-03
7.294E-03
7.856E-03
8._11E-03
. +
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Table 3-12 (continued)
.L-¸
ENERGY
MEV
1,400
1,500
1.600
I,700
1,800
1,900
2°000
2.200
2,400
2.600
2.800
3.000
3,500
4.000
4,500
5°000
5.500
6.000
6,500
7.000
7°500
8.000
8,500
9.000
9,500
10.000
20.000
30.000
WO,O00
50.000
60o000
80°000
I00.000
200,000
300.000
400.000
500,000
600.000
800,000
I000°000
STOPPING POWER RANGE RADIATION
COLLISION RADIATION TOTAL YIELD
MEV CM2/G MEV CM2/G MEV CM21G G/CM2
I,710E O0 2.883E-02 i°739E O0 6,949E-01 8,959£-03
1.709E O0 3.059E-02 I,740E O0 7o524E-01 9,501E-03
1o710E O0 3.236E-02 1,742E O0 8,098E-01 1,004E-02
1,711E O0 3°400E-02 1,745E O0 8,672E-01 1,056E-02
I°713E O0 3,580E-02 1.749E O0 9.244E-01 I°I09E-02
I°715E O0 3.761E-02 1,753E O0 9,815E-01 1.161E-02
1,717E O0 3,9_4E-02 1.757E O0 1.039E O0 1.212E-02
i°723E O0 4.317E-02 1,766E O0 I,152E O0 1.315E-02
1,728E O0 4,697E-02 1,775E O0 1,265E O0 I,_18E-02
I,73_E O0 5,08_E-02 1,785E O0 I,377E O0 I,520E-02
1.741E O0 5°483E-02 I,795E O0 I°_89E O0 1,622E-02
1.7_7E O0 5,883E-02 1,805E O0 l,600E O0 I,724E-02
1,761E O0 6,907E-02 1.830E O0 1°875E O0 1.980E-02
1,775E O0 7,963E-02 1.854E O0 2,I_7£ O0 2,237E-02
1,787E O0 9,053E-02 1,878E O0 2,_15E O0 2,_95E-02
1,798E O0 l.Ol6E-Ol 1,900E O0 2°679E O0 2°754E-02
1,809E O0 1o129E-01 1.922E O0 2,941E O0 3,014E-02
I°818E O0 i,243E-01 1,943E O0 3°200E O0 3,274E-02
I°827E O0 I°359E-01 1,963E O0 3,456E O0 3,53_E-02
I°835E O0 I°477E-01 Io983E O0 3°709E O0 3,795E-02
1.843E O0 1,596E-01 2,003E O0 3.960E O0 4,056E-02
1.850E O0 1.716E-01 2.022E O0 4.209E O0 4°317E-02
1.857E O0 1.838E-01 2.040E O0 4.455E O0 4.578E-02
I°863E O0 I°969E-01 2,060E O0 4°699E O0 _°839E-02
1,869E O0 2,093E-01 2.078E O0 4.940E O0 5,101E-02
1.874E O0 2,218E-01 2,096E O0 5.180E O0 5.362E-02
1.945E O0 4.885E-01 2.434E O0 9.599E O0 I°040E-01
1,983E O0 7.718E-01 2,755E O0 l,3W6E Ol 1.499E-01
2,010E O0 1.063E O0 3,073E O0 I°689E Ol I°909E-01
2°029E O0 I°360E O0 3,389E O0 I°999E Ol 2°276E-01
2.045E O0 1,660E O0 3.705E O0 2.281E 01 2.606E-01
2°070E O0 2.267E O0 _.337E O0 2.780E Ol 3.172E-01
2°089E O0 2.880E O0 _,969E O0 3°210E Ol 3,642E-01
2,147E O0 5.99&E O0 8,141E O0 4,766E Ol 5,172E-01
2,180E O0 9,144E O0 1,132E Ol 5.803E Ol 6.033E-01
2.204E O0 1.231E O1 1,_51E O1 6o581E O1 6_59gE-01
2,222E O0 1,5_8E Ol 1,770E Ol 7.204E Ol 7.003E-01
2,237E O0 1.865E Ol 2.089E Ol 7°724E Ol 7.310E-01
2,260E O0 2,501E Ol 2.727E Ol 8,559E Ol 7°747E-01
2,278E O0 3o137E Ol 3,565E Ol 9.218E Ol 8°0_8E-01
! •
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Figure 3-13
Energy Loss Per Unit Path Length for Protons
and Electrons in Model Biological MateriaLs
(After Janni et al (128))
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Figure 3-14
Neutron Mean Free Paths for ICRU Muscle Tissue and a Tissue Equivalent Manikin
(After Janni et al (128))
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Figure 3-15
Stopping-Power Curves as a Function of Range for Various Ions
as Calculated by a UCRL Computer Program. Various Ion Energies
in Units of MeV/amu Are Designated on Each Curve by the same
Symbols as Noted for H. (See text for details).
(After Steward and Wallace (262))
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Figure 3-15 (continued)
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Table 3-16
Composition of the Primary Cosmic-Ray Flux
Outside the Atmosphere in Northern Latitudes
(After Langham-NAS -NRC(145))
TYPE NLCI.EU$
He
ALPtlA
H PAR-
PROTONS TICLES CNO _g Ca Fe
Z': 1 2 7 12 20 26
Particle flux b 4,460 633 32 8.4 2.9 1.4
Absorbed dose
col_tribution
mrads/24 hr) 4 2.3 1.4 0.99 0.13 0.28
LET _kcV//.L tissue)
Minimum 021 0.84 10.5 30.3 84 142
Maximum 57.8 252 1,230 L,780 2,570 3,500
Absorbed dose to
central v traversed
cell (rads) _
Minimum 0+07 0.24 0.36 ] 2+85 4.8
Maximum 20 85 420 610 870 1.200
aZ numbers from 7 to 26 are ffroup represenLatlves.
_I'artJcle Inte s _: particles traversing sphere of 1 cm 2 crosl lectlon per hour from Ill
dirt_tlonll
cI_e per partl_.le ealculat_.d for a 10-_ cell at et.nter of try.ok.
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Figure 3-17
LET Distributions of Standard X-Rays
and of Heavy Galactic Primaries
in Tissue and RBE/LET Function.
(After Schaefer (239) and Cormack and
Johns (57))
7
spike at the upper end of the LET distribution remains uncertain. For this
reason the spikes in the lower graph of Figure 3-17 are drawn with the same
arbitrary height for all five components. Accordingly, the spikes should be
interpreted merely as denoting the position of the steep terminal rise of the
curve on the LET scale. A quantitative assessment of the extremely small
fraction of the energy dissipation at the maximum LET would require a
separate and entirely different approach. The fractional dose at the maximum
LET represents, radiobiologically, an essentially unknown quantity best
described dosimetrically with the term "microbeam" (145, Z47 ).
This track of a very heavy charged particle in tissue is characterized by
a very small central core of ionization caused by the particle itself, sur-
rounded by a much wider area of ionization caused by the secondary particles
ejected from the central core. Thus most of the volume of the track is at-
tributable to secondary radiation, and a living cell in the path of the track
would probably be affected predominantly by proton and electron radiation. It
has been suggested that only about 5 to 10 millirads/day of the 40 millirads/
day galactic ray dose at solar minimum haveaLET above 30 keV/_(Z38, 239).
A large part of galactic radiation exposure falls into the region of low and
very low LET values. For the proton component in particular, the bulk of the
energy dissipation takes place at LET values even below the lowest LET of
standard x-rays. In fact, the LET distribution of galactic protons closely
resembles the one for Co-60 ga_ma rays. This is to be expected since for
both radiations a large part of the energy dissipation is produced by secondary
relativistic particles of single charge. Since LET depends only on charge and
speed, but not on mass, there is no difference in the energy loss between
electrons and protons of the same speed.
For calculation of local, effective tissue doses especially under conditions
of low shielding, a reasonably satisfactory dependence of the RBE or QF on the
3-26
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local Linear Energy Transfer (LET), has been obtained and experimentally
verified (to some extent) by Rossi (Z15, 243). The relationship between RBE
or QF and local LET for protons, alphas, and electrons of specific energy
can be determined (Ii0, IZ8, 240 , 244). _igure 3-18a and b shows that for
alphas and protons, RBE values vary from unity at high particle energies
Figure 3-18
RBE Versus Energy or Particle Range
....... from Schaefer (244)
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increasing to ig at low energies where electron acquisition becomes important.
The upper critical energies, at which the LET = 4 keV/micron and, therefore,
the RBE equals I, are I0.8 MeV for protons and Z49 MeV for alpha particles.
The composlte I_BE values in infinite tissue (50 percent bone and 50 percent
muscle) for protons and alpha particles between their initial and final energies
are 2. i and Z. Z, respectively. Above 0. 5 MeV, the two independent calcula-
tions are in good agreement (Ii0, 240). Below 0. 5 MeV (6 microns residual
range), the Haffner calculations predict somewhat higher I_BE values. Pro-
bably saturation effects ( there are only so many atoms per unit path length
for the particles to 1onlze), which the Haffner calculation did not take into
account, are responsible for the differences. From the overall shielding
viewpoint the differences are unimportant.
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The RBE may be determined instantaneously or as the mean RBE of
a particle during dissipation of its entire energy. The differences are seen
in Figure 3-19.
7_ .4 ._ .8 2 4 6 8 10
KINETIC ENERGY - mev
Figure 3-19
Mean Versus Instantaneous RBE Values
for Protons.
Instantaneous and mean RBEs are shown for pro-
tons of different energms, corresponding to the
instantaneous linear energy transfer at energy E,
and the mean RBE for dissipation of the entire
energy from E down to zero.
(After Grahn (103) from the data of Schaefer (244)]
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varies for different biological systems. After acute doses, mammalian cells
tend to respond as seen in Figure 3-20.
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Figure 3-20
The Relative Biological Effectiveness (RBE) is Plotted
as a Function of Linear Energy Transfer (LET)
for Survival of Mammalian Cells Following Exposure
to Charged Particles at About 8.3 mev/nucleon
(After Grahn (103) Based on data from Sondhaus (258))
The proton RBE for many biological endpoints has been studied for dif-
ferent energies in many biological systems (135, 145 , 154). As predicted by
LET considerations and the calculations of Figure 3-18, the empirical RBE
(lethality) for protons and alpha particles >500 MeV is equal to or less than 1
(Tg , Z59, Z67). Depending on the particular type of radiation injury used as
criterion, RIBE values of 0. 6 to 0.9 have been determined (135, 145 ). RBE
values compared to Co 60 gamma rays of I have been reported for iridocyclitis
and erythema, and of 2, for epilation and desquamation in monkeys irradiated
focally with 14, 39, 185, and 730 MeV protons (Z09, 298). However, in
similarly irradiated animals, 730 MeV protons induced cataracts in 12 to 18
months at doses as low as 750 rads, whereas lower energy protons (14,40,
and ]87 l_4eV) were ineffective even at doses as high as 2000 rads. This
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observation of cataractogeneszs with high energy but not with low energy pro-
tons is of interest, slnce damage to the lens is generally considered to be
less pronounced with increasing energies of fast neutrons (158). More recent
data, however, indicate that several hundred rads of protons in all of the
energies under consideration can probably produce cataracts (18 , 19 ).
As a given particle degrades in tissue, the RIBE will rise as its energy
transfer per micron rises. At the same time, a heterogeneous beam of
protons will have an average RBE that tends to drop with increasing depth in
tlssue as the lower energy component becomes fully absorbed and the higher
energy component continues its traverse. For gamma radiation, average
body dose (ABD) is higher than midline tissue dose (MTD); and for protons, it
is lower in large animals (267). Figure 3-21 represents calculations for
depth-dependence of RBE for C-nuclei, alphas, and protons of 3 different
rigidities: Po = 50, 125, and 300 my. The conservative RBE-LET relation-
ship recommended by the ICRP was employed with a constant KBE of i0 being
used for all values of LET above 150 keV/_. The alpha and C-nuclei show a
pronounced decrease of local KBE extending down to tissue depths well beyond
I gm/cm 2.
f
. . - . .
i .-. _ '.'_,_..... . ..7 _
_- Poo 50 My
I
.I .25 .5 I 2.5
1 '"
I
Po= 125 Mv --
,I .25 5 2.5
Depth in Tissue,
] L
-- Po= 5OO My -
.I .25 .5 2.5
g/cm z
Figure 3-21
Local RBE or QF in Tissue
at Increasing Depth
(After Schaefer (242))
. . - . .
The concept of KBE cannot be applied in those cases where special types
of effects are produced by passage of very high LET particles and star for-
matlon in cosmic ray events (ZI5). It is seen in Figure 3-17 that the proton
contribution to the total dose from galactic primaries should be assigned an
RBE well below i. 0. For the alpha component, the bulk of the energy dis-
slpation falls well within the LET limits of standard x-rays, assuring that
for this dose contribution an I_BE of i. 0 is appropriate. The picture changes
as one proceeds to heavier components. For C nuclei, a sizable portion of
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the energy dissipation extends into the LET region for which the RBE factor :i :- . -
exceeds 2.0. If the mean RBE for the absorbed dose from the C component _ _
is computed by numerical methods from the LET and RBE curves, a value
of i. 56 is obtained. The corresponding mean RBE values for Ne and Ca
nuclei are Z. 86 and 6.64, respectively. Weighting these mean I_BE values _
for the individual components according to th_ir respective shares in the total
dose and us!ng a mean RBE of 0.75 for the proton contribution, one arrives '
at an overall mean RBE of i. 82 for the total dose from galactic primaries.
This value might appear unexpectedly low in the light of other estimates in the
literature (Z39). The discrepancy is due mainly to the fact that a ceiling value
of i0 for the RBE was used whereas in other estimates values up to Z0 have
been assumed. Justification or preference for either value is largely sub- _....: :-
jective, though the higher values may be reasonable for protracted exposure . -
and delayed effects.
It is possible to calculate the dose delivered to cells in a microbeam
track core and the approximate range of LET of the particles. This has been
attempted in Table 3-16. One cannot, however, assign LET or QF values to
these nalcrobeams (145). Attempts have been made to circumvent this prob-
lem but not enough data are available to substantiate the hypotheses (66).
The RBEor QF for electrons of all energies above .03 MeV is assumed
to be unity (ZI5).
The quality, nature, flux, and distribution of secondary radiations are
dependent on the characteristics (flux, energy, mass, and charge) of the
primary beam and on the materials and geometry of the spacecraft shielding
as well as on the tissues of the crew. Present assessments of RBE or QF
for secondary radiation doses for long-duration missions are estimates only,
derived by complex analysis and evaluation of each organ system individually
(290). Insofar as the QF's of various secondary radiations are concerned,
it seems reasonable to assume a value of unity for secondary electrons and
electromagnetic radiations, since their LET characteristics do not differ
greatly from those of conventional x and beta rays. The QF of secondary
protons may be assumed to be the same as for primary protons of comparable
LET. As with protons, QF values for secondary neutrons are complicated by
the dependence of effectiveness on energy, biological response (whether early
or delayed), the organ or tissue under consideration (ocular lens vs. bone
marrow, for example), and, to some degree, on depth within the body. Pres-
ently the most accepted values are those proposed by the NCRP (188). These
values are shown graphically in Figure 3-22 and represent late effects of pro-
tracted exposure at a depth of 3 mm in tissue. The broken-line portion of the
curve Is an extension based on the observations of the secondary-proton
spectrum (Z89). QF values applicable to early effects have not been specified
by the NCRP or similar committees, but experimental observations on animals
suggest values appreciably lower than those for production of late effects (41).
Reported RBE values of fission neutrons (mean energy 0. 5 to l MeV) for pro-
duction of 30-day lethality and other early responses in experimental animals
range from _i to _3 (145).
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Figure 3-22
QF of Neutrons for Late Effects as a Function of
Energy. Calculated for a Deoth of 3 mm in
Tissue Under Conditions of Protracted Exposure•
(After Langham-NAS-NRC (145) from the
data of NCRP (188))
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For the major space radiations, the LET decreases with increasing
shield thickness and with increasing depth in the body, approaching (behind
nominal shielding) that of conventional electromagnetic radiation at the depth
of the bone marrow and the gastrointestinal tract. The greatest contribution
of QF _o the estimation of the biological dose equivalent therefore would be
for early skin responses behind light shielding, as in the case of extravehicu-
lar operations.
Flux (Current)-To-Tissue Dose Conversion Factors for Nucleons
Conversion of particle flux data to tissue rads and reins is most difficult.
The interaction of high-energy nucleons with matter initiates a complex aval-
anche of secondary particles with lower energy which proceeds through the
medium, increaslng in population and decreasing in total energy as energy
is deposited in the medium. In general, a non-elastic interaction with a
nucleus produces, first of all, several secondary nucleons which are due to
direct interactions of the incident particle with the nuclear constituents and
which have energies ranging from a few MeV up to a large fraction of the
incident particle energy. There is left a highly excited, recoiling nucleus
which rids itself of most of its excess energy by evaporating nucleons and
heavy particles of relatively low energy of the order of a few MeV. Any
energy left after evaporation presumably goes into the production of electro-
magnetic radiation. As a consequence of the significant contribution of the
heavy particles and secondary protons to the rein dose, it is not reasonable
to expect that the rein dose at any depth from incident protons can be calcu-
lated very accurately unless the secondary radiation created in the body is
taken into consideration. For the case of incident neutrons this is obviously
true, because only through secondary radiations is it possible for neutrons
to deposit energy.
The data of Figure 3-23 and Table 3-24 were calculated by the Monte
Carlo technique for the study of the transport of nucleons of energies up to
400 MeV through quite arbitrary geometrical configurations (138, 139, 169,
i¸ - , = .
. • .-.., -
. • • . . ..
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170, Z95 The intranuclear cascade is treated by a subroutine version of
IBertini's code ( 27 ) which is itself a Monte Carlo nucleon transport calcula-
tion on an intranuclear scale and gives the velocities and types of particles
resulting from direct interaction processes. The evaporation portion of the
cascade is handled by Dresner's subroutine ( 77 ). Protons below 50 MeV
are allowed to proceeC to the end of their range with no nuclear interaction,
while neutrons below this energy are transported by neutron transport code
(77). The data on Tables 3-6 and 3-7 were used for tlssue factors in the
calculations. In order to provlde current-to-dose conversion factors which
could be used to estimate upper and lower bounds on the doses for most
practical cases of interest, the nucleons were made to impinge on a 30 cm
tlssue slab both normally in a broad beam and isotropically, with the expec-
tation that these two extremes of incident angular distribution would represent
the bounding cases.
.: . .
The dose as a function of depth was calculated in units of rads and reins.
Because of the uncertainties connected with the QF (quality factor) versus LET
curves, the dose data were recorded in energy intervals in a manner that any
preferred set of OF's could be employed to calculate the rein dose with rela-
tive ease. The energy deposition resulting from protons as they passed
through the energy ranges 0-i, i-5, 5-10, [0-50, and >50 MeV was recorded
separately. Average QF values, for each interval, of 8, 3, I. 25 and i,
respectively, were calculated from QF versus LET curves (190, ZI5 ). The
values of the energy of the protons were correlated with the LET values by
means of the stopping-power formulas. A constant value of Z0 for the QF
above a LET value of 1750 MeV/cm was used. This constituted a quite
arbitrary assumption that a saturation effect takes place and can be repre-
sented by a constant QF at high LET values. It should be noted, that under
all c_rcumstances, the QF value of 20 is applied to the dose from the heavy
evaporation particles and recoil nuclei in calculating the rein dose, slnce
their LET value is generally above 1750 MeV/cm.
Figures 3-23a and b present the average total whole-body tad and rein
doses for both normally incident neutrons and protons. Also shown is the
average whole-body rad dose that would be received if the proton beam were
totally absorbed. In comparison with the latter curve, it is easy to see that
below 215 MeV, little error would be introduced if the whole-body rad dose
were calculated on the basis that all the energy is totally absorbed. The
reason for the primary proton dose having a discontinuity at ZI5 MeV is that
above this energy the proton beam penetrates 30 cm of t_ssue and some of the
energy is not deposited. The decrease in dose with increasing energy above
215 MeV ,_saccom_ted for by the decrease in stopplng-power with increasing
energy in this energy range. Thus, less energy is deposited in the 30 cm
of tissue as the energy increases.
t
• "• _Y_ " k
The flux-to-dose conversion factors for average dose, 5 cm dose, and
surface dose as well as maximum dose along the particle path can be cal-
culated by an expression of the form:
logl0D = A - BE + CE Z (4)
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where D is the dose in rein per nucleon per cm 2 and V. is the energy m MeV.
Table 3-24 contains the values of the coefficients.
Computer codes have been used to generate depth-dose curves for protons
in spherical targets for cases where the usual slab techniques are inadequate
(290). Depth dose due to an incident isotropic flux of monoenergetic protons,
including the effect of primary and first-generation secondary protons can be
determined in spheres of arbitrary size containing tissue-equivalent material.
The sphere is chosen because it is, for present purposes, the simplest refer-
ence solid useful in showing the effects of the variables. Dose rate due to
primary protons and three classes of proton secondaries are treated by the
code. The secondary protons cover cascade, evaporation, and elastically
scattered (hydrogen nuclei) particles.
In Figure 3-25, the dose rate contributed by each of the proton classes
described above is recorded as a function of depth in the sphere. At each
depth, the dose rate deposited by protons in each of eight energy intervals
(0-1, i-2, Z-5, 5-10, 10-20, 20-40, 40-80, and 80-_ MeV)was tabulated
separately for each energy interval and each class of protons. Only the total
and primary dose contributions are indicated though others are available (290).
Similar deposition data are available for 32 and 35 MeV protons (268).
Tissue current-to-dose conversion factors for neutrons with energies
from 0. 5 to 60 MeV have been recently programmed (123).
Flux to rad conversion functions may be combined with RBE-ener_y
functions for protons (Figure 3-18a) to give rem dose/unit flux for each
particle energy after acute doses (i00, Ii0 ). Figure 3-26 represents such
conversions.
L
L
Shielding and Tissue Range
The design of shielding requires an understanding of the residual expos-
ure of the human target behind the shield. The stopping power and ranges of
various spacecraft materials for protons, mesons, electrons ( 24 ), and
heavy ions (262), have been calculated and can be used with Tables 3-9 to
3-12 to determine radiation input to internal organs. Proton penetration
codes are being continually refined (249, 250 ). Brehmsstrahlung from
electrons hitting thick targets are receiving current re-evaluation (248).
Table 3-27 gives the minimum kinetic energy and rigidity of protons and
alpha particles which can penetrate typical shielding projected for future
missions. In the actual situation, of course, the thickness of shielding will
be heterogenous in 47. geometry and will allow an influx of variable particles,
kinetic energies and rigidities to hit the human target (280). For the Apollo
vehicle, for instance, the range of shielding extends from 1.75 g/cm 2 to 212
g/cm 2, with lower thicknesses predominantly on the anterior side of the
astronauts and larger ones on the posterior side afforded by the heat shield
and fuel tanks, rocket engine, and other heavy equipment in the service
module. In such systems, the dose distribution throughout the body becomes
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Figure 3-23
Flux-to-Dose Conversion for High Energy Protons and Neutrons
(After Kinney and Zerby (139))
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Coefficients of the
Table 3-24
Expansion for the Rem Dose Log
(After Kinney and Zerby (139)}
D for Various Cases
, .. - .
k _
Normally incident protons
Average dose ...............
5-cm-<ieep dose .............
Surface dose ................
Maximum dose .............
--7.72+6.4X
-6.20--4.3X
6.27--4.6X
--6.64--2.2X
--6.02 1.2X
--6.62 1.1X
10-aE - 1.1X 10-SE_; 60(E(215
10-aE+ 5.5X 10-_E_; 215(E(400
10-3E+6.4X 10-6E_; 80_E_400
10-3E+2.9X 10-6E2; 60(E_(400
lO-3E; 60(E(215
10-3E; 215(E(400
Normally incident neutrons
Average dose ...............
5-cm-deep dose .............
Surface dose ................
Maximum dose .............
--7.43+2.7X lO-4E; 60<E<400
--7.38; 60_E<400
--7.59+3.7X lO-4E; 60<E<400
--7.35+3.8X IO-_E; 60<E<400
[ sotr opicall y incident protons
Average dose ...............
5-cm-deep dose .............
Surface dose ................
Maximum dose .............
-- 7.79+ 7.9X 10-aE - 1.7)< lO-_E2; 60<E<215
--7.07+ 1.2X 10-3E - 1.3X 10-6E=; 215<E<400
-6.57--5.4X IO-_E; 80<E<400
--6.30--2.7X 10-3E+3.7X 10-6E2; 60<E<400
--6.26 2.9X10-3E+4.1X10-eE2; 60<E'_400
Isotropically incident neutrons
k ' "
. -., .
-'. . ,.'. "...
Average dose ...............
5-cm-deep dose .............
Surface dose ................
Maximum dose .............
--7.26+5.6X IO-'E; 60<E<400
--7.18+3.9X IO-'E; 60<E<400
7.26+4.5X 10-'E, • 60<E<400
--7.18+4.0< 10-4E; 60,_ E<400
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Figure 3-25
Proton-Depth Dose Patterns in Spheres of 10 and 25 cm Radius
(Total primary plus secondary proton depth-dose patterns
due to monoenergetic isotropic fluxes of protons.)
(After Wallace et al (290)
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Figure 3-26
Flux to Rein Dose Conversion Function for Protons in Tissue
(After Haffner (110))
:. . -.
Table 3-27
Minimum Kinetic Energies and Rigidities for Protons and Alpha Particles
Required for Penetration of Typical Shield Thicknesses
(After Schaefer (243))
Kinetic Energy, Magnetic Rigidity,
Mdn. _]'_ield. Mev My
Eaulvalenl, Alpha Alpha
Space S/s_em 9/cm 2 Protons Parhcies Protons Particles
Since svll 0.1 8.4 33.6 125 252
Gem,n, veh c_e 0.2 12.3 49.2 152 303
0.5 20.5 82.0 197 392
-- 1.0 30.1 120 240 492
ApolLo vehicle 1.5 37.8 151 269 545
Pe rnanent ,unOr base 2.0 44.2 177 290 588
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extremely complex. Figure 3-Z8 compares the typical flux of primaries •
which pass through typical shielding during exposure to solar flare and galac- _
tic protons. The relative levels vary with time because the magnetic field
caused by the solar wind can screen off the galactic particles of low rigidity. /
The actual flux hitting the human target is not the primary, flux noted above, _
i
i •
_lo_ _m 2._25M,,s_oc,s_, Figure 3-28
12 C1 g/cm z, 290 Mv. Lunor Bose ' ._ " .
l 3"1o3 Comparison of the Differential Rigidity Spectra of Galactic ii':. .
-_ t _ :] / "_ i ! _- Protons and of Protons of a Typical Solar Particle Beam! "- : : "
8r \_ -_ ,/ _ \- ! iz _ (Note the great disparity of ordinate units differing by , .,. :-,-i_
-_ '. _, _ d _ \_ : j .. a factor of 36 million). Galactic spectrum is based on ; : ; i
%_ _ _" "r 7 _ -'_v. i- _ the data of Freier and Waddington(92); flare spectrum : - . - --_' :
-_ 41 kk_! /. . • _¢o j , _ pertains to event of 17 July 1959. _ - .
c_ - (After Schaefer (24311 "
O;........... 0
0i I I0
Mcgne_ic IR_lidity. Gv
but the secondary and higher order products after absorption process in the
barrier.
Tissue Range and Tissue Self-Shielding
where
For rough calculation of self-shielding or shielding by other humans, the
simple range-energy relations of charged particles in matter can be used (Z93):
R = 8_, n (5)
2
R : range, gm/cm
E = energy, MeV
6 = constant - specific for each particle
n - constant - same for all charged particles
For bone and muscle, these constants are:
Bone n = 1.779,
proton
Muscle n = 1.786, 5
proton
-3
= Z. 30xl0
-3
= 2. 03 x i0
Taking the human body to be 50% bone and 50% muscle (the bone is usually
weighted more heavily in this way because of the importance of the marrow),
the _ constant for protons becomes 2. 17 x 10 -3 and that for alpha particles
i. 87 x 10 -4
The range in tissue and stopping power vs. particle energy conversion
can be seen in Tables 3-9 to 3-11. However, geophysical data are often
expressed not as particle energy but in magnetic rigidity. Rigidity and depth
of penetration or range are disparate magnitudes. Since rigidity is the
momentum per unit charge, and alpha particles have twice the charge of
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protons, equal integral fluxes of the same rlgidity represent different fluxes
in terms of momentum, energy, or range spectrum. Figure 3-29 may be
used to convert rigidity spectra to tissue ranges. It shows that for a given
rigidity the corresponding ranges of protons and alpha particles differ greatly.
Figure 3-29
Range/Rigidity Function of Protons and Alpha
Particles in Human Tissues
(After Schaefer (240))
Since the presence of shielding by tissue ,;,,illalter the R]BE of the emer-
gent particles, the spectrum of the particles impinging the tissue must be
considered in any operational configuration. If a particle integral energy
spectrum is present of the form,
-a (6)
_(E>Eo) = AE °
where E and E o represent the range of external spectral energies to be con-
sidered, RBE due to particles in a given energy interval is the integral of the
product of the relationship of this power equation and the RBE factors of
Figure 3-18. The time-integrated energy spectra of solar proton events
appear to follow such a law down to _ I0 MeV. Solar alpha particle spectra
However, spectra behind tissue shields will be
may follow a similar law.
modified thus:
where
s )nsE = - (Ei
E = particle energy outside shield
o
E. = particle energy inslde shield
i
E' = particle cutoff energy of shield
n = constant for charged particles in the metallic
s shield material or in shielding tissue
Using the values of the constants n and [,in Equation (5), the particle
cutoff energy E' for tissue shielding for any finite tissue thickness X may be
calculated. Figures 3-30a andb give the emergent cutoff energy E I as a
function of the initial energy E o for protons at any tissue thickness. Figures
3-31a and b give similar values for alpha particles.
The feasibility of partial body shielding against ionizing radiation has
been recently revlewed (198, 253 ).
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Figure 3-30
Emergent Proton Cutoff Energy at Any Depth of Tissue for Different Initial Energies
(After Haffner (110))
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Figure 3-31
Emergent Alpha Particle Cutoff Energy at Any Depth of Tissue for Different Initial Energies
{After Haffner (110))
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LTypical Depth-Dose Patterns in Space Under Shielding
Several examples will be given of the typical depth-dose under shielding
of space radiation. Unfortunately, data are deficient on the charge and mo-
mentum spectra of solar flare particles measured directly in satellites.
Current estimates are based on uncertain and incomplete data (162, 295}.
Figure 3-32 shows the calculated dose from only protons at various
depths in tissue for inner Van Allen belt and the Solar Proton Event of
May 12, 1959, assuming cabin provides only 2 gm/cm 2 of shielding. The - " "
greater drop of tissue depth-dose from flare protons as compared to Inner i_ " _-. _
Belt protons is a function of the differences in the integral energy spectra _'_: :\ ! "
(see inset). The greater frequency of higher energy protons in the Inner Belt ....
increases the dose rate in deep tissues. Note the importance of knowing the
integrated energy spectrum of the proton radiation when considering the
critical targets -- i.e., bone rnarrow, spleen, and intestinal locations
beneath the surface. It is to be emphasized that no critical organ is located
at a discrete depth below the surface. Since the body self-shielding is non-
uniform, a more detailed analysis is necessary to determine the effect of a
given radiation exposure on specific organs or organ systems.
Table 3-33 shows typical depth doses beneath the 14 largest events of
solar cycle 19 under homogeneous shielding of different values. Since flare
events occur essentially at random during the active part of the solar cycle,
and slnce the magnitude of the individual flare dose does not show any cor-
relation with the phase in the active half-cycle, the preferred way of formu-
lating the flare hazard for the entire active period is to establish the proba-
bility of encountering, on a mission of given duration and for a randomly
chosen launch date, an arbitrarily selected dose (145). It can be derived
from Table 3-33 that 92 percent of the total dose is delivered in eight critical
time intervals, none of them exceeding 10 days' duration, spaced at random
over the 6 years. Sixty-four percent of the total is condensed still more to a
few large increments on the ominous dates of February 23, 1956; July 10, 14,
and 16, 1959; and November 12 and 15, 1960. As a consequence, the dose-
probability plot is not a smooth curve but exhibits an irregular pattern. It
should also be emphasized that the dosage received in the operational situa-
tion would be asymmetric and so the doses of Table 3-33 cannot be used
directly to estimate probability of symptoms (253). Calculations have been
made on the probability per week of different organs receiving varied doses
under different shielding conditions when exposed to spectra typical of solar
cycle 19 ( 80 ). Radiation shielding considerations and depth dose predictions
have also been prepared for interplanetary flights (142).
Figure 3-34 compares degradation of depth dose for specific solar flares
rigidities and inner Van Allen belt protons.
Figure 3-35 shows a rigidity spectrum of a typical solar flare of solar
cycle 19 converted into a differential range spectrum in tissue for protons
and alphas assuming a i:I flux ratio. The range spectra allow direct com-
parisons of fluxes that would reach the same depth in tissue or shielding
material. For low and very low shielding the alpha flux drops much more
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Figure 3-32
Depth Dose Under Solar Flare and Inner Van Allen Belt Exposure Under 2 gm/cm 2
(After Grahn (103) Adapted from Schaefer (246))
Table 3-33
Radiation Doses for the 14 Largest Solar-Particle Events of Solar Cycle 19
(After Langham (ed.)-NAS-NRC (145))
F_ DOSE AT TISSUE St_R_ACE
{fads)
DA'I7EOF SHLEU)Z NO
Ev_,_T (g/cm=): Y -_ 5
DOSE AT 4-ctI3 _fISSUE D_I'TIt
(rads)
10 I 2 4 6 l0
Feb 23. 1956 280 ]80 89 48 73 64 51 42 30
Mar. 23. 1958 148 54 [0 2.1 6.4 4.5 2.55 1.53 0.66
July, 7. 1958 150 54 9.5 1,93 6 4.3 2.35 1.4 0.59
A',t_ 16 1958 23.7 8.6 1.6 0,34 1.02 0.72 0.41 0.24 0.11
AU_ 22. 1958 45 14.7 2.24 0,38 1.33 0.91 0.49 0.27 0.1[
Aug. 26 1958 75 22.3 3 043 1.76 1.17 0.57 0.3 0,II
Ma', 10 1959 470 206 55 [5.6 38 2g.3 18,2 12.5 6.4
j'u[y [0, 1959 420 210 69 245 50 40 27.5 19,5 1 [.5
July 14 1959 650 273 72 19.5 48 36 22.8 15.1 7.5
July 16 1959 382 191 63 22.3 46 36 25 17.7 10.5
No*'. 12. 1960 484 263 I00 43 75 62 46 ,g4 20,B
NO'.'. 15. 1960 288 151 53 20,5 39.6 31.7 23 16.6 10.1
July 12. 1961 25.7 8.4 1.28 022 0.76 0.52 0.28 0.15 0.06
July 18, 1961 128 63 20.4 7.2 15 12 8.1. 5.7 5.3
Grand total of
all 50 events
of Cycle 19 3,914 1,837 584 21'7 426 342 241 176 107
• " . ,, . .
• ... , , - ::..
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Figure 3-34
Variation of the Percent of Skin Dose as a Func-
tion of Tisse Depth for the Three Solar Flare
Rigidity Spectra n the Range Expected
(After Jones et al (134))
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Figure 3-35
Differential Range Spectrum for Protons and
Alpha Particles of Solar Flare 19 Assum-
mga 1:1 Flux Ratio of These Particles.
(After Schaefer (240))
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steeply at greater depths than the proton flux. This indicates that possible
objectionable exposures from solar flare alpha particles can occur only for
low shielding as, for instance, for an astronaut outside the vehicle merely
protected by his space suit with equivalent shielding of only 0. 3 gm/cm 2 for
suit and thermal-meteorite coverall.
Figure 3-16 glves spectral absorbed dose contribution of typical primary
galactic cosmic ray particles and the dose per particle calculated for a i0 u
cell at the center of the track of heavy particles. The only available empiri-
cal data on absorption of galactic radiation with buildup of secondaries is in
the atmosphere. It has been estimated that the corresponding buildup in a
compact scatterer contalning high-Z materials would be substantially higher.
A total dose of 30 to 50 rnrads/24 hr would seem a conservatively high esti-
mate (145, 243). A major uncertainty is introduced by the neutron component
of the secondary radiation. Neutrons play an important role in the develop-
ment of nucleonic cascades, yet data obtained by various authors on the
altitude profile of the neutron flux in the atmosphere and the corresponding
transition of the local neutron energy spectrum seem to differ greatly. This
particular limitation of present knowledge on the transition of the galactic
beam is all the more important for assessments of tissue dosages because
the neutron component would require elevated QF or RBE, thus substantially
. -:.
• ,.
t
k
t k
k
3 -44
r " " ' -
enhancing the dose equivalents (see Figure 3-Z2). Discrepancies still exist
with respect to the exact configuration of the lower slde of the galactic energy
spectrum extending down to thermal energies. However, it now seems well
established that, contrary to the spectra of trapped or flare-produced particle
fluxes with their very large fluxes at low energies, the galactic spectrum
malntains its maximum flux at high energies "'ith values decreasing toward
lower energies. As a consequence, dose rates from the galactic field even
under worst conditions (solar minimum; location outside the magnetosphere;
low shielding) should not greatly exceed the estimate of 50 mrads/24 hr (145).
The actual doses received in space flight to date fall wlthin these pre-
dicted ranges for quiet solar years. American and Soviet space flights have
been well below the trapped radiation belts (275). The apogee and perlgee
for the highest prolonged Gemini flight were i00 and Zl5 miles respectively
for 128 orbits. The highest Soviet flight was the Voshkod 2 with perigee and
apogee at 107 miles and 308 miles respectively for 17 orbits. Beneath 3. 2
n_n_. of AI, the mean tctal radiation doses of the Soviet Cosmonauts in the
\_ost,:,Kseries were measured as ranging from 8.4 to 17 +2 mrads/day (286).
Ninety percent of the dose was from the prlmary cosmlc radiation and 10
percent from the Inner belts at an orbital vector of 65 ° and apogees of 409 krr..
In U. S. astronauts the highest dose rates in the South Atlantic anomaly were
recorded as 107 mrad/hr in the portable ionization chamber and 363 mrads/
hr in the fixed chamber of Geminl IV ( 14 ). Differential spectra of Gemini IV
and VI are available(126). Over the i0 day period of Gemini VII, the dose
rate per man averaged about ii mrad/day ( 26 , 241 ). Emulsions on MA8 and
MA9 showed that the inherent shielding of the capsule was sufficient to
absorb electrons and secondary brehmsstrahlung from the artificial belt.
Long duration missions on the moon reqmre the use of electrical power
sources other than solar cells. Such power sources are radioisotoplc and
rely on plutonium 238, curium 244, strontium 90, and others as the heat
generator (187, 234 ). Thermoelectrlc or thermionic converters are used to
convert the heat into electrical power. Since a i00 MeV alpha particle
requires only 0. 8 gm/cm -Z of alm_nlnum for absorption (0. 3 cm thick or 0. 12
inch), the shield around the unit will, for all practical purposes, absorb or
attenuate the alpha particles. This leaves a radiation environment of neutrons
and gamma rays from primary decay and secondary emlssion in the shield.
The external radiation characteristics of lunar, SNAP, radioisotopic
thermoelectric generator (RTG) modules or units at a distance of I meter
are as follows (96):
Neutrons Snap 19 Snap 27
-i
mrem hr I. 5 125
-2 -I 0 Z
neutrons cm sec i0. 5 8. 75 x i
Gamma
-i
mrads hr Z
-2 -i
ohotons cm sec 14
l I (_kto long RTG axis)
I. 7 ( IIto long RTG axis)
77
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For either the neutron or the gamma radiation, the mean energy is
nearly 1 MeV for these Pu Z38 RTG's. For a cluster of RTG's, the total
radiation dose is the sum of the individual doses, accounting for the distance
from each RTG. Data are available on the shielding and radiation fields for
other SNAP and reactor systems proposed for spacecraft and lunar surface
operations ( I0, 22 , 129 , 141 , 187 ).
EARLY EFFECTS OF ACUTE RADIATION AT HIGH DOSE RATES
Table 3-36 represents the expected early effects of acute whole-body
irradiation. It should be emphasized that these thresholds do not hold true
for partial body and protracted radiation of the same total dosage. They do
not cover exposure to simultaneous environmental stress of other types. The
latency periods and relative duration of symptoms are dependent upon the
penetration, quality factors, total dose, dose distribution, and intensity of
the exposure. In very general terms, limiting systemic and/or tissue
responses are:
I. Acute gastrointestinal or prodromal symptomatology, i.e.,
nausea, vomiting, diarrhea. These may appear within an hour
or two and subside within a day at any dose above about 50-
100 r at the midline.
Z. Acute hematopoietic symptomatology, i.e., thrombocytopenia,
leukopenia, hemorrhage, intercurrent infection. These symp-
toms will appear within a few days to a week and can reach a
clinically aggravating level at doses of 50-150 r or more to the
marrow within several weeks to a month.
3. Widespread erythema and skin blistering. Under certain cir-
cumstances, such as extravehicular operations, high intensity
surface exposure with little deep tissue dosage may occur.
Depending upon the quality of the radiation, erythema will appear
within a few hours to days following exposures of 400 r to 800 r.
Severe damage will occur at doses above 1400-2000 r. Due
to the restrictions and abrasive contacts of the space suit, even
a partial body moderate erythema could become extremely uncom-
fortable and somewhat incapacitating.
4. Degradation of general operational skills through direct and
indirect physiologic and neurologic injury, i.e., lassitude,
fatigability. At lower doses, acute systemic radiation injury
is accompanied by nebulous symptoms of reduced performance
capacity interfering with information processing, decision-making,
emotional stability, and motivation often related to the prodromal
symptomatology. At higher doses, vascular shock, cerebral
edema, and hypoxia of the central nervous system all contribute
to the entity often referred to as the "central nervous system
syndrome. "
l
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Dose in Rads
0 to 50
50 to l O0
i00 to ZOO
200 to 350
350 to 550
550 to 750
lO00
5000
Table 3-36
Expected Early Effects from Acute Whole-Body Radiation on Earth
(Modified from Glasstone (102))
Probable Effect
No obvious effect, except, possibly, minor blood changes
and anorexia.
Vomiting and nausea for about ] day in i0 to 20% of exposed
personnel. Fatigue, but no serlous disability. Transient
reduction in lymphocytes and neutrophils.
Vomiting and nausea for about i day, followed by other
symptoms of radiation sickness in up to 50% of personnel;
< 5% deaths anticipated. A reduction of approximately 50%
in lymphocytes and neutrophils will occur.
Vomiting and nausea in 50 to 90% of personnel on first day,
followed by other symptoms of radiation sickness, e.g., loss
of appetite, diarrhea, mlnor hemorrhage; 5 to 90% deaths
within 2 to 6 weeks after exposure; survivors convalescent
for about 3 months.
Vomiting and nausea in most personnel on first day, followed
by other symptoms of radiation sickness, e.g., fever,
hemorrhage, diarrhea, emaciation. Over 90% deaths within
I month; survlvors convalescent for about 6 months.
Vomiting and nausea, or at least nausea, in all personnel
within four hours from exposure, followed by severe symptoms
of radiation sickness, as above. Up to 100% deaths; few
survlvors convalescent for about six months.
Vomiting and nausea in all personnel within l to 2 hours.
Probably no survivors from radiation sickness.
Incapacitation almost immediately (several hours). All
personnel will be fatalities within one week.
• k -¸
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Figure 3-37 presents the mean survival time of man vs. the acute tad
dose of whole-body x-ray radiation. The major cause of death is indicated
for the appropriate dose range. The possibility of GI tract death and CNS
damage occurring at lower doses with protons and alpha particles will be
covered below. Defects in all functions of these organ systems can be
expected.
•0a p
E
I-
L
100
102
- SLJRVIVAL Ti_^E
VS. DOSE A_A FOR
i-iCMATGP Oi E TIC
DEATH N MAN
\
Hematopoietic G I Tract Central Nervous
'_Dep ressionSen u datio_'_'System De fec_-_
I
' , q , q , , ', { , • I '
1O" 1O4 105
DOSE- tad
Figure 3-37
The Relationship Between Mean Survival Time and
Acute Radiation Dose for Man
This curve is extrapolated from animal studies and
very few human studies. It holds only for acute
total body radiation. Note spread of oata.
(After Grahn (103) Adapted from Langham (146))
Whenever possible, the above responses will be examined in a probabilis-
tic manner. Not all individuals may show the symptoms mentioned above at
the stated dose levels, in defining upper-limit emergency doses, the lowest
limit will be the first determinant, modified by depth-dose protraction, dis-
tribution, and dose rate. For example, at high dose rate whole-body expos-
sure to a penetratlng radiation will undoubtedly cause the dose for prodromal
responses to be determinant. A more protracted exposure will bring hema-
topoietic injury into the determining position, and when moderate to high doses
of very low energy radiations prevail under certain unshielded exposure con-
ditions, skin injurywill be determinant.
E" _- " ...
i , , .
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Alteration of these response patterns by space radiation is not clear.
Protons, like neutrons, are more effective in producing gastrointestinal
symptoms following whole-body irradiation of several species (68 ,69 ,70 ,
72 , 134 , 154 , Z59 , 267). How much protonswill modulate the usual x-ray
response in humans is not clear since the effect is postulated to be a complex
function of relative secondary electron flux in bone, bone size, marrow
geometry, ionization density, LET, dose distribution, and dose rate. Early
reports that hemorrhage appears earlier and is more severe in large animals
irradiated by proton than by x-ray (69 , 70 , 108 , 178 ) have not always been
substantiated (267). Symptoms of the nervous system are variable. Death
is reported in animals exposed to Z000 rads of 187 MeV proton within 100 to
ZOO days after exhibiting central nervous system (CNS) symptoms (ZI6). It
has also been found that 6000 rads of 40 MeV protons to the whole-body
3 -48
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(given in two parts - upper and lower halves) caused convulsive seizures and
death in about 48 hours following exposure, suggesting a CNS radiation effect.
Possible latent or long-term effects based on this observation of a gradual
onset of lethargy, anorexia, and ataxia exhibited among survivors of whole-
body, proton-irradiated animals at Z i/2 to 5 i/2 months irradiation have
been suggested but not always found (267). In extrapolating from animal data,
profound species differences must be kept in mind (39, 61 ). The above
animal data should not be used as examples of dose-specific symptoms
expected in man after proton irradiation but as background information about
possible aberrant responses in humans to be guarded against when extrapolat-
ing to proton radiation effects from x-ray or gamma data obtained from
radiation of humans.
Even less is known about high energy alpha particles. Differences in the
timlng and severity of response between high energy protons and alpha parti-
cles in small animals have been demonstrated (258). Extrapolation to humans
is not as vet oossible from these data.
..- . : ,
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Lethality
In studying human lethality after irradiation many LD50 doses have been
proposed ranging up to 700 rads (28, 63, 10Z, 114, 154, 178, 179). The
spontaneous 60-day death rate for persons between 25 and 44 years is .02°70
(148). Data obtained from irradiation of patients (160, 292), atom bomb
casualties (39, 292), large animal studies (60), and evaluation committees
(145, 185, 278) have been reviewed, and the best probabilistic early-lethality
curve for acute total-body irradiation has been proposed as seen in Figure 3-38.
This study suggests an LD50 value of fi86± fi5 for normal man. The suggested
values for LDI0 and LD90 are given in Table 3-39. These recommendations
can be compared with previous LD50 estimates for humans indicated by
different committees and groups as seen in Table 40.
_- t DoGs--/,
9 2 3 4 5 6 7 8
DOSE(hundredsof RADS)
Figure 3-38
Derived Dose-Lethality Relationships for Dogs,Monkeys
and Human Patients and a Postulated Relationship for
Normal Man.
(After Langham (ed.)-NAS-NRC (145))
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Table 3-39
Estimated High-Intensity Whole-Body Dose Levels for Production of Hematopoietic Lethality*
(After Langham (ed.)-NAS-NRC (145))
Response
Probability
Level Dose
(per cent) (ra ds) _'._:',-"
i0 220
50 Z85
90 350
;:-'Symptoms begin wlthin a few hours with the prodromaI
reaction, followed by progressive hematological deDres-
slon terminating in death in 2 to 8 weeks.
;',_<:Point of interest for dose estimation: ll-cm depth;
QF assumed to be unity.
i " ' -
, '2;" ' " .
Table 3-40
Estimates of LD50 of Man for High-Intensity Radiation Exposure
(After Langham (ed.)-NAS-NRC (145))
Source
Patients,
Exposure Dose Reference
(R) (rads) a
pathology of
atomic bomb casualities
Committee evaluation
Mar shalles e observations,
large-anlmal studies --,350
Committee evaluation --
Whole-body exposure b
of patients 370
Whole-body exposure
of patients 380 b
Whole-body exposur e
of patients and
_,450
4OO -6OO 300b0b260-40
300
300-500 c
243±22
Z50±Z8
Warren and Bowers (292]
NAS-NRC (185)
Bond and Robertson ( 39
Cronkite and Bone ( 60 )
United Nations (278)
Lushbaugh et al (160)
Langham (ed. ]NAS-
NRC (145)
accident cases 430 b 285±25 Figure 3-38
a Average absorbed dose near mldline of the body.
b Assumlng radiation of the quality of 137 Cs gamma rays.
c Nature of radiation and point of dose assessment not specified.
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Partial-body, nonuniforrnly-distributed doses are less effective than a
uniform whole-body dose for production of lethality in the dosage range of the
early hematological syndrome. Except when exposure involves a major por-
tion of the trunk, this decrease in effectiveness is true, even when the dose is
expressed in terms of integral absorbed energy (kilogram-rads). A dose to
the extremities exclusive of the trunk would be much less effective. Based on
fraction of total body mass and active bone marrow, an arbitrary choicc of a
volume factor (f)of I/5 has been suggested for the extremities (145). Dose
, . , V •
dlstrlbutlon effects on lethahty are covered in section on Dose Distribution
Factors and Progressive Performance Decrement].
In animals, the LD50 dose increased with decreasing energy (decreasing
depth dose) (106). Sparing a portion of the bone marrow by nonuniform dose
distribution (either by irradiating only a portion of the body or by decreasing
depth-dose distribution) results In increased protection against early death
(145). Under operational space conditions, the geometry of a high-intensity
exposure through influence on depth-dose distribution may have a pronounced
effect on lethal response if the shielding geometry of the spacecraft and
position of the crewmen are such that dose delivery approximates unilateral
exposure. Use of rnidline tissue dose to characterize exposure seems to give
the most acceptable correlation with response for exposure geometries other
than unilateral exposure (39). The quality factors of Table 3-3 may be
applied. Protraction factors for lethal doses are given in Table 3-5, Figure
3-53, and the discusslon of Progressive Performance Decrement.
Prodromal Symptoms
in spite of individual idiosyncracy, the dosage parameters for prodromal
reaction follows a definite pattern ( 99, 10Z, 148 , 157 ). After a short latent
period, a feeling of fatigue is followed by depression and emotional distur-
bance accoPnpanied by anorexia, nausea, retching, salivation, and vomiting.
Intestinal cramps and diarrhea occur prodromally at lethal doses. Symptoms
reach a peak in about 4 to 6 hours and then improve rapidly. For 200 and 300
rads the peak may occur as quickly as 2 hrs after exposure. The degree of
upset and duration of recovery depend on size and location of dose, on indi-
vidual sensitivity, and, most importantly, on the dose rate. Radiation to the
eplgastrium is particularly productive of prodromal systems. The volume
factor (fv) for irradiation of extremities should be the same as that for lethal-
ity or hematologic response, or i/5 that for whole-body radiation (145). Anti-
nauseant and tranquilizer therapy are effective in reducing symptoms.
The time of onset of the prodrornal complex of nausea and vomiting,
empirically derived, may be seen in Figure 3-41.
The dose response is a probabilistic function expressed often as the 50%
symptom dose or SD50. The probability of symptomatlc response may be
expressed as a normal or logarithmic function:
or
Y = a ÷ b(D) (8}
Y = a + b(log D). (9)
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Figure 3-41
Anticipated Elapsed Time Between Irradiation and
Onset of Severe Nausea and Vomiting in a
Sample of 100 Persons Exposed to Radiation
Doses in the Lethal Range.
(After Langham (ed.)-NAS-NRC (145) Adapted
from Gerstner (99))
In either case, Y is the probability of the response as percent transformed
into probit units, D is the radiation dose, a is the intercept, and b is the
slope constant. Such dose-response relationships can be used to predict a
dose that will elicit any given level of response in an infinitely large number
of sublects, providing the fiducial limitations of the data are known. Data
from atom bomb casualties, nuclear accident victims, and irradiation of
cancer patients have recently been summarized (145).
The 1_ost well-controlled data were obtained from 105 patients treated
for neoplastic disease by isotroplc gamma radiation in the Cesium 137 total-
body radiation facility at the Medical Division of the Oak Ridge Associated
Universities (159, 160). The data were normalized to an effective rad dose
of the prodromally sensitive epigastrium (100 r to the midline results in only
66 rads to a i0 cc epigastric volume). A dose rate of i. 5 r/min was used.
Table 3-42 gives the extrapolated SD 10, SD50' and SD90 with account
Table 3-42
Estimated High-Intensity Radiation Dose Levels for Production
of Early Prodromal Response
(After Langham (ed.)-NAS--NRC (145) from data
of Lushbau§h et al (145'159'160))
i' '7
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ABSO_.BEI| DOSE FOR PROB_,BILI1 "iOF KESI'O_,SE _rads)
CL I-,IC,_t. $I(,N |0 PEECENT [,(}PERLt NT 90 PERCENT
Anore×]a 4(I 100 240
Nausea 50 170 320
VomHing 60 215 _,80
Diarrhea 90 2-1,0 $90
Point of interest for dose estimate: a 26-cm diameter sphere in the
mid-epigastric region; QF assumed to be unity.
made of the concurrent signs of disease by Abbottts method. Because of the
nature of the patients and the uncertainty of the corrections for concurrent
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illness, this table should be considered conservative with higher SD values
and wider range of distribution than would be expected in a normal population.
The data shown in Figure 3-41 and Table 3-42 are extrapolated from
x-ray and gamma experiments and may not be quantitatively appropriate for
space radiation, especially when depth dose variations'are brought to bear.
Appropriate modification of these probabilities for multi-energetic protons
and alpha particles as well as for specific dose rate factors is not known
from empirical data. Quality factors should follow suggestion of Table 3-3
slnce the radiation at midepigastric region should typically give a low enough
LET to have a QF of i.
Dose protraction is known to affect prodromal symptomatology (see
Table 3-5). Increased sensitivity to large second doses has been noted as
well as the prolongation of fatigability and listlessness for as long as 60 days
after sublethal exposures (145). Predictions for chronic low level exposure
will be covered below under Progressive Performance Decrement onp. (3-63).
• : r •
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Hematological Syndrome
Hematological responses to radiation are largely dependent on damage to
the marrow and lymphoid tissue (55 , 202). Damage to the chromosomal
mechanisms of the cell inhibit normal division and reproduction of the ele-
ments, resultingindecrease in blood counts. Signs and symptoms develop in
relation to depression of specific elements. Whole-body irradiation with
doses in the lethal range (above about 200 to around 600 rads) causes a
typical illness characterized by early transient nausea and vomiting (the pro-
dromal syndrome) followed by a latent period of several days or a week or
more, the length of which is inversely related to the dose (see Table 3-36).
Signs and symptoms then develop relating to depression of blood elements;
infections and fever, relating to granulocyte depression and impairment of
immune mechanisms; and bleeding and possibly anemia, relating to platelet
depression. Anemla from red-blood-cell depression does not usually occur.
These symptoms may lead to death if the bone marrow is incapable of re-
sponding in time by adequate cellular regeneration.
The time-course of changes in most of the peripheral-blood elements is
fairly well correlated with the dose of radiation to the bone marrow. The
description is taken from recent revlews of the subject (55 ,145 ). Based on
dose relationship of these changes, the following categories of prognosis in
irradiated persons may be made: (1) survival almost certain (dose <i00
rads); (2) survival probable (dose i00 to 200 rads); (3) survival possible
(dose 200 to 500 fads); and (4) survival very improbable (dose greater than
500 to 600 rads). Figures 3-43 a to d indicate roughly the smoothed aver-
age time-course, based on the human cases from accidental exposure, for
lymphocytes, neutrophils, andplatelets in these four categories (37 , 44 ,
6Z ,i09 , I15,117 ,124 ,145,159 ,254 ,288 ). The changes are represented
as percentages of normal counts (the average levels for the population), and
the curves portray generally the t_me-course of changes as a function of
radiation dose.
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Figure 3-43
The Time Course of Blood Changes After Different Doses of Radiation of QF = 1.
(After Langham (ed.)-NAS- NRC (145) from many sources '(see text))
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Thelvmphocyte count (Figure 3-43a) is significantly depressed in i to Z days
even wlth doses of less than i00 rads and approaches zero at that time with
near-lethal doses. The return to normal is slow and may be incomplete
months and even years later, as has been the case with the exposed Marshal-
lese people (56). Neutrophils increase in the first few days after exposure
to doses greater than I00 rads (Figure 3-43b). This initial leukocytos_s is
even greater with higher doses. The neutrophil count then declines steadily
and either levels off or has an "abortive rise" after about 8 to Z0 days unless
a lethal dose has been given. Absence of this latter phenomenon following
substantial radiation dose is a grave prognostic sign. Following the abortlve
rise, further depression ensues, the nadir being reached earlier with higher
doses (8-10 days with lethal doses to 40-45 days with sublethal doses). If
profound neutropenia occurs, serious or fatal febrile infections may develop.
If the bone marrow is able to regenerate sufficiently before overwhelming
infection and death occur, the neutrophil count will climb toward normal
during the ensulng weeks, and recovery of the individual is likely. Complete
return to normal counts may be delayed for months, or, with higher doses,
the counts may actually rise above normal levels for a time.
Changes in platelet counts are shown in Figure 3-43c. Lowest levels
are reached in about 24 to 32 days following all but lethal doses where levels
may approach zero by i0 to 15 days. Bleeding is likely to develop when the
platelets approach zero. With bone-marrow regeneration, platelet recovery
may begin rapidly but be incomplete for months or years.
Figure 3-43d shows an idealized average dose-response relationship
for lymphocytes, neutrophils, and platelets in which the nadir of each of the
blood elements is plotted against dose.
Daily fluctuations in individual counts and normal variations among
individuals limit the usefulness of blood counts as a direct biological dosi-
meter or precise detector of radiation damage. However, repeated hema-
tological examinations afford valuable prognostic information. The lympho-
cyte count is valuable as an early criterion of radiation injury. If there are
i, ZOO or more lymphocytes/mm_ at 48 hr after exposure, it is unlikely that
the individual has received a fatal dose. Lower lymphocyte counts at this
time indicate more serious exposure. Neutrophil and platelet counts are of
value in following subsequent progress of exposure cases and as general
indicators of the seriousness of the exposure.
Although preclse information is lacking on the threshold doses neces-
sary to produce symptoms from blood-cell depression, it might be stated
generally that only a few individuals would show hematological symptoms
following a whole-body dose of Z00 fads, but that a majority would show them
following about 300 rads.
The key points of the curves in Figure 3-43 are summarized in Table
3 -44.
Radiation doses to different parts of the bone marrow undoubtedly will
vary widely under space flight conditions owlng to variations in shielding
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of the spacecraft, in energy and penetrability of the space radiations, and in
distribution of active bone marrow throughout the body. The principal loca-
tions of active bone marrow are the pelvis, spine, ribs, and proximal ends
of the bones of the extremities ( 8 ). The depth of the bone marrow varies
from about i to 15 cm. For calculation and assessment of dose to the blood-
forming tissueg, the average effective depth of the active marrow is given
as 5 crn. Although no definitive statements can be made at this time regard-
ing the quantitative influence of nonuniform dose distribution on early hema-
tological response, animal experiments show definitely that uniform whole-
body exposure is more effective than nonuniform exposure for the production
of hematological effects, even when expressed as integral absorbed dose in
kilogram-rads ( _ ,I13 , 171 ).
Table 3-44
Estimated High-Intensity Radiation Dose Levels for Production of Hematological Depression"
(After Lanqham (ed.)-NAS-NRC(145))
An_x_r_Fl_ t_o_ FOR X]mC:TIO_ FRO_a _,or'qal rad_ **
CIRCVLA'FI_.c ;£I.EMENT 2 _, I'} RC{ "_; 50 I,F gCIN_ 75 PERCA n [
Platetcts " * "" 50 120 250
Lymph(,c,,les '* * _" 60 150 300
Neutrophils a- -,, a- 80 190 390
*Symptoms appear within 1 to 10 days after bone marrow exposure.
**Point of interest for dose estimation average depth of 5cm: QF assumed to be unity.
*** _3,25, and 30 days, respectively, for lymphocytes, neutrophils, and platelets.
Quantitative approaches to the evaluation of effects and recovery from
nonuniform exposure have been proposed ( 38, 202 ). Under nonuniform ir-
radiation the unequal distribution of dose to the bone marrow should permit
a higher rate of survival than if the same average dose were distributed
uniformly. This is due to the exponential nature of dose effect on survival
of bone-marrow stem cells. Furthermore, it is considered possible that
stem cells from unirradiated marrow migrate to irradiated areas and hasten -- - " "
regeneration. However, migration of stem cells may not be as significant , .... -..; , -
in hulxians as in small rodents. The strong dependence of early hematologi- ;-. - - -
cal effects on the region of the body irradiated suggests that emergency
partial shielding of the bone marrow be considered. Local shielding of the
pelvic region would probably be the most beneficial since about 40 percent
of the bone marrow is located there. Such a procedure would markedly
increase the chance of surwval in cases of high dose exposure. The volume
factor (fv) for irradiation of extremities should be about 1/5 that for whole-
body irradiation (145). (See Distribution, page 3-7.)
i k _ k_
- . " k
From several studies it is apparent that marrow exposures will be of
varying fractions of weakly-penetrating space radiation at high LET and
highly-penetrating radiation at low LET. (See Figures 3-25, 3-32, 3-34,
and 3-35). For rough estimation, work with primates suggests that the
overall LET is _<3. 5 keV/_ and that a QF of 1 should be used for the entire
flux as seen in Table 3-3 ( 68 , 69 , 70 , 71 , 135 , 145 , 153 , 154 ).
k ,
J
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Suggestions for dose protraction factors are given in Table 3-5.
Skin Reactions
Early responses of the skin to radiation exposure may be particularly
important to manned space-flight operations, especially those involving
extravehicular activity and light to moderate shielding. A few systematic
clinical investigations have been relied upon heavily in deriving the limited
dose-response relationships for human skin that are established at this time
( 7 , ZI , 78 , 81 , 131 , 161 , Z06, Z13, 214).
The levels of early skin response in order of increasing severity are
usually designated as (I) erythema, (Z) dry desquamation, (3) moist desqua-
marion (vesiculation), (4) slough of skin layers, and (5) chronic ulceration.
The first four levels of reaction are often followed by restoration of the
_rradiated skin to near-normal or pre-exposure conditions; however, clini-
cally evldent permanent changes occur regularly after doses that yield at
least a dry desquamation response.
Table 3-45 represents the air dose-response of the skin for early symp-
toms following acute x-radiation.
Table 3-45
Radiation Damage to the Skin*
(After Grahn (103) Adapted from Saenger (232) and Cronkite et al (183))
Afoist desquarnation Ulceration (third
Epilauo. Erythema (first and blistering (second degree burvJs)
.loss of hair degree burns) de_ree burns/
Rare at less
than 200 r
Partial epilat_on
at 350-450 r
Complete epilatlon
lr 16-18 days
at > 450 r
Permanent epilatlon
at > 700 r
Response is dependent
on energy, dose rate,
area exposed, & com-
plexlon of the xndividual.
Full effect in 1 to 3
weeks after:
200-400r (<150 key)
500-600 r (200-400 key)
800-1000 r (>400 key)
Response tn first _ours
at 1000 r
Effect m 1-2
weeks at
> I000 r
Rapidly progresstve
effect at > 2000 r
. .,.
t j" -,
z --
*These statements are based on air doses. Dose estimates are at 0.1 mm
depth where 1 r _ 1 rad.
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The ED's for skin responses have been evaluated in the light of un-
certainties regarding effects of quality of radiation, local skin areas, end-
points, etc. The only reactions with adequate statistical data are erythema
and moist desquamation for fields of tess than I00 cm 2 (145). The estimated
responses are seen in Figure 3-46. It is probable that the dose response
curves for more severe erythema and dry desquamation would lie between
these curves. The statistical projections are summarized in Table 3-47.
The factors modifying radiation effects on the skin are numerous and more
closely studied than many of the other responses. They include (i) quality
(LET) of the radiation, (2) dose fractionation and total time over which ir-
radiation occurs, (3) dose rate, (4) depth-dose distribution, (5) area of skin
irradiated, (6) anatomical region exposed, and (7) presence of other irritants
or trauma.
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Figure 3-46
Dose-Frequency Relationship of Minimal Erythema (177)
and Moist Desquamation (7,81,131,206) (Clinica Tol-
erance Response) forAcLLte Exposure 200kVl_ X-rays
for Areas of <100 cm_ and Dose Rates >30 rads/min
(After Langham (ed.)-NAS-N RC (145))
Table 3-47
Estimated Doses of High-Intensity Radiation (QF=I) at 0.1 mm Depth
for Production of Erythema and Desquamation of the Skin
(After Langham (ed.)-NAS--NRC (145))
A[I_ORBED DOSE FOE I'ROBABILIT_, (J} P_SI'O%SE rads
CLINICAL SIGN |0 PERCENT 50 PERCEN[ 90 PERCENT
E_'thema =J00 575 750
Desquamatlon 1,400 2.000 2.600
An overall modifying factor (QF E) weighted for LET should be applied
to the dose values given here (See Table 3-3). An area effectiveness factor
of 1.25 is suggested to reduce the dose values given here when exposure
involves skin areas up to or greater than 150 cm 2.
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Corneal lesions can occur after 2500 r of I00 kVp x-rays and lower energy
cathode radiation (220).
Quality
The sensitivity of skin to low energy protons and alpha of high LET has
already been covered. Primate studies with 1440 rads and 5200 rads of 32
MeV protons lacking sufficient range to penetrate to the marrow and gastro-
intestinal tract, show that the skin and subcutaneous tissues can bear the
weight of the injury ( 67 , 154). During an initial quiescent period of 2 weeks,
only epilation and erythema were noted on the skin, accompanied by anorexia
and dehydration. In the next two weeks the erythema turned to ulceration of
the skin and mucous membranes of the mouth with massive edema of the soft
tissue. The lesions began to heal poorly at 5 weeks. Capillary and lympha-
tic damage appeared to be a prime factor. These signs progress in primates
to severe fibrous contracture of the skin which leads to immobilization and
often death from starvation (178, 195).
The threshold dose for the late alpha and proton effect in humans is not
yet known. Animal studies with electrons of varying penetration suggest that
the threshold dose at 0. l mm for death of the critical basal layers of the
epidermis is about IZ00 to 1700 rads for transdermal injury; 1800 to 2500
fads for atrophy and chronic inflammation. Comparative data for pertinent
protons and alpha may be extrapolated from the RBE or QF - LET relation-
ship of Table 3-3. Some reservations should be held because of the under-
tainty regarding dose-rate-dependent quality factors in skin radiation (131,
14_).
For high-intensity single exposure, observed RBE values for radiations
of LET >3.5 keV/u (largely soft x-rays and fast neutrons) for production of
early skin reactions have been in the range of 2 to 3. In converting absorbed
dose of space radiations to local dose equivalents for production of early
skin responses, it should be kept in mind that for high-LET radiations, QF
appears to increase more slowly with increasing dose fractionation than for
conventional x-ray exposure (145) (see Figure 3-49). Some compromise
between the recommendations of Tables 3-Z and 3-3 will have to be arrived
at for fractionated dosage patterns leading to subacute injury (see below).
.. , _ . .
Dose Fractionation
The repair of sublethal injury in the surviving cells and the proliferation of
the surviving cells between fractions determines the dependence of ED50 and
TD50 (doses required to produce 50 percent erythema and moist desquamation
response, respectively) on fractionation number and total time required for
dose administration (89). The •repair of sublethal cellular injury after moder-
ate doses is complete or very nearly so in less than Z4 hr. Cellular repopula-
tion of irradiated tissues is a much slower process. Accordingly, the ED50
and TD50 are sensitive to the number of equal fractions into which the total
dose is divided (administered at ->24 hr intervals) and are less sensitive to
the total time of its administration (7, 53, 54, 82, 161, Z06, ZI3, ZI4, Z64).
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Figure 3-48 shows the effect of daily fractionation of dose on the ED50
and TD50 of 200- to 250 kVp x-rays (30 to 60 rads/min, 35 to a I00 cm 2
area). In none of the clinical studies are there applicable data for more than
about 40 fractions. If the expressions shown in Figure 3-48 are to be extra-
polated to long times or to large fraction numbers, a slope constant of per-
haps 0. 25 may be more appropriate (145).
Figure 3-49 suggests that radiations of low LET show a greater RBE
sensitivity to dose fractionation than do radiations of higher LET.
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Figure 3-49
Effect of Dose Fractionation or Overall Exposure
Time on Dose Producinq 50 Percent Probability
of Erythema (ED=n) (16"1,213,214) and Moist
Desquamation (T[_50)(81'131'206)_ of Human
Skin (200-250 kVp x-rays).
Dependence of Erythema (ED50) and Moist
Desquamation (TD50 _) of Human Skin on
Radiation Quality (LET).(fn = fast neutrons)
(After Langham (ed.)-NAS-NRC (145})
(After Langham (ed.)-NAS-NRC (145))
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Dose Rate
A given dose of radiation administered continuously at relatively low dose
rates is known to be less effective in producing early skin reactions than is
the same dose given at a rate of >_30 rads/min. Clinical estimates of the
dependence of skin reaction on dose rate (for a single exposure only) are
shown in Figure 3-50. The only empirical data are the symbols and solid
lines (206). ALl other points are extrapolations (145).
Depth Distribution and Area Factors
It has been determined from study of effective depth-dose patterns with
different isotopes that any dose to a depth of >_0.9 mm should be considered
as capable of producing full skin reactions (177).
The dose required to produce a given response is larger for an area of
a few cm 2 than for one of a few hundred cm 2 withboth x-rays (81 , 131,
i_
i_ ••', , _
:. "-
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53 , Z06) and electrons (Z56). Above _ 400 cm 2, the size of the area irradi-
ated has little effect on the dose required to produce a given level of response.
Figure 3-51 illustrates the effect of area irradiated on skin-tolerance dose(TD 50) over the range of 30 to 600 cm 2 for Z5 treatments given over a period
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Figure 3-50
Dose-Rate Dependence (Single Exposure Onlv)
of Erythema (ED50) and Moist Desquamation
(TD50) of Human Skin (200-250 kVp x-rays).
(After Langham (ed.)-NAS-NRC (145) Adapted
from Paterson (206)).
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Figure 3-51
Effect of Area on Response of Human Skin to
Radiation Exposure (Upper Curve, Skin Tol-
erance Dose, TD50, for 25 Treatments Given
Over 5 Weeks; Lower Curves, TD50 and ED50
for Single Exposure).
(After Lanqham (ed.]-NAS-NRC (145) from data
of Paterson -(206))-
of 5 weeks (upper curve). The lower curves demonstrate the possible effect
of area irradiated on the slngle high- intensity exposure TD50 and ED50. In
this case, the TDs0 and EDs0 curves are drawn parallel to the upper curve
through the established points of 2,000 and 575 rads for the high-intensity Z
tolerance and erythema doses, respectively, for an exposed area of i00 cm
In view of the limited data, it has been suggested that the erythema and toler-
ance-dose values perhaps should be lowered by about 20 to 25 percent if
applied to situations in which the potentially exposed skin area may exceed
i00 to 200 cm 2 (145). These considerations are related only to effect of
area exposed on the ED50 and TD50 and do not apply to effect of area of skin
involved on the degree of discomfort and the probability of producing decre-
ment in performance. It is suggested, therefore, that in calculating RES,
the space-radiation dose (D) be multiplied by an area-effectiveness factor
(fa) of I. 25 to evaluate the reference equivalent space exposure (RES) when
exposure involves skin areas greater than _150 cm 2(see Distribution, page 3-7).
The less sensitive regions of the body are the face, trunk, arms, and
legs; more sensitive regions are the dorsa of the hands and feet, the scalp,
the eyelids, and the perineum. Data are not available from which an esti-
mate of the ED50 or TD50 for hands and feet can be made. The response
threshold for skin of these regions appears to be about 15 to Z5 percent less
than that for skin on the trunk (145).
. ,,..
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Irradiated skin exposed to chronic irritation or trauma, such as from
tightly fitting clothing, will develop a more severe reaction than would non-
traumatized skin. The increase in severity would be a function of the type of
trauma and whether the area was being continually subjected to traunha during
the course of the development and healing of the reaction. Exposure to ele-
vated local temperature would alto act to augment the reaction. It has been
suggested that exposure of irradiated skin to trauma and irritants could effect
a reduction in ED50 or TD50 by a factor of_0. 25 (145).
Germinal Epithelium
- . - - . • -
The sterilizing effect of radiation will not affect the success of a specific .....
mission, but may have a second-order psychological bearing on crew effec-
tiveness during the whole program. Due to the high radiosensitivity of the
gametogenic epithelium, the gonads are probably the most sensitive organs
of the human body. Table 3-5Z represents the expected dose-response curve
for nzale sterility obtained from experience with electromagnetic radiations.
Table 3-52
Radiation Damage to Gonads
(Adapted from Brown (42), Oakes and Lushbaugh (200) and Heller (116)
Dose Response
[5-100 rad
Z00-300 tad
400-500 tad
500-600 tad
Progress*re reductmn tn fertility with dose
reduced sperm counl _ oligospermia) and
increased frequencv of abnormal sperm.
Above 100 fads, azoosperm_a :s usually
evident at 10 weeks.
Temporary, absolute sterility (azoospermia)
for approximately iZ-15 months after [0 weeks
Temporary sterihty for [8-24 months
Probably permanent sterility, if indivxdual
survxves.
The time course of decreased sperm count is related to the fact that post-
spermatogonial cells are quite resistant to radiation. Cells beyond the second
and third phases of spermatogenesls continue to develop. Below 300 rads,
there is a normal sperm count for about 46 days with a sudden drop over the
next 10 or 12 days to a nadir at about 80-120 days depending on dose (146).
Above 300 fads, the sperm count falls after several weeks. Libido and
potency are unaffected up to about 600 rads. The lower the dose, the more
rapid the recovery. Beyond 500-600 rads, little or no recovery is seen (182).
A revlew of gonadal response after clinical x-ray exposure is avai[able (118).
The principal effect of radiation on the germinal epithelium is a direct
one (95). Therefore, nonuniformity of dose distribution, both topically and
in depth, would influence response of the germinal epithelium to space-rad-
lation exposure. For purposes of effective dose calculation and measure-
ment, the average depth of the testes is assumed to be Z. 5 cm (145). It
should be remembered that the testes are shielded in operational conditions by
at least 37 steradians of body shielding. The fact that radiation effect on the
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germinal epithelium is predominantly a direct one suggests the feasibility
of local shielding, if necessary, to lessen the probability of response.
The QF-LET factors suggested in Table 3-3 appear appropriate for
acute exposure of the germinal epithelium ( 20,145 , 199 ). It has been
pointed out, however, that in small animals some testicular cells are very
sensitive to high LET radiation; 6 rads of alpha particles causing a slgnifi-
cant effect (270). Under conditions of fractionated or protracted exposure
the QF-LET factors of Table 3-5 appear reasonable (260).
PROGRESSIVE PERFORMANCE DECREMENT
Where exposures are at low levels and where no early manifestations
occur, continued or periodic exposures can lead to a progressive decay in
health and in performance necessary to maintain flight operations. Quanti-
fication of this problem encompasses one of the most difficult areas for the
predictlon of biological effects.
Radiation injury has a comparatively slow time-course of expression
and its manifestatlons will progressively emerge, then subside. Expres-
slon and recovery are concurrent. When the exposure is essentially con-
_inuous but at a low daily rate, injury and recovery will probably equilibrate
and a steady state will be maintained for long periods. Such observations
have been made in experimental animal populations and certainly would occur
in man, but there are not yet sufficient data available to establish the kinetics
of injury and recovery with any degree of confidence (228).
One theoretical approach to this problem has lead to the evolution of the
"equivalent residual dose" (ERD) concept (32 , 73 ,148 , 172, 191,231 ).
This assumes a simple linear additive model for injury accumulation and con-
current recovery. The assumptions and constants employed in the ERD
calculation have never been validated in man and are often, for specific bio-
logical end points, in conflict with much present day radiobiological data
(201). The ERD concept is not based upon a correlation of physiological or
cellular injury with lethality, and therefore it cannot determine in any
realistic way a dose accumulation that can be related to an acute end point.
Dose protraction studies in larger anlmals may shed more light on the
problem ( 2 , 205 , 297 ).
The following discussion is taken directly from the recommendations
of the Space Radiation Study Panel of the Life Sciences Committee, Space
Science Board, NAS-NRC (145).
The possibility of radiation-induced progressive performance decre-
ment will increase with increasing mission duration. The highest-intensity
exposures will occur very infrequently and then only over a period of a few
days, such as during solar flares. Most exposures to radiation in space
flights are, therefore, expected to be at low dose rates, Since radiation
effects decrease roughly proportionately with decreasing dose rate, the early
effects described above for high-intensity exposures will become less marked
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or even absent under sufficiently protracted exposure, even though the dose _ i -....-_ ::_
rate during an occasional episode may be relatively high. Under these condi-
tions, as a result of a gradually accumulating injury to the blood-forming
tissues, more subtle effects may occur that may be accompanied by a reduc-
tion of the spacecrew's ability to maintain normal flight operatlons. This
injury may be characterized by vague symptoms of fatigability, headache,
dyspnea, reduced resistance to general stress, increased incidence of low-
grade infection, and decreased blood-oxygen transport.
In space radiation exposure, the expressions of injury and recovery are
concurrent. When the exposure to reference-quality radiation is essentially
continuous but at a low daily rate (perhaps 1 rad/day or less for man), the
rate of injury and recovery may approach equilibrium, and a steady state may
be maintained for long periods. Although the phenomenon of equilibrated
injury and recovery has been quantitatively defined in experimental animal
populations under specific conditions of exposure, the kinetics of injury and
recovery for man cannot yet be given with any degree of confidence.
.- . , - :- ...
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Prediction of man's response is difficult even when a regular pattern of
protracted or fractlonated exposure is involved. The erratic pattern of
exposure that may occur in most projected space flights, and the accompany-
ing moderate to serious depth-dose inhomogeneity, make extrapolation
virtually impossible at present. Sufficient dose protractlon {whether by low
dose rate or by fractionation) will lessen or even preclude the occurrence of
prodromal symptoms and early skin responses. Restricting one's selftoinjury
to the blood-forming tissues, the important questions are to what extent
damage to the bone marrow will be lessened and what time factors are
involved.
In the absence of any well-substantiated method of estimating an individual's
residual radiation damage from intermittent exposure and his capacity to
tolerate additional doses, the Panel suggests that a dose-accumulation pro-
cedure as outlined below be utilized. The procedure allows for any changing
effectiveness of accumulating dosage by taking dose rate into account. Al-
though there are insufficient data to permit a high degree of precision, the
Panel feels that some evaluation of dose-rate effects under the anticipated
conditions of exposure is important in determlning the radiation status of a
spacecrew. A suggested approach is outlined below.
l. Radiation absorbed by a crew on a deep-space mission will
typically result from occasional limited perlods of exposure
at elevated dose rates (which will vary from period to
period and with time during each period} superimposed on
a continuous low-dose-rate ambient cosmic-radiation back-
ground. The irregularities in dose rate can be smoothed
for calculation and accumulated on a mean-daily-dose basis.
Z. It is assumed that the effect per unit dose will decrease
linearly with decreasing dose rate.
3. For bone-marrow responses, doses delivered at dose rates
of 50 rads/da_ and above are assumed to produce maximum
injury per raa, while exposures at rates of 1 rad/day and below
are assumed to produce minimum injury per rad accumulated.
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/4. A dose-rate accumulation effectiveness ratio of 3 will be
assumed between these limiting dose rates, and linear inter-
olations of the accumulation-rate factor (RFA) may be made
r all intermediate dose rates (Figure 3-53). RF A should
not be confused with [r {Table 3-5), which applies only to
early responses withln,,_30 days after high-intensity exposure.
5. The RF A values taken from Figure 3-53 may be applied to
the space-radiation dose (D) in the general equation (3) to
derive a value for RES that allows for differences in
progressive bone-marrow injury as a result of differences
in dose-accumulation rate. It has been suggested that, for
extended missions, the acceptable mission-accumulated
exposures be set on the basis of the lowest dose rate
(1 rad/day or less) (see Table 3-66). This recommenda-
tion is consistent with standard practice in occupational
radiation protection. In contrast to early responses
where the standard exposure situation has always been
the high dose rate producing maximum effect, the standard
for protracted low dose-rate exposures has always been that
associated with minimum effectiveness. Therefore, RES
for progressive bone-marrow injury will only be subject
to upward adjustments by multiplying the space dose (D)
by RF A (which is always _I) to allow for increasing
effect as dose rate increases above 1 rad/day. As dose
rate and dose accumulation are protracted, expression of
bone-marrow injury approaches that of late or delayed
responses. It seems, therefore, that quality factors for
late responses (QFL) should be used for evaluating pro-
gressive bone-marrow injury. Quality factors for late
responses are given in Table 3-Z and equation (i).
It was also recommended that the contribution of daily dose increments
(assuming exposure of a major portion of the bone-marrow) to the accumu-
lated RES for progressive bone-marrow injury be evaluated as
RES (reu) = D (fads) x QF L x RF A (I0)
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Figure 3-53
Accumulation Rate Factor (RF A) for Progressive
Bone-Marrow Injury as a Function of Mean
Daily Dose Rate.
(After Langharn (ed.)-NAS-NRC (145))
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and subtracted from a pre-established acceptable mission reference-
equivalent space exposure (RES m) expressed in reu to give a chronological
record for the remaining allowable mission exposure.
An example of the manner in which a record may be kept of the accumu-
lated marrow exposure received by a flight crew during a hypothetical l-year
mission is shown in Table 3-54. In this example, it is assumed that the
Table 3-54
Example of a Dose Accumulation Record for a Hypothetical 1-Year Mission
(After Langnam (ed.)-NAS-NRC (145))
ELAPSED MEASt RED IEST"IM ATED A LI.OWA B|JE
TIME M_.AN DOSE ( D ) RE$ R_Sm
pERIOD DOS_ RATE RECEI_'ED RECEIVED b REMAINING
(days) tlads/day) (rads)* Rra (rcu) (reu)
-- 250
0-1 I0 10 1.4 14 236
2-150 < [ 15 1 35 221
151-152 20-30 45 2 90 131
153-364 ,<1 20 1 20 Ill
365 15 15 1.5 23 89
TOTAt 105 162
SAt 5-em _epth, t_ue-equivxlent: total-body expoQure.
b_ L assumed to be unity.
k ".,
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acceptable RES m,established on the basis of a risk-versus-gain philosophy,
was set at ZS0 reu. It is assumed also that exposure involved two traversals
of the geomagnetically trapped radiation fields, continuous low-level back-
ground radiation (_0. i rad/day), and interception of one major solar-flare
even on the 151st day. The example illustrates how such a chronological
record may give some feeling as to the progressive bone-marrow exposure
status of the crew during an extended mission.
The uncertainties in evaluating the risks from space-radiation exposure
increase disproportionately with increasing mission duration. For missions
up to 30 to 60 days, risk evaluation is based on a reasonable amount of factual
information. For missions beyond i year, evaluation becomes more and more ....
a matter of judgment. In an effort to provide some guidance for long-duration =
missions, suggestions of annual exposure-accumulation factors are given in
Table 3-55. The factors are given as a set of multiples of a l-year exposure
on the assumption that the l-year exposure is in the range of 200 to 300
reference equivalent units (reu). The factors are selected on the judgment
that any derived RES values will produce no clinical signs or symptoms of
hematological injury (such as infection, hemorrhage, fatigue, or fever) if
exposure is generally distributed or fractionated over the indicated time ,
periods. The factors do not increase in direct proportion with time; they .
drop away from simple proportionality to allow for uncertainties of damage
to recovery mechanisms and for possible cumulative effects of other stresses
associated with space flight.
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Table 3-55
Examples of Exposure-Accumulation Factors or Multiples
of the 1.Year RES a for Missions of Specified Duration
(After Langham (ed.)-NAS -NRC(145))
MISSION DURATION
_ycars)
NIUL'[I PLE
1 1.0
2 1.8
3 2.4
4 2.8
5 _.0
eat 5-cm depth, ti._Bue-equivalent tota]-[_od} exposure,
The NAS-NRC Panel believes that present knowledge permits a limited
prediction regarding tolerance to progressive bone-marrow injury. Although
it may be possible to judge from existing experlence when a population is
approaching the limits of its tolerance (the point where overt signs and
symptoms may appear), there is no way at present to predict individual
variations in sensitivity or distribution of sensitivities in the populatlon. The
variance of the population is an extremely important parameter of any
quantitative prediction, and present knowledge is far from adequate. In
general, the variance may be a function of age, dose rate, total accumulated
dose, post-irradiation time period, radiation quality, presence of other
physiologic stresses, and particular tissue or system involved. Since most
or all of these factors will be variables in space flight, quantitative and
accurate predictions will not be possible. With the above considerations in
mind, the consensus of the Panel is that a safety factor or uncertainty factor
(as the case may be) of Z may be inherent in the exposure-accumulatlon
multiples glven in Table 3-55. As exposure and time accumulate, the safety
factor becomes more of an uncertainty factor because of the gradual shift
of the response pattern into the late-injury mode. The limiting consideration,
therefore, is ultimately the extent to which long-term risks are acceptable.
Although it is not possible to avoid all risk of radiation injury, signs
and symptoms of early and intermediate injury to the blood-forming system
can be selectively avoided by controlling the exposure-accumulation rate.
However, the probability of manifestation of late radiation injury and general
life-shortening will increase in proportion to the total accumulated exposure.
.- -..._ _..,: _.
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LATE OR DELAYED EFFECTS OF RADIATION
Late or delayed manifestations of radiation damage are those that do not
appear until after a latent period of months, years, or the remaining life
span of the individual. These effects are nonspecific in that they cannot be
correlated to any particular radiation exposure. Lack of correlation between
a particular dose and ultimate manifestations of effect arises partly as a
result of the relatively long latent period before appearance of injury and
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partly because the effects from continuous exposures, multiple exposures, or
both are additive, but not necessarily in a I:I ratio in their final expression.
Late responses in what would appear to be a reasonable order of
relative importance to manned space flight are changes in the ocular lens,
permanent impairment of skin, general life-shortening, increased incidence
of leukemia and other neoplastic disease, and genetic manifestatlons. The
genetlc manifestations differ from the others in that they affect the progeny
of the irradiated individual rather than his health or faculties. The others
are manifestations of cumulative somatic injury.
In general, late (or delayed) effects are qualitatively the same, regard-
less of the nature of the radiation and whether exposure is continuous, inter-
mittent, or from a single high-intensity dose. Although modified quantitatively
by a variety of factors (including dose rate or protraction, depth-dose
distribution, portion and region of the body irradiated, and nature and quality
of the radiation), some delayed effects (life-shortenlng, increase of incidence
of malignancy, and genetic manifestations) are considered nonthreshold
phenomena and impose on an exposed individual a probability of response in
proportion to the total accumulated dose. In this case, the associated
actuarial risks provide both the necessity and the basis for limits to radiation
exposure in long-duration missions and space-flight careers.
Ocular Lens
Either acute or chronic exposure of the ocular lens will result in opacities
which may go on to true cataracts depending on dose (51, 5Z, 145, 168). The
time of appearance is highly variable and may range from as early as 6
months to many years after exposure. The higher the dose, the earlier the
appearance and the greater the degree of impairment. Because of the varla-
bility of clinical and accidental exposures, no definite response-probability
values for production of lens opacities can be assigned to specific radiation
doses. About 150 to g00 rads of reference-quality radiation is the minimum
cataractogenic single-exposure dose, and some lessening of effect appears
to result from dose protraction over a period of at least 2 to IZ weeks. This
is summarized in Figure 3-56.
It appears also that a single dose of about 650 to 750 rads of reference
radiation may have a cataractogenic probability approaching unity, 50 percent
of which may be progressive, resulting ultimately in impaired vision. The
slope of the time-dose response curve between single (l-day) exposure and
exposure protracted over an average time of _7 weeks suggests a ratio of
protracted dose to single dose of _Z for the doses required to produce the
same level of response. The dose protraction factor for lens opacities is,
thus, much less than for other tissues (79, 145, 161).
The incidence of cataract after a given dose level fractionated over Z to
12 weeks is shown in the histogram of Figure 3-57. The available data
suggest a log-normal dose-response distribution between the probability
limits and predict that doses between 550 and 950 rads (average 800 rads)
delivered over periods from Z weeks to 3 months may produce an opaclty in
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Figure 3-56
Time-Dose Relationship for Production of Late
Radiation Changes in the Ocular Lens, Sug-
gesting Probability Limits of 0 <= p <=--1.
(After Langham (ed.)-NAS-NRC (145)
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Incidence of Late Lenticular Changes
in Patients Who Received Photon
Exposures Fractionated over 2 to
12 Weeks.
(After Langham (ed.)-NAS-NRC {145)
from data of Merriam and Focht {167_)''
about 70 percent of those exposed. Of these, about 30 percent may be pro-
gressive and eventually result in impafred vision. On this basis, one might
estimate that about 20 percent of flight crews who receive lens exposures
of'_800 fads of ionizing radiation (equivalent in effectiveness to Z00-kVp
x-rays) in an interval from a few weeks to about 3 months may develop
clinically significant cataracts at some time during their lives. Table 3-58
represents a probabilistic summary of the dose response relationship after
acute and protracted radiation.
Review of animal and human data suggests an RBE of at least I0 for late
lenticular effects from recoil protons of neutrons under conditions of protracted
Table 3-58
Suggested Absorbed Doses a of Reference Radiation
for Production of Late Changes in the Ocular Lens
(After Langham (ed.)-NAS-NRC (145))
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pRIIllABILIT_ ¸ OF S[N(;LZ ([-D^'f_ DOSI I}OSl ¸. C
a_.s],o_ s_ (rads) (rads)
Minimal (p >_ O) 150 300
Mcdian (p _ 0.5) d 300 600
Maximal (,b --< 1) 650 1,300
a. Point of interest for dose estimation, 3-mm depth.
c. Dose protracted over 7 weeks or longer.
d. Assuming log-normal distribution of response.
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exposure (I, 166). Demonstrable observations of an increase in the RBE of
high-LET radiations with increasing dose protraction indicate that the slope !i"
of the time-dose curve approaches zero with increasing LET. It is advisable, l_
therefore, to use the QF-LET relationship given in Table 3-Z and the local
LET spectrum at the depth of the lens when considering delayed cataractogenic
effects of space-radiation exposure. Curves have been recently published on
specific QF values for different proton energies in lenticular radiation (75).
It has been noted that protons and neutrons may tend to produce more vacuolar
degeneration of the lens in animals than do other forms of radiation (Zll). :
• 77 i; .
Topical nonuniformity of dose distribution is highly important and suggests :'ii I
the feasibility of locally shielding the eyes to lessen the probability of late
lenticular changes from space radiations. Because of the rapid drop-off in
dose and local LET of the principal sources of space-radiation exposure,
nonuniform depth-dose distribution may also be significant. The average
depth to the surface of the lens is estimated as _3mm. Dose evaluation for .
late cataractogenic-effects, therefore, should take into consideration dose
and local QF at a depth of 3ram (145).
The RES for late changes in the ocular lens may be evaluated by the
expression
RES (reu) : D (rads) x QF L x Fpr (11)
where D is the space-radiation dose and Fpr is the protraction factor equal
to unity for protraction times of 7 weeks and greater and linearly increasing
to 2.with decreasing time to l day. As an example, if the pre-established
acceptable exposure risk for a mission of 7 weeks or longer (F r = l)
corresponds to minimal probability of lens response (RES = 30_reu), and
that exposure is anticipated to a space radiation having a predicted mean
QF L of 3, the allowable space-radiation dose (D) would be i00 rads. If
delivered in a l-day exposure, however, the allowable dose would be only
50 rads.
i " "F
It should be kept in mind that the greater the level of exposure, the
greater will be the probability that any cataracts produced will be progressive
and the shorter will be the latent period before development.
Chronic ulcerative lesions and opacification of the cornea can result
from 100 kVpx-rays in the Z000 - 3000r range, from lower doses of soft
x-rays (<75 kVp), and from _ radiation of <I-Z x 106 eV. (50, 220). Retinal
vascular occlusions have also been reported following x-radiation in excess
of that necessary to cause lenticular changes (50).
Permanent or Late Skin Effects
In the review of early skin effects (see Table 3-45 and discussion of
Figure 3-46), it was mentioned that clinically evident permanent changes in
the skin occur regularly after radiation doses that yield at least a dry
desquamation response. Furthermore, induction of skin malignancy is known
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to be one of the late or delayed oncogenic effects of single high-intensity and
protracted radiation exposure. The characteristic late radiation changes in
the skin are referred to collectively as 'chronic radiodermatitis" and consist
of telangiectasia, loss of hair, pigmentation, parchment-like appearance
with atrophy, keratosis, malignancy, and sensitivity to mild trauma. The
latter, combined with decreased capacity for healing, predisposes to chronic
ulceration. As with other late effects, manifestations of chronic radio-
dermatitis do not occur until many months or many years after exposure, and
their frequency and severity are proportional to the accumulated dose to the
exposed area.
Although minimal delayed radiation changes in the skin are not serious
per se, there is a general feeling by some that severe or symptomatic
radiodermatitis is a dangerous lesion because it is progressive and may
eventuate in carcinoma of the skin if the affected person lives long enough
(43, 204). The most common type of skin tumor resulting from radiation
exposure is squamous-cell carcinoma, although basal-cell carcinomas occur
frequently and appear to occur more frequently in the less severe and more
superficial type of radiodermatitis. The time between the first evidence of
skin changes and appearance of the cancer can average 7 years, with a
variance of I to 25 years. Tumors developing in irradiated skin appear to
possess a relatively low degree of malignancy with infrequent metastases.
Rates of ultimate mortality reported from radiation cancer of the skin,
however, have ranged from 5 to Z5 percent (145, 204).
Clinical experience has dealt largely with small exposure areas. No
observations are available on delayed consequences of whole-body skin
exposure. Data may become available with time as a result of total-body
electron exposure in the treatment of extensive skin diseases. Whole-body
exposures of primates to >900 rads of 3Z mev protons, has lead, as early as
i year, to severe fibrosis and contracture of the skin with immobilization and
starvation as the cause of death {178, 195). In these primates, no tumors
have been seen after 2 I/Z years.
Depending on total dose and dose protraction, late radiation changes in
skin vary from minor telangiectasia of cosmetic interest only to development
of the most serious sequela, metastatic carcinoma. However, quantitative
dose-response relationships for the varlous manifestations of chronic
radiodermatitis do not exist. There seems to be a correlation, however,
between production of an early desquamation reaction and manifestations of
minimal late effects (telangiectasias, mottled pigmentation) in that clinically-
evident permanent changes are observed regularly after early desquamation.
Based on this premise, the single-exposure dose-response relationship
for production of minimal late changes in the skin would be parallel to and
approximately the same as that for early moist desquamation shown in
Figure 3-46. Indirectly at least, there are observations that support the
above contention (145, 266). Back extrapolation from protracted dose
schedules suggest a single-dose equivalent of ---2,800 rads (small exposure
fields, _10 cm Z) for production of 50 percent probability of late necrosis
(8Z, 145, Z73).
i
ik
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As with early desquamation, the total dose required to produce chronic
radiodermatitis should show parallel dependence on dose protraction and
fractionation resembling that for early responses. This is seen in the
extrapolations from tenuous observations in Figure 3-59 (8Z, 145, Z66, Z73).
The late effects appear less sensitive to protraction than early effects. It
should b, emphasized, however, that, with sufficient protraction, enough
dose can accumulate to produce severe radiodermatitis, including cancer,
wnhout ever producing any early response.
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Figure 3-59
Comparison of the Time-Dose Curves for Late Radiation
Necrosis and Early Moist Desquamation.
(After Langham (ed.)-NAS-NRC (145) from the data
of Sulzberger et al (266), Traenkle and Mulay (273),
and von Essen (82))
Table 3-60 probabilistically summarizes the suggested absorbed doses
for production of late skin necrosis. As with ocular-lens changes, the time-
dose response curve for skin necrosis suggests a decreasing effect with
increasing dose protractlon, such that the ratio of protracted dose (approxi-
mately equally distributed in daily increments over ,-_7 weeks or longer) to
szngle dose (i day) required to produce the same probability of response
is -..2.3.
Table 3-60
Suggested Absorbed Doses a of Reference Radiation for Production
of Late Skin Necrosis.
(After Langham (ed.}-NAS-NRC (145))
k- . -.
I'ROB=.BILIT'I OF HIEH'INT_NSITY FRACTIONATIED OR
:_1_,I'O_,S£ _IN6LE (] -DA_) DOSE I'ROTRAC[LD DOS[ b
percent) (rads) (fads)
l 0 2,000 4.600
5(I 2 ._;(_0 6.400
9(J 3.600 8,200
a, Point of interest for dose estimation, 0.1 mm depth; area exposed <150 cm 2.
b. Dose protracted over 7 weeks or longer.
The late skin effects are very sensitive to the LET factor. Fast neutrons
are at least 3 to 5 times as effectlve as Z00-kVp x-rays in producing late
radiation sequelae and even more effectzve in producing late responses than
early ones (265). It is suggested that the QF in Table 3-Z be used for late
skin effects and that an area effectiveness factor (Fa) of 1.25 for areas
>150 cm 2 be used in risk evaluations. The recommended dose protraction
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factor Fpr is I for protraction times of 7 weeks and longer and the For
linearly increases to 2.3 with decrea'sing time to l day. Equation (it)may
be used to calculate the RES for late effects with these QF and Fpr factors.
As an example, if the space-radiation dose (D) to an area of> 150cm Z accumu-
lated (in approximately daily increments) during a mission of 7 weeks or
longer (Fpr = I) is 1,000 rads of radiation with an average QF L of 3, the
RES would be 3,750 reu. Comparison of this value with the fractionated
dose-response relationship indicated in Table 3-60 (on the basis of I reu = I
rad of reference radiation) suggests about a 3 percent probability of necrosis
or chronic radiodermatitis. If fractionated more or less equally over 25
days (Fpr = 1.65), the probability of necrosis would be of the order of 50
percent (RES = 6,200 reu). In this case, however, the appearance of early
skin responses would definitely have been mission-limiting. In evaluating
risk from late skin effects, it should be kept in mind that from 5 to 25 percent
of cases of chronic radiodermatitis (in small areas) progress to the malignant
stage, and that the area damaged may have a considerable influence on the
probability of malignancy since the number of potential cells exposed to
malignan_ conversion is proportional to area. It is not clear if there is a
specific body site which shows predilection to chronic necrosis or malignant
change (204, 273).
General Life-Shortening and Carcino_enesls
Life -shortening
A convincing body of data indicates that a statistical sample of an animal
population exposed to radiation has a shorter median life expectancy than
does an unirradiated sample of the same population. The data further show
that the degree of life-shortening is a function of accumulated dose. If a
group of animals receives a dose of radiation insufficient to cause early
lethality, the animals appear to recover completely. Blood counts return to
normal, gastrointestinal symptoms disappear, and weight returns practically
to normal. Organ function tests, such as liver or kidney, are within normal
limits. Nevertheless, on a statistical basis, these animals die sooner than
their unirradiated controls (64, [Zl, 133, 137, 145, 152, 196, 261). Gen-
erally, no new or different disease syndromes have been observed as late
effects in irradiated animals, and all causes of death so far studied, with only
minor exceptions, are accelerated by radiation. Symptoms of delayed radia-
tion effects appear to be so much like those of aging that the syndrome has
often been termed "radiation-induced aging, " and typical signs of aging con-
firm this impression.
There is little reason to doubt that radiation exposure would have the
same qualitative effect on life expectancy and general well-being of man.
With regard to space crews, selection of dose limits for early effects
automatically establishes certain probabilities of general life-shortening
and other late responses, and forces consideration of placing limits on the
associated actuarial risks as they would apply to long-duration missions
and space-flight careers. No definitive data exist on the radiation dose-
response relationship for general life-shortening in man, but useful data may
eventually result from the Atomic Bomb Casualty Commission's studies of
the Japanese atorr_ic-bomb survivors. At present, however, it is necessary
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to rely almost entirely on anlmal observations, tenuous extrapolation from
experimental animals to man, and limited data on the mortality rates of
several age-cohorts of American radiologists.
The degree of life-shortening caused by a single radiation dose delivered
to young adult rats or mice is nearly a straight-line functlon of dose. There -._ .
is a decrease in mean survival time of about 0.04z/0/rad with a range of _....
0.01_0/rad to 0. 10%/rad. If it is assumed that the percentage of life-span _-'.
decrement per rad is the same in all species, then a single high-intensity :-. " : ' ::
dose of I rad of x or gamma radiation would have a statistical life-shortening - : . _.i
effect in man of _i0 days (45). Alternatively, if it is assumed that the . " . "
slngle-exposure LDs0 dose for man is 300 rads and that equal fractions of the
LD50 for the different species produce the same percentage life-span loss, a
high-intensity absorbed dose of l rad at the midline would have a life-shorten- •
ing effect in man of,,_20 days (65). It may be assumed also that flight crews -
(in the 30- to 40-year age interval) at the time of exposure will have only
about one half their life expectancy at risk. On this basis, the life-shorten-
ing effect per rad may be modified downward from the above values. A con-
troversy exlsts over the methods of extrapolation from animals to man and
over whether life-shortening from single high-intensity exposure increases
linearly or nonlinearlvwith increasing dose(152, 229). It can probablybe assumed
arbitrarily for space-flight applications that the actuarial risk from high-intensity
exposure to radiations with an LET of 3, 5 keV/_and below is of the order of
i0 days/rad {145). About four times more gamma radiation is required at
low dose rate than at high dose rate to produce comparable statistical life-
shortening in mice. Application of a factor of 4 to the assumed life-shorten-
ing value of_ I0 days/rad for high-intensity exposure in man gives a statis-
tical decrement of,-_Z. 5 days/rad for low-dose-rate exposure. This value is in
general agreement with other estimates which have been made for man of I day/
rad for continuous exposure at dose rates not in excess of _0. 5 rad/day (86).
Ifthe dose rate is increasedabove 0. 5tol rad/day its effectiveness on life-short-
ening may be expected to increase, finally reachinga figure about four time the
low-dose-rate value when the dose is received promptly. The dividing line
between acute and chronic exposure is not known, but there is almost certainly
a gradual transltion from one to the other. Present knowledge of rate-
dependence of life-shortening effects would hardly seem to justify attempts
to refine the quantitative influence of dose protraction and fractionation
beyond that given above. Table 3-61 and Figure 3-6Z show the suggestion of
the NAS-NRC Panel on dose protraction factors in life-shortening (145).
Comparison of fisslon neutron vs. gamma ray or x-ray effects suggest
that the life-shortening effectiveness of low-LET radiation is more highly
dose-rate dependent than high-LET radiation (145). The RBE of low-LET
neutrons increases from Z to I0 as protraction is prolonged (145). For the
typical space proton dose and dose rate behind nominal shielding at the
probable site of the life-shortening effect, the bone marrow, a QF = l can
probably be assumed (3, 105, 106, 145). Table 3-63 represents a current
estimate of quality factor for high-LET radiation of cosmic ray type (Z43).
Applying upper limit estimates to total body dose for man of 40 m rad/day
and [20 m reins/day for Z-; incidence of the full galactic flux at solar minimum,
it can be calculated that the life of a crewman will be shortened by about
i/4 a day for every day he spends in space under these conditions (238, Z45).
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Table 3-61
Suggested Reference Radiation Dose-Response Relationships for General
Life.Shortening and Increased Incidence of Leukemia
(After Langnam (ed.]-NAS-NRC (145))
I i(,11. ,TENSIT_ I,O_-I_TI NSITY
REgPONSE EXPOSURE a EXPOS(IRE b
Life Shortening C _ 10 dass/rad _3 da_,-s/rad
Leukem_ C 2-4 per lO' man-yr/rad 1-2 per I0 _ roan-_ r/rad
a. Assumed to be 50 rads/day and greater.
b. Assumed to be 1 rad/day and less.
c. Site of interest for dose estimation, 5 cm depth; whole-body exposure.
2O
a: 18
<
o 14
z
z 12
u.
J
/D _::HIGHINTENSITY (=50 RAD
: ..,': ._-'_' "_ 2 i _3"_'_ LOi IN:E hlilTy {_16 RAIDID_' i 8
ACCUMULATED DOSE (hundredl of RADS)
Figure 3-62
Relationship of Accumulated Dose and ntensiW of Reference-Quality
Whole-Body Radiation to Life-Shortening Probability
(After Langham (ed.)-NAS-N RC (145))
Table 3-63
Estimates for Life-Shortening of Man from Exposure to High-LET Ionizing Radiation
(After Schaefer (243))
k _.-
k
T),pe of Rad;atlon
Life _orteninB, days/rod
Acute Exposure Chronic Exposure
Low LET
(Electrons, x-or gamma roys) 12 3
High LET
(Low-E protons or neutrons,
medium and high-E heavy nuclei) 24 24
Extremely high LET
("Microbe_ms" of heavy nuclei *
ender$) ? ?
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The induction of leukemia and other neoplastic diseases contributes
L
specifically to the statistical life-shortening effect of cumulative radiation ....
exposure (IZI). Although this problem has been under study since the early i : _ : _ _
1900's there are still very few quantitative dose-response data available for . :" '_ '_:_
man. This is not due entirely to lack of information, but rather, to the _ i _ •
complex statistical and actuarial aspects of the problem Since no new or
unique types of cancer are produced by irradiation, one must seek d_fferences : _ j
in either the age of appearance, the frequency of occurrence, or both. Since _!S_I'_-!!i_i'iImost causes of death are increasing exponentially with age beyond young !:i 'i_/i iadulthood, it becomes difficult to be certain without careful statistical analysis i i
when a change in frequency may be attributed to some factor other than sheer
chance. In addition, most human data involve fairly small groups-at-risk,
and, therefore, the probability of detecting a significant age-specific death i:i_/ ,_ _- _ , :
rate for a given malignancy is very small. The present Atomic Bomb
Casualty Commission (ABCC) studies exemplify many of these statistical -. ii
difficultie s.
Leukemia is one neoplastic disease that characteristically occurs sig-
nificantly earlier in life in irradiated populations than in nonirradiated
populations and, depending upon dose, at a significantly higher percentage
(121, 277). Several studies have substantiated the higher-than-average
number of deaths from leukemia in irradiated human populations. The most
significant data are those obtained from the survivors of the Hiroshima and
Nagasaki bombings (12, 40). Exposure in both cities involved prompt
weapon-quality gamma radiation with some fission neutrons, the neutron
component being higher in Hiroshima. The predicted excess death rate lies
between one and two deaths per million exposed per rad per year (I to Z
per 106 man-years/rad). According to present indications, this rate is
likely to be maintained for at least 15 to Z0 years after exposure.
All other epidemiologic studies of irradiated adult humans also give
strong evidence of man's sensitivity to the leukemogenic effect of ionizing
radiation (277). These studies include a group of adult British males given
therapeutic irradiation of the spine for ankylosing spondylitis (58), the study
of professional radiologists, and the evaluation of Danish cancer registry
data (84). Virtually all induced leukemias are of either the acute granulo-
cytic, acute lymphocytic, or chronic granulocytic forms. The incidence of
chronic lymphocytic leukemia is not detectably increased by radiation.
Recent suggestions that the incidence of multiple myeloma, lymphosarcoma,
and Hodgkin's disease is higher among the proximally irradiated Japanese
(within 1,400 m of the hypocenter) should be noted with caution, since only
between one and four such cases have been observed (5). However, a survey
of leukemia deaths among U.S. radiologists, does offer evidence in support
of a significantly increased mortality ratio from multiple myeloma (151).
The latent periods for acute forms of leukemia and for chronic leukemia
have been fairly well defined as 1 to 5 years and I to I0 years, respectively
(85). The duration of an elevated death rate from leukemia is not absolutely
defined and may or may not exceed 15 years (31, 58).
There is evidence from several sources that radiation to the thyroid and
pituitary gland may increase incidence of thyroid adenomas and carcinoma
(7, 8, 9, 155, 212, 257, 272). The dose-response relationship is not clear.
i _i _• ¸ /
• .• i," _
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Although risk estimates for thyroid cancer have been made for the case of
children exposed to single doses, no valid estimate is available for the
irradiated adult. The estimate for children is similar to the leukemia risk
(about l per I06 man-years/rad), but the negative data for adults suggest
that the risk may be somewhat lower for that group (145).
The evidence for skin cancer has been covered above. Osteogenic
sarcoma also appears to follow radiation. The present consensus is that, if
no complicating bone pathology is present, at least 3,000 to 4,000 rads are
required to induce bone cancer (33, 132). No risk factor can be derived
from the data s_nce they are based on case-history reports and not on
epidemiologic surveys. For the same reason, the minimum sarcoma-
inducing dose cannot be considered definite. Many other unfrequent tumors
have been reported in following radiation of man and animals (145). For
example, the ratio of mortality from all cancers among U. S. radiologists
is 40 percent higher than among a non-exposed medical-specialty group (252).
Unfortunately dose-response relationships are not clear.
IJ_the case of neutron irradiation of high LET, there appears to be much
less recovery of chromosome damage and a concomitant higher RBE for
tumor formation (64). High LET radiations have not unequivocally demon-
strated a higher tumor induction rate than that normally associated with
their acute or chronic lethal effectiveness. Soviet studies suggest that pro-
tons may have a higher carcinogenic effect in small rodents than equivalent
doses of x-ray or gamma radiation (Z70). Until more specific knowledge is
available, it is recommended that the QF-LET relationship proposed by the
NCRP (Table 3-2) be used to estimate the risk of malignant disease following
exposure to space radiations. The dose rate sensitivity of carcinogenesis
appears to be greater than that for life-shortening (40, IZI, ZSZ). However,
the exact protraction factors are far from clear. Table 3-61 and Figure 3-64
present the proposed relationship for space radiations. Since none of the
human data are sufficiently accurate or extensive to favor any one of the dose
response models over the other, the simplest linear relationship has been
accepted as adequately descriptive of existing data, although it should be
appreciated that the present evidence for man and animals does not generally
support simple linearity (46, 47, 151). In view of these uncertainties in
dose-response curves, any errors in risk estimate will tend to be in the
conservative direction (that is, to overestimate response), particularly at
doses below i00 fads (145).
The organ specificity, region, area, and volume factors for carcino-
genesis are far from clear. Organs in children appear generally more
sensitive than those in adults. Astronaut age of predominantly 30 to 40
will certainly reduce the probability of thyroid neoplasia, may reduce the
possibility of cancer involving the skeletal, connective, and integun-.entary
tissues, but is not likely to modify the probability of leukemia.
Since the relationships of Table 3-61 and Figures 3-6Z, 3-63, and 3-64
may be modified by such factors as radiation quality, dose distribution, and
dose rate, any attempt to refine risk evaluations by adjusting the space-
radiation dose to give reference-equivalent space exposure (RES) is probably
an unjustified refinement in view of the large uncertainties in the dose-response
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Relationship of Accumulated Dose and Intensity
of Reference Quality Whole-Body Radiation
to Increased Probability of Leukemia.
(After Langham (ed.)-NAS-NRC (145))
.-,• . . - - . . .
• ~ ,: . . _.
_.• .
• ._ .-
.r,
relationships. It is possible, however, to make such adjustments of RES and
to record chronologically the life-shortening and leukemia-risk status of a
flight crew in a manner analogous to that suggested for progressive bone
marrow injury, using Equation (i0) and Figure 3-53. If it is assumed that
the effective tissue depth for generalized late effects is 5 cm, QF L of the
major space radiations {inside current spacecraft shielding) for production
of life-shortening and leukemia will be approximately unity. QFL, however,
may be estimated from the calculated local LET using Equation (i). A
dose-rate accumulation-effectiveness factor (RFA)for each daily-dose incre-
ment may be taken from Figure 3-53. To evaluate the probabilities of life-
shortening and increased leukemia incidence, it is necessary only to multiply
RES (reu) for each daily increment by the respective probability values for
low-intensity reference-radiation exposure shown zn Table 3-61 and sum the
incremental probabilities.
• -... "_
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Genetic Manifestations
The reports of the National Research Council Committee on Genetic
Effects of Atomic Radiation present a clear review of general knowledge of
the genetic effects of radiation exposure and stress the responsibility of all
public and private agencies to keep the radiation dose to the population below
their recommended value of 10 rads/generation, or about 0.3 fads/year
(145, 180). Subsequent recommendations by the International Commission
on Radiological Protection suggest a dose of 5 rads in 30 years, or about
0. 17 rad/year (IZl). The potential radiation exposure of astronaut crews
should not make a significant contribution to this average per capita figure
(145). The individual astronaut will undoubtedly be subject to gonad doses
well above those normally allowed persons operating under the exposure
limits established for routzne occupational radiation hazards. The concept
of permissible dose as that which entails a negligible risk of severe somatic
or genetic injury has to be set aside when considering the space-radiation
problem (145, 2Z7). Even so, knowledge of the radiation dose received by
the gonads permits an estimate of the probability of mutation in the spermato-
gonial cells and of its expression in the offspring. Such a calculation assumes
3 -78
. < . . • . ,
- : - j
:easonable knowledge of the following parameters (the values given in
_arentheses are based largely on animal data):
1. The mutation rate per rad/gene (U = 5 x 10 -8)
Z. The number of genes per haploid set (n = 104 )
3. The probability of expression of the new mutation in the
first generation heterozygote (s = 5 x I0 "Z)
The gonad dose (D).
For example, assumlng a dose of I00 rads,
(5 x to -8) (to 4) (5 x 10 -z) (10 z)= Z. Sx 10 -3
,vould be the probability of a new mutation in the immediate offspring. Such
probability statements must be accepted with considerable reserve, but they
_o serve to indicate that the genetic risk to the individual astronaut is not
_nacceptably high (145). Since the mutation rate in the advanced germinal
:ell stages of the mouse is twice or three times that observed in the
spermatogonia, it can be recommended that conception of offspring be
:Lvoided during the postflight period in which irradiated postgonial cell stages
are still present (227).
Dose rate and fractionation effects are not yet clear (Z25, 227}. Low
dose-rate exposures are not as effective as high-intensity exposures in
inducing mutations. In mice, the difference may be a factor of 4 to I0 and
apparently is operative at dose rates of less than 0. i to 1.0 rad/min. How-
ever, this dose-rate dependence is observed only in the immature germ
cells, not in spermatozoa. This finding is consistent with the concept that
metabolic activity is a prerequislte to repair and that low dose-rate exposure,
as with somatic injury, permits concurrent repair in conjunction with less
damage to repair mechanisms (172). Present data on the effects of fractiona-
tion are limited to studies on mice using high dose rates and exposure inter-
vals where high mutagenic sensitivity is known to exist. This sensitivity
itself is of some concern, however, since existing data suggest that a fractiona-
tion interval of about 1 day causes the response to a second exposure to be
greater than the normal expectation for that dose (224). Widely fractionated,
low dose-rate exposures (comparable to most in-flight possibilities} would
probably have approximately the same mutagenic effects as continuous expo-
sures to low dose rates, but these rate and interval parameters have not yet
been tested. There is a significant increase in quality factor with increasing
LET, especially in protracted exposures, but the exact relationship is not
clear {226, Z51).
As a general operating principle for the next few decades, the NAS-NRC
Panel believes that the probability of such late responses as general life-
shortening and increased likelihood of malignancy may be considered of
secondary importance in evaluating the risks of manned space flight (145).
This attitude contrasts sharply with the manner in which occupational risks
are evaluated, where late effects are of primary importance. The relative
sizes of the astronaut and occupational groups provide the major reason for
attaching less importance to late effects of radiation. The astronaut population
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may be about 30 to 50; occupational groups may comprise hundreds of
thousands of humans. Such late radiation injury is measured in statistical
terms - an increase in age-specific death rate, a reduction of after-
expectation of life, an increase in incidence of malignancy. Nevertheless,
an awareness must be maintained in respect to the astronaut population of
the late somatic and genetic manifestations of radiation injury. As noted /
earlier, selection of acceptable RES values for short-term responses of the •
gastrointestinal and hematopoietic systems will automatically entrain certain .
probabilities for occurrence of leukemia, generalized life-shortening, and : _i i
other late manifestations.
Establishment of a career dose appears premature. If establishment of
such a dose is a necessity then some value or set of organ-specific values
must be established as acceptable integrated annual dose increments. Previous
attempts along this line have been made, but have been thought by others to
provide unrealistically low values that have no meaning or relationship to the
biological effects they are designed to protect against (I04, 147, Zl0). There
is no obvious interim approach to the problem of developing radiation guides
for evaluating long-term risk without also establishing career-exposure
limits. Since a lack of both radiobiological knowledge and operating experience
precludes the establishment of such dose limits at the present time, an
alternate suggestion is offered as an approach to the question of general life-
shortening. The long-term radiation risk may be compared with the accepted
risks associated with piloting high-performance aircraft. It has been esti-
mated that the latter occupation is characterized by a life-shortening probability_
of approximately I0 years. If this risk is assumed to be additive with the
radiation hazards, the question then becomes how much additional probability '-
of life-shortening may be acceptable. This is covered in the section on dose :
limits, below. .....
Soviet approaches to radiation safety in space flight have been reviewed
(19Z).
SECONDARY FACTORS IN RADIATION INJURY
Environmental Factors
A number of environment factors in space flight having potential inter-
action with radiation differ markedly from normal terrestrial conditions.
These include weightlessness, a pure-oxygen environment, periods of vibra-
tion and thermal load, and brief periods of excessive g loads. Unfortunately,
there are few data on these interactions in humans. Animal studies suggest
the interactions noted in Table 3-65. In this table, additive means slmple
summation of effects; synergistic means an interaction that produces a greater
than additive effect; antagonistlc means an interaction that produces a less
than additive effect; and neutral means no detectable effect of the nonradiation
stress alone or in combination. Synergistic potentials predominate and
suggest that the conservative end of any proposed radiation dose-effect range
should probably be used for first approximations in the hazards analysis.
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Though animal data supporting these conclusions are available, it should be
stated that this Table represents a tentative appraisal of the problem and will
require revision as new data are made available (145, Z94).
A synergistic factor frequently raised in considering the design of
radiation shielding is the effect of space-cabin atmosphere (ZZZ). A parallel
has been drawn between the mechanism of tissue damage seen in oxidation
syndromes that follow radiation (221). High pressure of oxygen has been
Table 3-65
Summary of Stress Combinations and Types of Interactions
(After Langham {ed.)-NAS-NRC (145))
.* - . - .
Rad_a t*on noise
R ad hit _on-h _ lmlh('rmia
Kad_a _on--h_, perlncrmn_
Radiauo_-h_ poxla
Radia _ion-h ypcroxia
Ra<halion physiological [aclors
Radiation-emotional [aclors
Rad_ation-_ ibratlon
Kadiation-accclera tion
Radiat ion-weighlle_snes_
Radiation-veslibu]:lr lact oJs
Radia tion-em_rgeno s*t uatlons
"three-st res5 interactions
Neufra[ {o synergnst/c
Neutral Io s',nerglsllc
Neutral Io _',nerg[slic
Svncigl_t*c (ant_gonlsl*¢ [or o.|v hrie[
periods during exposure)
Nc-utral to additive
_vnergistic
Indel_nninate
Nculra| to additive" to synergistic
Antagonistic to neutral to _,_nergistl¢
Additive lo synergistic
Neutral to _dclilive
Neu{ral to synergistic
Indeterminate
used to sensitize tissue to radiation during x-ray therapy for cancer (107).
Protective effects of antiradiation drugs against oxygen toxicity have also
been shown. At present there appears to be no requirement for the alteratlon
of shielding calculations due to the presence of 5 psia - I00_/0 oxygen in
future space-cabin atmospheres. However, several studies suggest that
some synergism may be present. It has been shown that mice exposed to
750 r of gamma radiation from cobalt 60 given at 90 r/min have a survival
about 10% lower in 5 psia - I00°/o oxygen than in air (23). At 900 r given at
a rate of 38 r/rain, the synergism was much less. On the other hand, mice
exposed to 800 r of 250 kVp x-rays at only 14 r/min have shown no synergism
with 5 psia - 100% oxygen (136). The type, total dose, and the dose rate of
radiation may be significant variables in these studies of synergism. In tissue
culture, at least, there is a steady reduction of the oxygen effect with increase
stopping power until its apparent abolition by radiation> than 3000 MeV/cml/g
(271). The exact stopping power at which the OP effect becomes undetectable
in intact animals or isolated cells has not been established. Further research
along this line is needed.
Alteration of the vestibular apparatus after human exposure to radiation
has Teceived recent study (176). Such alteration may play a significant role
in degrading astronaut performance in zero g or during reentry and certainly
requires further study.
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Anti-radiation Therapy
The potential use of anti-radiation compounds in space operations has
been recently reviewed (13, 16, 48, 145). The amino-thiols have received
the most study and appear to be quite promising (13). However, the doses
i _
calculated as required for human protection are well within the human toxic _ _i
range and can provide little protection against chronic or continuous radiation _
(13, 149, 193, Z33, Z65, 269, Z76, 279). Much more data are required on !_ i _ i•i_ii•_ 'toxicity mechanisms in humans. Maximum dose reduction for lethality is
about 1.7 or 1.8, but this factor is much lower for other end points, i
Other drugs such as PAPP and serotonin appear to be less effective
than the amino-thiols, especially against radiation of high LET. Both MEA
and PAPP protect mice against 440 MeV protons (203). Combination of
different drug types has been tried with slightly more success than with in-
dividual drugs (165, 194, Z69, Z79, Z83, 291). Combinations tend to alleviate
the toxicity problem but certainly do not solve it.
Post-irradiation therapy consists of antinauseant and vomiting drugs
(130, 143), intravenous fluids, anti-microbial agents, and supportive care.
Leukocytes from leukemia patients (94) and bone marrow (6, 36, 59, 164)
have been used with variable success in humans. The case for using auto-
logous marrow in space operations has also been reviewed (48). Problems
in obtaining sufficient amounts from each astronaut and the training of crews
for administration of the marrow are superimposed on the basic storage
difficulties. Cryogenic storage of blood and marrow in space is under con-
sideration (173, 219).
Treatment of the irradiated skin with topical and oral cortisone has been
tried with little success in relief of discomfort in early or late phases. In
vlew of its penetrability and anti-radiation properties, the drug DMSO may
offer some promise as a topical prophylactic against skin reactions (48).
In view of the lag times in arrival of solar flare particles after early
electromagnetic warning signals and knowledge of the power-flux-time
spectra of flares, it may be possible to predict the magnitude of integrated
exposure expected during a flare from measurements made early in that
same flare (93). In the future, prophylaxis with improved protective agents
may well be tailored on a flare-by-flare basis. At the present state-of-the-
art, however, prophylactic agents should not be entered into the basic hazard
analysis even for acute flare exposures.
Performance After Radiation
The literature on the effects of radiation on the nervous system and
behavior is large and complex (97, III, llZ, 145, Z17, Z8Z). The Soviet
literature indicates many reflex changes In animals following radiation but
the significance of parallel changes in humans is not clear (156, 287). Damage
to the nervous system may even be the primary cause of death at very high
dose levels (See Figure 3-37). The quantification of specific behavioral effects
is confused by the prodromal syndrome which, by itself, can have profound
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effects on behavior and yet may not involve irradiation of the central nervous
system (see Table 3-36 and Figures 3-38 to 3-4Z). Whole body exposures of
100 to 130 rads of reference quality radiatlon can give fatigue, apathy, dizzi-
ness, headache, and depression which seriously alter behavior (150, 174, Z07).
Low doses of x-ray down to I0 rads can be detected by behavioral responses
in some animals (98).
Observation of trained primates suggests that limiting mechanisms in
each behavioral test may be key lactors in interpretation ol radlatlon ellects.
For example, protracted irradiation may tend to increase attentiveness to
the immediate field of concern by depressing attention to peripheral informa-
tion. Animals can continue to learn and can continue to express previously
learned behavior (i.e., retained their learning) during and after considerable
radiation to the head up to many hundreds or thousands of rads in short expo-
sures. It should be remembered, however, that although the tests used
involve fairly complex procedures they do not measure total performance
under a wide range of circumstances. Some neurological deficits which affect
behavior have followed exposure of the head to the higher doses just mentioned
- often with concomltant morphologic changes (145).
Short of prolonged interplanetary flight, the microbeams of galactic
radiation will probably not produce much of risk factor as far as brain, and
eye damage are concerned (145, Z99, 300). It is assumed the same holds
true for the audiovestibular mechanism, though this is far from clear (176).
Similar ignorance exists with respect to the retina where radiations of high
LET may cause irreversible damage.
RADIATION DOSE LIMITS IN SPACE OPERATIONS
According to the NAS-NRC Panel, the rationale for an independent review
of radiation protection in specific space flights should be reflected in the
following points (145):
I. Radiation is only one of many recognized and accepted
potential risks that may jeopardize the success of any
flight mission.
Z. Individual astronauts are carefully selected for their
special skills and motivation. The application of
existing standards of radiation safety established for
large, occupationally exposed groups would unduly
limit the ability of this small group of specialists to
achieve their objectives.
3. The parameters of some space-radiation risks cannot
be precisely predicted; therefore, optimal protective
measures will not always be available or even feasible.
Since any radiation shielding will add to the weight of
a spacecraft, the reduction in risk to be achieved by
the shielding must be balanced against the other uses
to which this weight might have been put.
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/. Since flight missions may vary in both duratlon and
radiation exposure, the probability and importance of
the radiation risk compared with those of other risks
must be taken into account for each specific mission.
A risk-versus-gain philosophy is most appropriate
for this comparison, and the philosophy is particularly
useful for evaluation of radiation risk. The latter is
generally a cumulative one that should not require an
urgent all-or-nothing type of decision as had been
previously proposed (29, 101).
Risk Analysis
In view of this proposed risk versus gain philosophy and judgment, it is
expected that the results of this judgment will probably vary for each mission.
It has been suggested that the space radiation hazards and risks be evaluated
in the following terms (145):
i. Immediate or early performance decrement (early
responses) occurring within a few hours to one month
following a major exposure.
Z. Progressively increasing performance decrement or
serious loss of performance over long periods of
flight as a result of an accumulating exposure (pro-
gressive injury to the blood-forming system).
3. Probability of delayed or chronic radiation response
that may require interrupting a planned series of
flights and which may limit an astronaut's career.
Within each of these categories, the significant clinical symptomatology
or responses must be defined on the basis of importance to crew safety and
mission success. The relative significance of responses will be mission-
dependent. The following suggestions may assist in identification of the
important responses and in evaluation of their significance for each specific
mission.
I. Any amount of radiation exposure should be considered
as potentially detrimental and, therefore, the exposure
should be kept at a minimum consistent with the risk
versus gain philosophy.
Z. Radiation guides should be set below the level that might
result in an unacceptable probability of in-flight response
capable of jeopardizing crew safety.
3. Elapsed time between recurrent or repeat use of an
individual or crew should take into consideration the
nature and extent of previous exposure, the predicted
exposure risk of the contemplated mission, and the
degree to which mission success may depend on
individual or crew experience.
L:
:
7•! •• •
i_:•• • . -
] • •
%• •
3-84
r_
.
.
The dose or doses established for early effects auto-
matically entails acceptance of certain probabilities
of occurrence of generalized life shortening, leukemia,
and other late manifestations.
The radiation responses may be subdivided into
"in-flight" and 'post-flight" categories. Although this
subdivision is somewhat arbitrary, it is time-dependent
and may be important under special circumstances, for
which certain higher risks may be acceptable if it is
clear that the latent period for expression of injury will
automatically cause the response to occur post-flight.
In view of the above operational requirements and hazards analysis, it
has been suggested that any radiation exposure that might exceed the dose
limits set for the misslon may be permitted if the concomitant risk incurred
by action to avoid the radiation fields or to protect oneself against the potential
injury is determined to be greater than the hazard associated with the excess
radiation dose. There is no immediately obvious way of approaching the
problem of setting limits for the long-term effects that does not also imply
certain career-dose limits and the lack of operating experience precludes
establishing a firm committment here.
As a first order approach to permit test of the trajectories for the AAP
program, the radiation exposure levels have been suggested according to the
following provisional operational criteria (208):
Planning Operational Dose (POD): The dose which should not be exceeded
without requiring a mission modification of some degree. The degree of
modification will be a function of the magnitude of the excess dose and will be
formulated by mission rules. This dose will be used for mission planning
purposes to determine if proposed trajectories and time lines are acceptable.
Maximum Operational Dose (MOD): The dose which should not be
exceeded without specific modification of the mission to prevent further
radiation exposure. Such an exposure would be considered to result in a
potentially harmful in-flight response in terms of crew safety and post-flight
response in terms of delayed radiation injury.
In establishing the POD and MOD limits it has been suggested that each
response and its effect on the mission and crew are considered independently,
and no adjustments are made for known or suspected uncertainties in radio-
biological data, shielding calculations, or environmental data. As an example
of this approach, the preliminary radiation limits for Apollo Applications
Program are presented. Current recommendations for radiation exposure
guidelines for missions of 30-60 days only are listed. It should be emphasized
that the radiation units shown are for use in early planning of the AAP Program
and will be updated as better knowledge becomes available.
The doses are expressed in rads of a reference radiation taken to be
equivalent to 250 kVp x-rays whose mean LET is _3.5 key/micron of track
length in wet tissue. No radiation QF or RBE has been applied.
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The following doses found in Table 3-66 have been established on the
assumption that the crew will be exposed to small increments of dose on each
orbit and no allowance is made for pulses of radiation received at higher
intensities. (See Section on Progressive Performance Decrement).
Table 3-66
Provisional Radiation Dose Limits Suggested for Preliminary
Evaluation of a 30-60 Day Mission
(After Grahn (208))
Tls sue Depth POD MOD
Skin 0.1 nlJT 1.5 rads/day 5 fads/day
Eye 3.0 mlr [.25 raos/da, 2.5 rads/da_,
I
Bon_ !
Nlarr_w 5.0 cn ] 0. o rads_da_, l.O raQ day
.. • " ...
Dosimetry for Characterizatlon of Space Radiation Exposure (145)
From a physical point of view, the type of radiation, flux density, and
energy spectrum completely define the radiation field which produces a
biological change. From a biological point of view, however, it is the energy
transferred by this field to the biological entity under consideration which is
most important. When the physics of interactions between tissues and
incident radiations are known, then the physical specification suffices, although
in many instances computer programs are required to apply such physical k
knowledge. The most logical choice for space radiation monitoring, in view
of the above difficulty, appears to be a tissue-equivalent system (49, 83, 119,
1 27, 175).
The problems associated with radiation monitoring of a manned space
flight must, in other words, be clearly distinguished from the acquisition
of geophysical data or of information aimed primarily at computation of
shielding requirements. The chief requirement is for an instrument which
will yield a direct indication of absorbed dose in tissue in real time. Such a
requirement rules out instruments which are only capable of measuring flux
or even flux plus energy distribution because of the complexity of using such
data to provide dosimetric information. The dependence on geometrical
variatlon, angular incidence, self-shielding, lack of accurate physical data
on interaction properties between the radiation and tissue, plus the degree of
complexity of the computations themselves, tends to rule out this method.
It seems reasonable to conclude that knowledge of the physical characteristics
of the radiation environment, although it may provide data for other scientific
or engineering purposes, is not immediately applicable to radiation monitor-
ing. Such information, therefore, should be gathered and treated separately
from the problem of crew safety. For the latter problem, a practical approach
to a detector whose atomic composition Is as close as possible to that of
tissue and whose response is proportional to energy absorbed, rather than to
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flux density, appears to be the best course to follow, even within the limitations
and compromises necessary (15).
The NAS-NRC Panel has suggested that the development of such a system
should take two lines of approach (145). First, a system to supply both rate
and total absorbed dose in rads as a function of mission time should be en-
gineered for space vehicle application. Absorbed dose should be determined
in such a manner as to supply values at superficial points and at critical
depths in the body. Second, a tissue-equivalent system for determining the
energy absorbed per event in a representative tissue volume centered at the
points where absorbed dose has been measured should be developed on a
simplified basis so that energy deposited per event can be classified into
several broad LET groups. Total absorbed dose and dose rate should be
displayed and weighted in accordance with LET distribution if the situation
warrants. Absorbed dose, dose rate in rads, and LET groups should be
recorded for future reference.
Dose should obviously then be defined in terms of rads, and preferably
it should be measured in a tissue-equivalent system at at least three levels,
including 0, 5 and possibly i0 cm in equivalent tissue depth, if possible,
doses should be measured at the 0. 1 mm and 3 cm levels noted in Table 3-66.
Accuracy of these determinations should be no less than ±15 percent, if
compromise is required, it would then seem that at least two measurements
should be made: one at the equivalent level of the skin and a second at about
5 cm, assuming it to be the mean depth of the bone marrow. The spanning
measurements suggested above are statistically better but probably would
invoke a greater weight penalty and instrument sophistication. A practical
approach to the solution of this problem is under development (83).
A very important question that has been debated repeatedly concerns
the alternative whether the radiation field inside the vehicle should be probed
with stationary sensors distributed throughout the ship or whether micro-
sensors on the bodies of the crew members should be given preference. It
could be argued in favor of the first alternative that stationary sensors would
free the crewman from additional gear in his space suit. Furthermore, such
sensors could be of greater weight and bulk, thereby allowing a more elaborate
analysis of the local radiation level. In favor of the second alternative,
sensors on the body would indicate the radiation level exactly at the location
where it counts. It is even conceivable that the differential reading of a pair
of sensors on the chest and back would provide a crude measure of depth-
dose. However, the validity of the data beyond a measure of local surface
doses is open to question. Multiple sensors do allow estlmation of the
general homogeneity of the dose and could be used to estimate the degree of
partial body exposure for risk analyses (Z70). The main argument in favor
of sensors on the body naturally rests in the advantage that it would cover all
contingencies of each individual's activity. In terms of the Lunar Mission,
surface dosimeters require no changes or adjustments whether the individual
is in the heavily shielded Apollo vehicle or in the extremely light Lunar
Module, or is engaged in extravehicular activity. To be sure, for the last
named condition, it should be recognized that there are very high fluxes of
low-energy electrons and protons at many locations in the space environment.
These should be detected and measured on the outside of the vehicle prior to
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any outboard excursion, since they can potentially produce a very high surface
tissue dose.
A final question concerns the need of LET sensors as a component of
dosimetric instrumentation in space. In discussing the problem, measure-
ment of heavy nuclei is excluded. In its conventional interpretation, LET
defines the inhomogeneity in the distribution of the ionization events at the
microscopic level. The diameter of the ionization columns which heavy
nuclei produce in tissue exceeds the dimensions of a single cell, creating a
peculiar exposure pattern with a few cells exposed to very high doses and the
surrounding bulk of the cell population remaining entirely unaffected. It is
not generally agreed upon that the biological significance of this type of
exposure cannot be dealt with adequately in terms of the conventional LET
concept (236, 243). Some feel that the LET concept is still useful in this
context, and with the appropriate study, could be applied to the primary
galactic cosmic radiation (Z70). As has been indicated above, the dose of
microbeam radiation will probably not play a significant role in gross brain
or eye damage in most space missions of less than l year duration (145).
However, one must keep in mind the irreversible nature of the lesions in such
areas as the gonads, lens and retina from very high-LET radiation (270).
If heavy nuclei are excluded, the LET problem appears only of limited
importance for the remaining types of ionizing agents represented in the
galactic radiation beam (243). The two main components of the primary
galactic beam (i.e., protons and alpha particles) produce LET values exceed-
ing those of standard x-rays only at energies from a few MeV down to the
Bragg peak. These energies are not represented at all in the incident beam.
Low-energy protons and alpha particles originate only locally in nuclear
disintegrations in absorbing material. It should be remembered that the
spectacular multipronged disintegration stars which cosmic-ray primaries
release in collisions with silver and bromine nuclei of nuclear emulsions are
absent in materials made up of low Z components such as living tissue. The
number of prongs per star in these substances is small and the star frequency
low; hence, terminating protons and alpha particles contribute only insignificant-
ly to total ionization dose. Since the remainlng dose of the galactic beam is
produced mainly by protons of very high energies, the question could be
raised whether a QF considerably smaller than i would not be applicable to
the total absorbed dose from the galactic beam. (See Table 3-16 and Figure
3 -17).
The situation is different for the proton and alpha fluxes of solar particle
beams. Protons and alpha particles reaching the end of their ionlzation
ranges (so-called "enders") contribute noticeably to the total ionization dose
in systems of medium-light shielding (1.5 g/cmZ) and become the predominant
contributors to the total dose in the skin and subcutaneous tissue behind low
shielding. Under the latter conditions, calculation suggests a QF of 4 to 5
for late effects from combined proton and alpha particle dose to a depth of a
few mm. On the other hand, it is not possible to say unequivocally whether
these very special conditions would justify the great complications which a
separate determination of LET would introduce in dosimetric instrumentation.
Since the conditions in question occur only under conditions of low shielding
and are always accompanied by a very steep drop in absorbed dose in the first
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mm, it is possible that measurement of dose in rads with application of a
suitable Q_" factor to the skin dose would suffice. (See Figure 3-25).
Dose Limits for Ground Personnel
Maximum permissible radiation doses in adult radiation workers and
ground personnel as recommended by the Federal Radiation Council (88) are:
Type of exposure Condition Dose (rem)
Radiation worker:
(a) Whole body, head and
trunk, active blood-
forming organs,
gonads, or lens of
eye.
(b) Skin of whole body and
thyroid
(c) Hands and forearms,
feet and ankles.
Accumulated dose 5 times number of years
beyond age 18
13 weeks 3
Year 30
13 weeks 10
Year 75
13 weeks Z5
(d) Other organs Year 15
If it is not feasible to govern exposures to internal emitters by applying air-
borne radioactivity concentration standards, the following radiation protection
standards can apply: (ZSI)
Type of exposure
Whole body, active blood-
forming organs, gonads.
Thyroid
Bone
Condition
Year
13 weeks
Year
13 weeks
Other organs Year
13 weeks
Dose (rem)
5
3
30
i0
Body burden of 0. |
microgram of radium-
ZZ6 or its biological
equivalent *
15
5
_ Exposure must be governed so that the individual's body burden does not
exceed this value l) when averaged over any period of IZ consecutive months
and Z) after 50 years of occupational exposure.
The quality factor for calculating rem values applicable to low dose
exposure and risk of late effects in occupational exposure are given in
Table 3-Z (41).
A Radiological Safety Handbook for the John F. Kennedy Space Center
is available (186). Data are available on the hazards of radioisotope thermo-
electric generators for remote stations around the world ([87).
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